,Document,Topic,Name,CustomName,Representation,KeyBERT,Llama2,MMR,Representative_Docs,Top_n_words,Probability,Representative_document
0,"federica picarello, phd, postdoctoral researcher and psychologist, king's college, london, spoke about fatigue mechanisms in patients with ms based on presentations from the ec trims congress.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
1,ectrims 2022: dimethyl fumarate demonstrates benefit in people with radiologically isolated syndrome multiple sclerosis,12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,False
2,novel risk allele identified as the first genome-wide significant genetic modifier of ms severity adil harroud () shares the results of his work on genetic contributions to ms severity: ec trims #neurology #neurotwitter multiple sclerosis,16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,1.0,False
3,reliable. innovation. community. just a few words our participants used to describe ectrims in this year's highlight video. a humble reminder that we will continue to aim for excellence as we serve the ms community learn more about our mission,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,1.0,False
4,"ec trims the investigational immunotherapy ata188 continues to ease disability and prevent brain tissue shrinkage in people with progressive forms of ms, according to the data, now reaching up to four years, on patients in an ongoing clinical trial.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
5,"ec trims - treatment with #tecfidera significantly reduces the risk of experiencing the first multiple sclerosis symptoms in adults with radiologically isolated syndrome, according to data from a phase 4 clinical trial. multiple sclerosis msresearch",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
6,in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims,18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,1.0,True
7,"at the 2022 congress, october 26-28, in amsterdam, the netherlands, multiple analyses from the phase 3 n-momentum trial of inebilizumab () were presented. ec trims ms view:",12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,False
8,"ec trims - remyelination, or regeneration of the myelin sheath thats progressively damaged and lost in multiple sclerosis, may be less effective for those who develop ms later in life, new research suggests. msresearch multiple sclerosis msnews",24,24_disease progression_late_onset_sclerosis news today,Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair,"['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'remyelination', 'multiple sclerosis', 'msresearch ec trims', 'sclerosis news today', 'sclerosis', 'today ec trims', 'msnews', 'msresearch', 'disease progression', 'new research', 'onset', 'today ec', 'cis', 'disease', 'multiple', 'progression']","['Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair', '', '', '', '', '', '', '', '', '']","['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms', 'ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch', 'ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today']",disease progression - late - onset - sclerosis news today - news today - multiple sclerosis news - sclerosis news - progression - news - msnews - disease - today ec trims - today ec - later - cis - life - suggests - effective - sclerosis msnews - multiple sclerosis msnews,1.0,False
9,ectrims 2022: progression independent of relapse activity occurs less often in pediatric-onset than adult-onset ms multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
10,"ec trims - an infection with the epstein-barr virus consistently preceded elevations in neurofilament light chain, an early biomarker of nerve cell damage, in people who went on to develop multiple sclerosis, new data show. #ebvandms msnews",18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,1.0,False
11,via : focusing only on processing speed during an assessment could hinder the identification and treatment of cognitive impairments in patients with ms: ec trims multiple sclerosis #neurologytoday #neurotwitter,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
12,"in an early trial, investigational treatment ata188 stabilized or eased disability in most people with non-active, progressive forms of ms for up to four years. multiple sclerosis msnews msawareness msresearch ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
13,"in the same appointment that my ms specialist diagnosed me with ms, he also asked me what my goals were. he has referred back to those goals in his notes a few times when talking about treatments and symptom mitigation. i'm glad he thought to ask.",10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,1.0,False
14,via : hematopoietic stem cell transplantation performed as well as or better on some disease-modifying therapies in patients with relapsing-remitting ms: ec trims multiple sclerosis #neurologytoday #neurotwitter,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.8873856968761091,False
15,multiple sclerosis controversies escalation strategy vs. high-efficacy dmts at early stages: what is preferable and for who? jaume sastre-garriga of discusses: ec trims #neurology #neurotwitter ms,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,1.0,False
16,hey that's me! thanks for having me at ec trims and ms took a lot from me but it also gave me the #idgaf attitude that i needed to pursue my dream of becoming an independent (copy)writer,31,31_ec trims great_trims great_really_face,Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis,"['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['ec trims great', 'day ec trims', 'ec trims', 'day ec', 'ec', 'enjoyed', 'remyelination', 'community', 'colleagues', 'meeting', 'shared', 'thanks', 'meet', 'looking forward', 'new', 'trims', 'wonderful', 'sharing', 'great', 'scientific']","['Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['completely blown away by the city of canals and ec trims . what a great conference, we had a fantastic time. cant wait for next year! #neurology multiple sclerosis', 'it was a week full of scientific and clinical discussions at ec trims . it was great to meet face to face again and have lively relevant discussions. i was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in ms.', 'last day ec trims already. great reconnecting with global colleagues and sharing advancements for those living with ms. looking forward to continuing the conversation:']",ec trims great - trims great - really - face - great - day ec - day ec trims - day - having - gave - wonderful - enjoyed - morning - way - needed - like - colleagues - thanks - trims - ec trims,1.0,False
17,"findings suggest that rituximab a cancer treatment that can be used off-label for ms cannot be considered as good as ocrevus, despite their similar mechanism of action. multiple sclerosis msnews msawareness msresearch ec trims",23,23_ocrelizumab_ocrevus_real_relapse,Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.,"['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ocrelizumab', 'ocrevus', 'msnews', 'ec trims22', 'disease modifying', 'today ec trims', 'trims22', 'patients relapsing', 'efficacy', 'evidence', 'relapsing remitting', 'relapses', 'vs', 'today ec', 'patients', 'effects', 'relapse', 'reducing', 'late breaking', 'relapsing']","['Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.', '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract', 'since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>', 'we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims']",ocrelizumab - ocrevus - real - relapse - vs - showed - world - relapses - relapsing - therapy - efficacy - msnews - safety - study - patients - patients relapsing - today ec trims - ec trims22 - effects - trims22,1.0,False
18,ectrims 2022: rituximab tied to more relapses in rrms than ocrelizumab multiple sclerosis,23,23_ocrelizumab_ocrevus_real_relapse,Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.,"['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ocrelizumab', 'ocrevus', 'msnews', 'ec trims22', 'disease modifying', 'today ec trims', 'trims22', 'patients relapsing', 'efficacy', 'evidence', 'relapsing remitting', 'relapses', 'vs', 'today ec', 'patients', 'effects', 'relapse', 'reducing', 'late breaking', 'relapsing']","['Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.', '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract', 'since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>', 'we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims']",ocrelizumab - ocrevus - real - relapse - vs - showed - world - relapses - relapsing - therapy - efficacy - msnews - safety - study - patients - patients relapsing - today ec trims - ec trims22 - effects - trims22,0.8197016084933665,False
19,"ebv is a suspect in the development of multiple sclerosis (ms), and recent research developments have strengthened that connection. ec trims #pedstwitter",18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,0.6068028187594631,False
20,how can i get my neurologist to understand what i need? chat with and at turn on notifications to watch the full video live with us on 15/11/22 at 16:30 gmt #wehavems ms,17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,0.8821804158241748,False
21,"the associate professor of neurology at the university of california, san francisco, discussed the key points from an oral presentation at ec trims on understanding postpartum for patients with ms and #nmosd.",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.643282784273539,False
22,did you know there were different types of relapses? nadas journey continues as she learns of the differing impact of relapses in people with neuromyelitis optica spectrum disorder and multiple sclerosis ec trims #nmosd multiple sclerosis,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.9787948294641727,False
23,this is one of our top three editorial picks from ec trims: ahsct is better than gilenya and tysabri at preventing relapses in people with highly active rrms. multiple sclerosis msnews msawareness msresearch ec trims,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.7745755394550322,False
24,"ebv is a suspect in the development of multiple sclerosis, and recent research developments have strengthened that connection. ec trims #medtwitter",18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,0.483348590626777,False
25,"an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #medtwitter",26,26_cognitive_reduced_therapy_based,Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients,"['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['progressive ms', 'ms multiple sclerosis', 'patients ms', 'ms multiple', 'ms', 'cognitive', 'cognition', 'interventions', 'neurotwitter', 'new research', 'therapy', 'treatment', 'rehabilitation', 'reduced', 'reduce', 'research', 'symptoms', 'patient', 'trials', 'trims']","['Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients', '', '', '', '', '', '', '', '', '']","['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #neurotwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #psychtwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #medtwitter']",cognitive - reduced - therapy - based - symptoms - shows - compared - cognition - new research - patients ms - treatment - patients - trial - ms - patient - new - interventions - evolving - center - understanding,1.0,True
26,long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,True
27,"ms/ptsd did the way your doctor tell u you had ms lead to you having post traumatic stress disorder (ptsd)? , ec trims , ,,,, here is h mah's insightful piece:",10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,1.0,False
28,"ebv is a suspect in the development of multiple sclerosis, and recent research developments have strengthened that connection. ec trims #neurotwitter",18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,0.5971290480005489,False
29,experimental therapy ublituximab works better than aubagio at easing disability independently of relapses and at reducing overall disease activity in adults with relapsing forms of ms. multiple sclerosis msnews msawareness msresearch ec trims,12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,False
30,"audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms",24,24_disease progression_late_onset_sclerosis news today,Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair,"['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'remyelination', 'multiple sclerosis', 'msresearch ec trims', 'sclerosis news today', 'sclerosis', 'today ec trims', 'msnews', 'msresearch', 'disease progression', 'new research', 'onset', 'today ec', 'cis', 'disease', 'multiple', 'progression']","['Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair', '', '', '', '', '', '', '', '', '']","['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms', 'ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch', 'ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today']",disease progression - late - onset - sclerosis news today - news today - multiple sclerosis news - sclerosis news - progression - news - msnews - disease - today ec trims - today ec - later - cis - life - suggests - effective - sclerosis msnews - multiple sclerosis msnews,1.0,True
31,"nondisabling relapses that occur early in the course of relapsing-remitting multiple sclerosis signal faster accumulation of disability relative to no early relapses, new research suggests. ec trims",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
32,please join and myself tonight from 6pm gmt to discuss some highlights ec trims ms you will be able to speak up!,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
33,this is one of our top three editorial picks from ec trims: tecfidera can reduce the risk of experiencing the first ms symptoms in adults with radiologically isolated syndrome. multiple sclerosis msnews msawareness msresearch ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
34,"an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #psychtwitter",26,26_cognitive_reduced_therapy_based,Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients,"['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['progressive ms', 'ms multiple sclerosis', 'patients ms', 'ms multiple', 'ms', 'cognitive', 'cognition', 'interventions', 'neurotwitter', 'new research', 'therapy', 'treatment', 'rehabilitation', 'reduced', 'reduce', 'research', 'symptoms', 'patient', 'trials', 'trims']","['Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients', '', '', '', '', '', '', '', '', '']","['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #neurotwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #psychtwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #medtwitter']",cognitive - reduced - therapy - based - symptoms - shows - compared - cognition - new research - patients ms - treatment - patients - trial - ms - patient - new - interventions - evolving - center - understanding,1.0,True
35,"ec trims disability progression in the absence of relapses is less common in children and adolescents with multiple sclerosis than among people with adult-onset disease, according to data covering more than 5,000 patients with relapsing forms of ms.",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
36,one study has suggested that recently diagnosed ms patients with two forms of chronic active brain lesions on their mri scans experience greater disability progression. multiple sclerosis msnews msawareness msresearch ec trims,3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,0.7891014725896449,False
37,is anyone on #tysabri considering switching to #ocrevus following the recent data from ec trims ?,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.4924378393578914,False
38,stem cell transplant is better than gilenya and tysabri at preventing relapses and reducing disability in people with highly active rrms. it also appears to be as effective as ocrevus. multiple sclerosis msnews msawareness msresearch ec trims,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.9386844719417332,False
39,the future & the present for some. ms #multidisciplinary #centerthepatient #icymi ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
40,no but on ectrims was presented study comparing hsct vs natalizumab for progressive ms,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,1.0,False
41,"nasal administration of #foralumab showed positive clinical effects for 2 patients with nonactive #secondaryprogressivemultiplesclerosis (#spms), according to findings presented at the congress of the mscommunity ms multiple sclerosis ec trims",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.42495115524781474,False
42,"ec trims - #ocrevus, an anti-cd20 therapy developed by genentech, seems to be superior to rituximab at lowering relapse rates among patients with relapsing-remitting multiple sclerosis, according to data from two large ms registries. msnews",23,23_ocrelizumab_ocrevus_real_relapse,Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.,"['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ocrelizumab', 'ocrevus', 'msnews', 'ec trims22', 'disease modifying', 'today ec trims', 'trims22', 'patients relapsing', 'efficacy', 'evidence', 'relapsing remitting', 'relapses', 'vs', 'today ec', 'patients', 'effects', 'relapse', 'reducing', 'late breaking', 'relapsing']","['Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.', '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract', 'since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>', 'we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims']",ocrelizumab - ocrevus - real - relapse - vs - showed - world - relapses - relapsing - therapy - efficacy - msnews - safety - study - patients - patients relapsing - today ec trims - ec trims22 - effects - trims22,0.7728838824632431,False
43,ectrims 2022: early nondisabling relapses tied to risk for disability accumulation in relapsing-remitting ms multiple sclerosis,12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,0.8882215940289364,False
44,ec trims highlights from national ms society.,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,1.0,False
45,many thanks for your interest in becoming a #mri in multiple sclerosis expert! we all hope you will enjoy this winterschool.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
46,"an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #neurotwitter",26,26_cognitive_reduced_therapy_based,Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients,"['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['progressive ms', 'ms multiple sclerosis', 'patients ms', 'ms multiple', 'ms', 'cognitive', 'cognition', 'interventions', 'neurotwitter', 'new research', 'therapy', 'treatment', 'rehabilitation', 'reduced', 'reduce', 'research', 'symptoms', 'patient', 'trials', 'trims']","['Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients', '', '', '', '', '', '', '', '', '']","['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #neurotwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #psychtwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #medtwitter']",cognitive - reduced - therapy - based - symptoms - shows - compared - cognition - new research - patients ms - treatment - patients - trial - ms - patient - new - interventions - evolving - center - understanding,1.0,True
47,"biomarkers, diet, progressive ms, and epstein-barr virus were among research news shared at ectrims, the worlds largest msresearch conference. check out highlights: .",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.6578294951248705,False
48,"at this year's ectrims congress, marisa mcginley of sat down with us to discuss how telehealth and digital measures can help with monitoring the progression of patients with ms. watch here:",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,1.0,False
49,ec trims targeting ebv key in progressive ms: experts | ata188 may be 'game changing' treatment for non-active forms | multiple sclerosis news today,18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,0.3115653029980684,False
50,"what are the 'do's' and 'don'ts' of having a baby when you live with multiple sclerosis? you'll be surprised by the answers from neurologist, dr rhonda voskuhl of multiple sclerosis ec trims",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
51,"thank you for having me along with the 70 students from over 50 countries! what a privilege to learn about all things #mri to accurately diagnose, evaluate effectiveness of treatment and monitor progression of ms.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
52,"& warmly welcome all participants to the 1st winterschool on #mri in diagnosis, prognosis and treatment monitoring of multiple sclerosis where i have the pleasure & honor to serve as local organizer together with",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
53,"is hsct really that good? this analysis at ec trims (unrandomized) found hsct is better than gilenya but similar in efficacy to ocrevus and tysabri (in relapses, disability progression), though improvement was more common with hsct.",5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.7611506403383504,False
54,"early use of dmts among people with spms may lead to overall lower levels of disability. however, staying on treatment does not appear to significantly slow disability progression over time. multiple sclerosis msnews msawareness msresearch ec trims",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,0.8846592133064388,False
55,"this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,1.0,True
56,"ec trims - long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of multiple sclerosis continues to maintain ms relapse rates, and keep mri lesion activity low. msnews msresearch mstreatments #rrms ms",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
57,ec trims - long-term treatment with #gilenya continues to be safe and lower the rate of relapses in children and adolescents with multiple sclerosis more than #avonex (interferon beta-1a) does. mstreatments msresearch multiple sclerosis,3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,0.7189552093998781,False
58,fantastic to see of our ms research flagship virtually present his work about employment transitions in people with multiple sclerosis on the world stage,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
59,"we were in amsterdam last week, attending ec trims -- the largest ms research conference in the world. today, executive vp of research, dr. bruce bebo, shares the research and presentations that got his attention. multiple sclerosis",16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,0.3170894041792723,False
60,ec trims smartphone tap speed may help in monitoring ms: tap speed or how quickly one types on a smartphone keyboard may be a useful tool for monitoring ms severity and detecting the transition to a progressive form of the disease. msnews,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
61,"there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis",16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,0.38208164572614256,True
62,ectrims 2022: behavioral interventions may help alleviate cognitive problems in ms multiple sclerosis,26,26_cognitive_reduced_therapy_based,Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients,"['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['progressive ms', 'ms multiple sclerosis', 'patients ms', 'ms multiple', 'ms', 'cognitive', 'cognition', 'interventions', 'neurotwitter', 'new research', 'therapy', 'treatment', 'rehabilitation', 'reduced', 'reduce', 'research', 'symptoms', 'patient', 'trials', 'trims']","['Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients', '', '', '', '', '', '', '', '', '']","['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #neurotwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #psychtwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #medtwitter']",cognitive - reduced - therapy - based - symptoms - shows - compared - cognition - new research - patients ms - treatment - patients - trial - ms - patient - new - interventions - evolving - center - understanding,1.0,False
63,"ec trims - exposure to high-efficacy disease-modifying therapies is associated with an increased risk of cervical abnormalities in women with multiple sclerosis, recent data suggest. msresearch msnews multiple sclerosis ms msawareness",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
64,tecfidera reduces the risk of patients experiencing the first ms symptoms in adults with radiologically isolated syndrome when patients have ms-like lesions on mri scans but lack symptoms. multiple sclerosis msnews msawareness msresearch ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
65,"ec trims - genetic variants in genes mostly active in the brain and spinal cord the central nervous system are associated with the severity of ms, and linked to a faster accrual of disability and greater signs of brain tissue damage. msnews",16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,1.0,False
66,"scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis",16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,1.0,True
67,"ibudilast has a significant beneficial effect on slowly evolving lesions in patients with progressive ms, new data suggest. ec trims",12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,False
68,"at ec trims, riley bove, md, sat down with us to discuss the safety profiles of anti-cd20 therapies for women with ms who may be pregnant. listen in to her thoughts",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.511827187714907,False
69,ectrims 2022: disease-modifying therapy effects diminish in secondary progressive ms multiple sclerosis,12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,False
70,"columnist ed tobias discusses the week's top ms news, which includes a new study on ocrevus and details about why stopping a dmt could be risky. multiple sclerosis msnews msawareness msresearch ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
71,"ec trims - treatment with #ocrevus before or during pregnancy does not seem to increase the risk of major pregnancy or infant complications, with 79% of the pregnancies leading to live births, according to data from more than 2,000 women with ms.",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
72,ec trims vumerity lowers rrms activity over 2 years | multiple sclerosis news today,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
73,"ec trims evobrutinib reduces ms relapses over 3 years | long-term use of ms therapy candidate safe, effective: trial data | multiple sclerosis news today",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
74,"""we thought that progression in ms was something that happened later on in the disease. but more & more we are seeing that this is a process that in fact starts much earlier: ectrims president from #sciencepodcast",21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,0.6705687605641408,False
75,"new research confirms the importance of covid-19 mrna booster doses for patients with ms who are receiving the anti-cd20 monoclonal antibody ocrelizumab, as currently recommended. ec trims #neurotwitter",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.8409885886343279,False
76,"ec trims - columnist ed tobias comments on the week's top ms news, including important reports from this year's ectrims conference. msresearch msnews mscommunity ec trims mstreatments msawareness",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
77,"treatment with vitamin d was shown to be unsuccessful in preventing cis from developing into ms. executive evp of research, dr. bruce bebo, discusses the research and presentations that got his attention at ec trims multiple sclerosis",16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,0.4248777694626568,False
78,have you seen our videos from yet? we spoke to last week to bring you the latest on the most efficacious treatments for multiple sclerosis ec trims,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.5599678802596,False
79,"bruce cree, md, phd, mas, faan, discussed the need for measures that track disease progression in #nmosd, and the shift in focus similar to the multiple sclerosis field. ec trims ms watch:",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,1.0,False
80,"dimethyl fumarate could delay or even prevent clinical symptoms in patients with radiologically isolated syndrome, the earliest detected preclinical phase of multiple sclerosis. ec trims",12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,False
81,people who achieved confirmed disability improvement with investigational immunotherapy ata188 also showed potential signs of remyelination. multiple sclerosis msnews msawareness msresearch ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
82,"ec trims: fertility treatments do not significantly increase the risk of relapse in women with ms, even among those who undergo treatment protocols associated with greater levels of hormone exposure, according to a recent u.s.-based analysis.",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,0.9902402922642657,False
83,ec trims ocrevus superior to rituximab at reducing relapses in study | lower relapse rate found in patients on ocrevus vs. rituximab | multiple sclerosis news today,23,23_ocrelizumab_ocrevus_real_relapse,Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.,"['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ocrelizumab', 'ocrevus', 'msnews', 'ec trims22', 'disease modifying', 'today ec trims', 'trims22', 'patients relapsing', 'efficacy', 'evidence', 'relapsing remitting', 'relapses', 'vs', 'today ec', 'patients', 'effects', 'relapse', 'reducing', 'late breaking', 'relapsing']","['Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.', '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract', 'since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>', 'we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims']",ocrelizumab - ocrevus - real - relapse - vs - showed - world - relapses - relapsing - therapy - efficacy - msnews - safety - study - patients - patients relapsing - today ec trims - ec trims22 - effects - trims22,1.0,False
84,ec trims job prospects can gradually decline after cis diagnosis | study: job prospects lower among cis patients who progress to ms | multiple sclerosis news today,24,24_disease progression_late_onset_sclerosis news today,Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair,"['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'remyelination', 'multiple sclerosis', 'msresearch ec trims', 'sclerosis news today', 'sclerosis', 'today ec trims', 'msnews', 'msresearch', 'disease progression', 'new research', 'onset', 'today ec', 'cis', 'disease', 'multiple', 'progression']","['Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair', '', '', '', '', '', '', '', '', '']","['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms', 'ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch', 'ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today']",disease progression - late - onset - sclerosis news today - news today - multiple sclerosis news - sclerosis news - progression - news - msnews - disease - today ec trims - today ec - later - cis - life - suggests - effective - sclerosis msnews - multiple sclerosis msnews,1.0,False
85,"we had a great time last week; sharing the latest data, research and innovations that have the potential to improve outcomes for people living with ms. check out our highlights video below! ec trims",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.6314428141426506,False
86,"if you didn't get a chance to see us at ec trims last week, you can now read our poster on remote web-based assessment of #cognition for people with multiple sclerosis:",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
87,"happy friday! ive got a brand new #mindmoments for you! this time, were highlighting some of the hot topics and conversations from ec trims, featuring a number of experts in multiple sclerosis. listen here",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
88,a big thank you to everyone at and the amazing speakers who made the meeting so interesting! ec trims was a brilliant opportunity to share the new developments in msresearch. check out interviews from the meeting at ms multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
89,mentioned the key advances in understanding how to navigate the postpartum period for patients with ms and the types of data she would like to see conducted in the future in this field. ec trims ec trims watch:,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.4308959663447519,False
90,no magic cure in the sunshine vitamin then early reports from ectrims suggest vitamin d supplements do not reduce ongoing ms disease activity,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
91,"laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:",15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,1.0,True
92,"ec trims - ocrevus safely and effectively reduces disease activity in people with early-stage relapsing-remitting multiple sclerosis, trial data show. multiple sclerosis msnews msawareness msresearch",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
93,"bruce cree, md, clinical research director of the ucsf multiple sclerosis center provided insight on an abstract from ectrims 2022 regarding inebilizumabs mechanism of action to prevent nmosd attacks. watch here",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,1.0,False
94,"exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,True
95,"there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis",16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,0.40728458035711607,True
96,"ec trims - for women with multiple sclerosis in the u.s., fertility treatment was not associated with an increased ms relapse risk, a study found. multiple sclerosis msnews msawareness msresearch",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,0.9528915588410292,False
97,ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch,3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,True
98,"'s ocrevus stole the show at last months meeting, particularly in relapsing-remitting ms. #genentech #roche ec trims",22,22_present_ocrevus_ocrelizumab_ectrims 2022,Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.,"['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['ocrelizumab', 'ectrims 2022', 'multiple sclerosis', 'ocrevus', 'remitting ms', 'relapsing remitting ms', 'sclerosis', 'ectrims', 'ms', '2022', 'disease activity', 'oct', 'research', 'new', 'results', 'data', 'disease', 'relapsing remitting', 'multiple', 'patients']","['Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.', '', '', '', '', '', '', '', '', '']","['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -', '$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022', '$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022']",present - ocrevus - ocrelizumab - ectrims 2022 - 2022 - new - data - ectrims - research - sclerosis - multiple sclerosis - multiple - center - remitting ms - relapsing remitting ms - significant - relapsing remitting - remitting - disease activity - meeting,0.3208897885520701,False
99,ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch,18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,1.0,True
100,is haematopoietic stem cell transplantation the most effective treatment for multiple sclerosis? hears about the latest clinical trials from prof richard nicholas of during #hsct #stemcells,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.9304868133859889,False
101,"ec trims - new research suggests that remyelination, or regeneration of the myelin sheath thats progressively damaged in ms, may be less effective for those who develop the condition later in life. multiple sclerosis msnews msawareness msresearch",24,24_disease progression_late_onset_sclerosis news today,Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair,"['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'remyelination', 'multiple sclerosis', 'msresearch ec trims', 'sclerosis news today', 'sclerosis', 'today ec trims', 'msnews', 'msresearch', 'disease progression', 'new research', 'onset', 'today ec', 'cis', 'disease', 'multiple', 'progression']","['Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair', '', '', '', '', '', '', '', '', '']","['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms', 'ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch', 'ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today']",disease progression - late - onset - sclerosis news today - news today - multiple sclerosis news - sclerosis news - progression - news - msnews - disease - today ec trims - today ec - later - cis - life - suggests - effective - sclerosis msnews - multiple sclerosis msnews,1.0,False
102,genetic variants in genes mostly active in the brain and spinal cord have been linked to ms severity findings that will help prioritize the development of ms treatments. multiple sclerosis msnews msawareness msresearch ec trims,16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,1.0,False
103,favorite ec trims news for of : #genetics and progressive ms.,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.40254080802866243,False
104,"ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch",24,24_disease progression_late_onset_sclerosis news today,Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair,"['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'remyelination', 'multiple sclerosis', 'msresearch ec trims', 'sclerosis news today', 'sclerosis', 'today ec trims', 'msnews', 'msresearch', 'disease progression', 'new research', 'onset', 'today ec', 'cis', 'disease', 'multiple', 'progression']","['Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair', '', '', '', '', '', '', '', '', '']","['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms', 'ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch', 'ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today']",disease progression - late - onset - sclerosis news today - news today - multiple sclerosis news - sclerosis news - progression - news - msnews - disease - today ec trims - today ec - later - cis - life - suggests - effective - sclerosis msnews - multiple sclerosis msnews,1.0,True
105,"""the talk on the ability to connect the genetic underpinnings potentially around disease severity in progressive ms was really a breakthrough session that left me inspired"": from at ec trims listen now ec trimspodcast",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
106,ec trims - a slower tap speed on a smartphone keyboard was linked to greater disability and worse function in people with multiple sclerosis in a study. ec trims #news multiple sclerosis msnews msawareness msresearch,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
107,data from a meta-analysis of trials evaluating dietary approaches in ms showed that there are several effective approaches in reducing fatigue and improving physical and mental quality of life. multiple sclerosis ec trims view:,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
108,"ec trims - among people with ms, lower smartphone tapping speeds were linked to worse disability, poorer dexterity and walking abilities, and lower cognitive function. multiple sclerosis msnews msawareness msresearch",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
109,an open-label extension phase 2 trial showed that evobrutinib-treated patients with #rms had increased s1/s2 immunoglobuin (igg) antibody levels after being given two doses of the mrna #covid-19 vaccination. read:,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,1.0,False
110,"ec trims - in trial, tecfidera was found to significantly reduce the risk of first ms symptoms in adults with radiologically isolated syndrome. ec trims #news multiple sclerosis msnews msawareness msresearch",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
111,"ec trims - long-term gilenya use effectively continues to outperform avonex at lowering relapse rates in children and adolescents with ms, data show. ec trims #news multiple sclerosis msnews msawareness msresearch",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,0.7099102132546051,False
112,"ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch",18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,1.0,True
113,"ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,True
114,"ec trims - the higher cancer lesion risk seen in ms patients on high-efficacy dmts may be due to immunosuppression and exposure to hpv, scientists say. multiple sclerosis msnews msawareness msresearch",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
115,ec trims - new findings indicate that nearly 80% of people with early-stage rrms show no evidence of disease activity after two years of treatment with ocrevus. multiple sclerosis msnews msawareness msresearch,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
116,"ec trims - data on spms and ppms patients given ata188 for up to four years in embold trial show continued gains in disability scores, mri findings. multiple sclerosis msnews msawareness msresearch",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
117,ectrims2022 - cervical cancer risk and high-efficacy dmts | study finds elevated risk in ms patients | multiple sclerosis news today,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
118,"tomas kalincik, md, phd, discussed the role of stem cell transplantation as it gains popularity within the ms field. he also mentioned the progress previously made in terms of stem cell research and patients with ms. watch:",5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,1.0,False
119,dr rozanna meijboom presented her work on upper cervical spinal cord atrophy in early relapsing-remitting ms at ec trims #futurems #iwims,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.37433669657432156,False
120,why clinicians need to get better at delivering an ms diagnosis ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
121,"ec trims - progression independent of relapse activity (pira) also can be common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
122,"laurits taul madsen, phd student at aarhus university provided insight on his study presented at ec trims congress on an innovative way using neuromuscular measures to discriminate those with ms at high risk for falls. watch:",15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,1.0,False
123,"columnist ed tobias comments on the week's top ms news, including important reports from this year's ectrims conference. #columns ec trims #themswireacolumnbyedtobias",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
124,ec trims - new findings that identify genetic variants tied to faster multiple sclerosis progression may help 'prioritize' treatment development in ms. ec trims #news multiple sclerosis msnews msawareness msresearch,16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,1.0,False
125,ec trims tecfidera lowers risk of 1st symptoms in ris in trial:,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
126,"continuing treatment with two common ms medications during #pregnancy is associated with significantly lower relapse rates and few pregnancy-related complications, new research shows. ec trims",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
127,"ec trims - treatment with ocrevus before or during pregnancy does not appear to increase the risk of major complications, with 79% of the pregnancies leading to live births. multiple sclerosis msnews msawareness msresearch",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,0.9151373832196997,False
128,"at ec trims, tomas kalincik spoke on his research looking at stem cell transplantation and its efficacy vs previously approved dmts for ms.",5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,1.0,False
129,ec trims genetic variants tied to worse ms id'd in study | findings will help scientists to prioritize ms therapy development | multiple sclerosis news today,16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,1.0,False
130,"ms news notes: ectrims, ocrevus, kesimpta, epstein-barr, dmts | multiple sclerosis news today",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
131,"dr. beaber, did you see the null vitamin d trial in cis presented at ectrims: no benefit for 1,000iu/day 5,000iu/day 10,000iu/day compared to placebo over 48 weeks #vitamind multiple sclerosis ms",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
132,commonly asked questions about #ocrelizumab #ean2019 ec trims,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.5103624415461975,False
133,"it was amazing to see so many people from the global msresearch community come together last week for ec trims. representatives from 108 countries came together to share learnings, ideas and research findings. here are some photo highlights.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
134,have you caught up on the latest in remyelination? with and multiple sclerosis ec trims,27,27_remyelination_imaging_sclerosis_multiple sclerosis,Advancements and challenges in remyelination research for Multiple Sclerosis.,"['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['remyelination', 'trims multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'updates', 'latest', 'question', 'latest updates', 'neurotwitter', 'topic', 'ec trims multiple', 'highlights', 'evidence', 'hear', 'ec trims', 'trims', 'insights', 'therapies', 'multiple', 'ec']","['Advancements and challenges in remyelination research for Multiple Sclerosis.', '', '', '', '', '', '', '', '', '']","['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['have you caught up on the latest in remyelination? with and multiple sclerosis ec trims', 'live at ec trims | cristina granziera () shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice ms #neurotwitter multiple sclerosis', 'catherine lubetzki at ec trims : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at']",remyelination - imaging - sclerosis - multiple sclerosis - multiple - latest - question - latest updates - therapeutic - practice - shares - novel - updates - leading - evidence - hear - topic - live - insights - therapies,1.0,True
135,"thanks for spreading the word we've covered more trending topics in ms treatment and research from , including #hsct, high efficacy dmts and #fatigue",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
136,"since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>",23,23_ocrelizumab_ocrevus_real_relapse,Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.,"['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ocrelizumab', 'ocrevus', 'msnews', 'ec trims22', 'disease modifying', 'today ec trims', 'trims22', 'patients relapsing', 'efficacy', 'evidence', 'relapsing remitting', 'relapses', 'vs', 'today ec', 'patients', 'effects', 'relapse', 'reducing', 'late breaking', 'relapsing']","['Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.', '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract', 'since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>', 'we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims']",ocrelizumab - ocrevus - real - relapse - vs - showed - world - relapses - relapsing - therapy - efficacy - msnews - safety - study - patients - patients relapsing - today ec trims - ec trims22 - effects - trims22,1.0,True
137,"tjalf ziemssen, a good friend and colleague, gave me a personal copy of 'stay connected' a collection of hilarious and well-considered cartoons created by one of his patients about ms and its management. thank you. ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
138,"in a late-breaking poster at ectrims, data showed that rituximab failed to show noninferiority to ocrelizumab. additionally, the therapy had a higher annualized relapse rate ratio.",23,23_ocrelizumab_ocrevus_real_relapse,Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.,"['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ocrelizumab', 'ocrevus', 'msnews', 'ec trims22', 'disease modifying', 'today ec trims', 'trims22', 'patients relapsing', 'efficacy', 'evidence', 'relapsing remitting', 'relapses', 'vs', 'today ec', 'patients', 'effects', 'relapse', 'reducing', 'late breaking', 'relapsing']","['Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.', '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract', 'since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>', 'we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims']",ocrelizumab - ocrevus - real - relapse - vs - showed - world - relapses - relapsing - therapy - efficacy - msnews - safety - study - patients - patients relapsing - today ec trims - ec trims22 - effects - trims22,1.0,False
139,"in a late-breaking presentation in ectrims, data from the msbase international registry was suggestive of higher disability accumulation risk compared with those who did not experience relapse, in both treated and untreated patients with ms.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
140,"ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,True
141,"personalised dmt dosing - the future? pre-covid pandemic, it was thought tysabri/natalizumab shld be taken every 4 weeks. however neuro zoe van kempen at ec trims showed this could be pushed to 8 weeks - with no disease rebound. personalised dosing of ocrevus poss too.",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.7547537213000343,False
142,"today i had the honour of meeting of , & . he is an inspiration and will change the world for a better place with his research into ms multiple sclerosis #spms. ec trims $tlsa #tils #foralumab",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
143,how many people in this picture have multiple sclerosis?,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
144,how many of these people in the picture have multiple sclerosis? we do not need more dmd's we need research for cure ms.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
145,this double-blind placebo-controlled randomized study of #vitamind supplementation in high-risk #cis indicates that vitamin d supplementation is not an effective treatment to prevent development of #rrms. ec trims #icymi,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
146,'s top ec trims takeaways: 1. #ebv 2. bruton tyrosine kinase (#btk) inhibitors (btki) 3. radiologically-isolated syndrome (#ris) 4. ocrelizumab vs. rituximab 5. #ahsct vs. natalizumab 6. flipping the pyramid and smoldering ms (#timeisbrain) 7. #vitamind,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.39829532811334845,False
147,"#vitamind to ameliorate ms (#vidams) trial is a multicenter, randomized controlled, double blind trial: findings provide class i evidence that high dose vitamin d3supplementation, as add-on to ga therapy, does not reduce disease activity in established #rrms. ec trims #icymi",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
148,ectrims 2022: network lens could explain paradox in multiple sclerosis ec trims #neurology,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
149,"thank you and #amsterdam for hosting a well organized, very productive ec trims congress. we already look forward to attending ec trims2023 in #milan! #immunic $imux #scientificresearch msresearch",30,30_booth_brain_like_forward,Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.,"['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['ec trims', 'ec', 'updates', 'brain', 'latest updates', 'seen', 'trims', 'neurology', 'attending', 'meet', 'thank', 'attending ec', 'nmosd', 'tomorrow', 'insights', 'looking forward', 'visit', 'ec trims congress', 'forward', 'booth']","['Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.', '', '', '', '', '', '', '', '', '']","['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['we are with the north-european team at ec trims. please visit our booth and follow us for the latest updates on our treatments and pipeline. #sanofi #neurology ms', 'seen our eposters at ec trims yet? meet our co-authors, like thibo billiet at our booth and get the nitty gritty on #brain volume analysis in #mogad #nmosd & ms.', ""the ec trims has kicked off! please come for a 'brain break' to our booth #neurology #sanofi ms""]",booth - brain - like - forward - neurology - seen - latest updates - needs - catch - amsterdam - challenges - attending ec - mogad - updates - trims congress - ec trims congress - analysis - tomorrow - thank - attending,1.0,False
150,ectrims 2022: network lens could explain paradox in multiple sclerosis #biotech #pharma,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
151,"a huge congratulations to our medical student pavel, who presented a poster at the european committee for treatment and research in multiple sclerosis in amsterdam, the largest event dedicated to ms in the world! ec trims22",19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,1.0,False
152,early ms & the amsterdam temprano cohort: findings replicate previous that cognitive impairment is present in ~25% of patients #early after diagnosis & that #visuospatial memory problems are one of the first domains affected. ec trims #icymi,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
153,i think this is a great idea! i love to see more about the nuances of autoimmune disease on women including the impact of menopause ms #autoimmunedisease,10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,0.9904293207663944,False
154,how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims,15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,1.0,True
155,my ec trims highlights - it is all about flipping the pyramid and going beyond inflammatory disease activity and focusing on smouldering ms. the latter includes targeting ebv as a potential driver of ms disease activity. do you agree =>,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.8936835815800322,False
156,biogen #data at ectrims 2022 highlight innovation in #digitalhealth focused on advancing treatment & personalized care of people living with ms #ai #artificialintelligence #algorithm #ml #machinelearning #deeplearning #dl #neuroscience #healthcare #medtech,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,0.8526191147150346,False
157,professor alan thompson spoke at a patient meeting at the european committee for treatment and research in multiple sclerosis () conference in amsterdam on saturday. ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
158,ectrims2022. hsct is no better than current high efficay dmt,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.2299145036255697,False
159,"dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,1.0,True
160,discussed his takeaways from the #latebreaker study presented at 2022 . he spoke about a subgroup analysis from the open-label extension and his reactions to the findings. ec trims ms watch :,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
161,"my first thought. but not surprised as my ms neurologist effectively told me it was 'over', most cases were now mild & as i'm fully vaxxed i'll be fine. mmmmm.....",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
162,"bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms",9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.7876819748888056,True
163,", do, , shares her thoughts on #telehealth care, increasing access to care and addressing health disparities in the neurology field. ec trims ec trims ms",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
164,"new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,1.0,True
165,ec trims long-term gilenya reduces pediatric relapses | multiple sclerosis news today,3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,0.6895589585773343,False
166,"brenda branwell, md, , talks about her background with pediatric-onset ms and the transformation that she saw her patients go through over time with the disease. ec trims ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
167,"high-efficacy therapies for ms have improved disease outcomes for many patients, but there are concerns over long-term safety, and some physicians and patients remain wary of them. ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
168,"at the end of ec trims, our co-founder, brett drummond, & ceo, dr travis stiles, reviewed the final day. a key focus of this chat is the role of lipids in multiple sclerosis, exploring interesting & innovative work by prof .",14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,1.0,False
169,"how many people in this picture have multiple sclerosis? how about the new president? we need a cure ms!!. we need scientist working on a cure, we don't need more ""new"" dmd""s.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
170,how many people in this picture have multiple sclerosis? cure ms!!! we do not want more dmd's. promote hsct the only. option for remission.,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.10880588069622725,False
171,"continuing treatment with two common ms medications during pregnancy is associated with significantly lower relapse rates and few pregnancy-related complications, new research shows. ec trims",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
172,"to diagnose ms, the central vein sign on brain mri appears to work as well as oligoclonal bands in csf, and combining the two biomarkers yields the highest predictive value for ms, a new study indicates. ec trims",6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.48016878741430824,False
173,do you have multiple sclerosis?,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
174,cure ms!!! i wish the ms society/foundation would of been a champion for hsct. the only option for remission for us. dr.richard burt's book is available for pre-order. he's a great champion of hsct. the ms society told me i could die well at 53 had hsct & it saved my life.,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.35220972879530876,False
175,"a great pic of from our multiple sclerosis research flagship expertly presenting his research 'longitudinal transitions of employment status after a first episode of cns demyelination' from hobart, tasmania to attendees in amsterdam ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
176,falls are common in patients with ms and a new study suggests impairment in a specific aspect of neuromuscular function can identify those at highest risk. ec trims,15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,1.0,False
177,insight living well without multiple sclerosis so happens when ccsvi causative factor symptoms is treated with venous angioplasty symptoms of the unproven autoimmune theory ms often ease/disappear!!!,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.8936835815800322,False
178,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms | biogen - biogen,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,1.0,False
179,for years pregnancy has been an absent or rarely addressed topic in ms. this is changing & we now have many sessions on how to face pregnancy & integrate it into the patients journey: ectrims president listen on spotify,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,1.0,False
180,awaiting news & data from ec trims abot ms #exercise #research,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.9522068365665383,False
181,it is been a fantastic closing event for ec trims. thanks to helga weiland and for showing us the path we need to follow as a leading organization in multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
182,"big thanks to for bringing information to patients in a session dedicated for people with ms today! with more than 900 patricipants online and in person! with alan thompson, birgit de jong, helga weiland",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
183,"wellness service at amsterdam airport! 4 days of ec trims marathon. mastermind, do your thing! #meditation multiple sclerosis #wellbeing #livingwell",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
184,poster on the role of insula in modulating aerobic training effects in people with multiple sclerosis ec trims #rehab rai amsterdam,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.7362545462813592,False
185,"patients with relapsing-remitting ms treated with autologous hematopoietic stem cell transplantation were 74% more likely than those taking fingolimod to be relapse-free 1 year after treatment, a new study suggests. ec trims",5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.869797816313821,False
186,ec trims ebv antibodies precede nerve damage signs | developing ms triggered by ebv infection: study | multiple sclerosis news today,18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,1.0,False
187,ec trims smartphone tap speed may help to monitor ms | slower tapping on keyboard linked to worse ms disability: study | multiple sclerosis news today,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
188,1/2 in this poster presented at ec trims we show that ms patients treated with #cladribine tablets have sustained positive vaccine-specific serology response following the second and third vaccine dose of the bnt162b2 mrna vaccine.,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.7082906858334393,False
189,and that's a wrap for ec trims! it was invigorating to talk with visionaries from across the world about multiple sclerosis. braindates were a fun way to link up with folks with shared interests and missions. pumped for the joint ec trims - #actrims meeting in msmilan2023!,31,31_ec trims great_trims great_really_face,Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis,"['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['ec trims great', 'day ec trims', 'ec trims', 'day ec', 'ec', 'enjoyed', 'remyelination', 'community', 'colleagues', 'meeting', 'shared', 'thanks', 'meet', 'looking forward', 'new', 'trims', 'wonderful', 'sharing', 'great', 'scientific']","['Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['completely blown away by the city of canals and ec trims . what a great conference, we had a fantastic time. cant wait for next year! #neurology multiple sclerosis', 'it was a week full of scientific and clinical discussions at ec trims . it was great to meet face to face again and have lively relevant discussions. i was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in ms.', 'last day ec trims already. great reconnecting with global colleagues and sharing advancements for those living with ms. looking forward to continuing the conversation:']",ec trims great - trims great - really - face - great - day ec - day ec trims - day - having - gave - wonderful - enjoyed - morning - way - needed - like - colleagues - thanks - trims - ec trims,1.0,False
190,"in this ectrims podcast episode, ec trims president wraps up ec trims, offering insight on key topics & discussing new initiatives to expand learning opportunities for the msresearch community listen on apple podcasts",14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,1.0,False
191,team lni immensely enjoyed our first ever meeting over the past couple of days! amazing ms science was displayed and this was skillfully summarized by already looking forward to ec trimsmilan2023,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
192,'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims,10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,0.9138643221728328,True
193,"a big thank you to for their session this morning with highlights from the last 3 days for people living with ms, and also for including the #patientvoice with speakers helga weiland () and - very impactful!ec trims #plainlanguage",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
194,proud to have presented at the most important session of ec trims event for people with multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
195,"starting in 15mins, all the highlights from ec trims for people living with multiple sclerosis >>>",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
196,"progressive multiple sclerosis anti-inflammatory, antioxidant-rich diet + synbiotic supplementation reduced gut inflammation (faecal calprotectin) +'improved clinical manifestations' 6m randomized trial (n=69) ec trims ec trims #ppms #spms",8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
197,ectrims2022,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
198,its time to tailor therapy with mab! ec trims ec trims multiple sclerosis,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.6835062965051125,False
199,solution flghting for treatment cause of the symptoms of so called multiple sclerosis!!!,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
200,"an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,1.0,True
201,"the best talk, amazing, in my opinion, of ec trims congress: confavreux lecture: ""the future of neuropathology in ms"", by christine stadelmann nessler. the neuropathology is and will be the main driver of new visions of multiple sclerosis.",17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,0.7401846305334854,False
202,"cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims",15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,0.8831169967467499,False
203,data suggest that glial fibrillary acidic protein is a more useful biomarker for progression in multiple sclerosis compared with neurofilament light. ec trims ms view:,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
204,"cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter",15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,1.0,True
205,help facilitate research cerebrospinal venous blood flow baseline primary care option treating neurovascular disease like covid-19 and so called ms! longevity quality life depend! #bloodflowmatters #longcovid,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,1.0,False
206,future ms research needs. do you agree? ec trims,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,1.0,False
207,some ways to increase #cooperation to leverage #global understanding and move ms treatment forward. do you agree? ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
208,"disease management, from clinical studies utilizing viewmind's motor function and precision neurocognitive digital biomarkers. multiple sclerosis ec trims #precisionmedicine #healthcare #pharma",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
209,attending ec trims? join us for viewmind inc.'s poster presentations sharing our latest data on multiple sclerosis multiple sclerosis ec trims #precisionmedicine #healthcare #pharma,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
210,excellent talk by dr. bove about e-health in multiple sclerosis at the ec trims,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,1.0,False
211,ec trims awards! meier: serum glial fibrillary acidic protein compared w neurofilament light chain as biomarker for ms disease progression colombi: csf inflammatory profile in pts w chronic active lesions distinctive & consistent w innate & adaptive immune activation,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
212,"dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims",5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,1.0,True
213,#pediatric ms: #cognitive #impairment is associated with posterior & subcortical resting state functional connectivity abnormalities. b16evere rs fc reduction with worse cognitive scores; a16=maladaptive rs fc increase. maturationignificant impact. ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
214,dr darin okuda: ris radiologically isolated syndrome is the earliest detectable preclinical phase of ms - he looked at early treatment to prevent clinical onset of ms ec trims,12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,0.964848693265941,False
215,"completely blown away by the city of canals and ec trims . what a great conference, we had a fantastic time. cant wait for next year! #neurology multiple sclerosis",31,31_ec trims great_trims great_really_face,Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis,"['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['ec trims great', 'day ec trims', 'ec trims', 'day ec', 'ec', 'enjoyed', 'remyelination', 'community', 'colleagues', 'meeting', 'shared', 'thanks', 'meet', 'looking forward', 'new', 'trims', 'wonderful', 'sharing', 'great', 'scientific']","['Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['completely blown away by the city of canals and ec trims . what a great conference, we had a fantastic time. cant wait for next year! #neurology multiple sclerosis', 'it was a week full of scientific and clinical discussions at ec trims . it was great to meet face to face again and have lively relevant discussions. i was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in ms.', 'last day ec trims already. great reconnecting with global colleagues and sharing advancements for those living with ms. looking forward to continuing the conversation:']",ec trims great - trims great - really - face - great - day ec - day ec trims - day - having - gave - wonderful - enjoyed - morning - way - needed - like - colleagues - thanks - trims - ec trims,1.0,True
216,"impact of #environment factors on employment difficulties is disease-related factors. changes in attitudes of coworkers & workplace flexibility can enable people with ms to #work longer. ""you don't realize that you still have #value until somebody tells you."" ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
217,an important discussion on spinal cord atrophy in ms and our data on cervical spinal cord imaging in patients with ms ec trims,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.6703754301933222,False
218,"not bad, , for your first . thanks for bringing the latest research to the ms community! enjoyed finally meeting you in person, dom. loved talking to you about #remyelination with . keep up the advocacy!!!",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
219,"late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.",5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,1.0,True
220,we made a splash at ec trims this year! so thankful for all the wonderful colleagues i met at and also my incredible colleagues. #precisionmedicine multiple sclerosis #biomarkers #mri #patientcare #neuroscience #neurology,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
221,what a league table - well done barry & all #tweetms activists for keeping #ppie & colleagues in ms involved in ec trims see you soon,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
222,"at atara, we draw inspiration from those who face a daily battle against serious diseases. at , we presented a late-breaking poster highlighting open-label extension & imaging data for investigational ata188 in progressive forms of ms. more:",28,28_label_progressive multiple sclerosis_progressive multiple_presents,New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022.,"['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['progressive multiple sclerosis', 'multiple sclerosis', 'mri', 'ectrims 2022', 'progressive multiple', 'sclerosis', 'imaging', 'data', '2022', 'news', 'presented', 'ectrims', 'clinical', 'new', 'multiple', 'face', 'details', 'late breaking', 'progressive', 'study']","[""New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022."", '', '', '', '', '', '', '', '', '']","['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', '$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', 'atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 businesswire']",label - progressive multiple sclerosis - progressive multiple - presents - phase - progressive - study - mri - data - new - ectrims 2022 - ectrims - 2022 - forms - presented - details - central - catch - multiple sclerosis - sclerosis,1.0,False
223,great seeing everyone at ec trims! looking forward to implementing advancements from biomarker testing to ris treatment to our ms patients in the clinic. see u soon!,10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,0.9115980176006852,False
224,"tianrong yeo, phd, discussed what he looks forward to at the upcoming meeting such as hearing about the newest happenings in ms, including the latest treatments, and his colleagues presentation as well. watch:",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.6359293853251305,False
225,"last day of ec trims was great! lots of espresso, saw my #mentor & cant wait to work together on a new multiple sclerosis #mri project! also so proud of for his eposter on #myelin changes in #mogad & now time to relax a bit! ty!",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
226,"ec trims plenary session 2: closing session. and present the clinical highlights: reconsidering how we envision ms as a disease and its evolution, imaging and molecular biomarkers closer to clinical use, and het/individualised treatment.",21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,1.0,False
227,"wonderful experience with team at . going home with new ideas, exciting collaborations and fresh energy to tackle ms",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
228,"late breaking news at ec trims surprising or not? propensity matched study of #hsct versus #natalizumab in #progressive ms revealed no difference in efficacy. early treatment best, applies to both",5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.9416786179613539,False
229,i was honored and humbled to speak alongside dr dr elliot and dr. dsouza on new tools & challenges in ms 2022! ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
230,"listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .",14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,1.0,True
231,hot-off-the-press from late breaking news at gives his summary of ec trims and the most up-to-date information in ms research it's possible to have multiple sclerosis,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.42634147294072644,False
232,ms hangout live from ectrims2022,14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,0.6483887212514141,False
233,dr. oreja-guevara knocks the ec trims clinical summary out of the park highlighting paramagnetic rim lesions #prls as a marker of disability in ms and predictor of ms in #cis among many other research from ec trims multiple sclerosis,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.578240748088045,False
234,ectrims 2022: network lens could explain paradox in multiple sclerosis (free article access w/ registration) ec trims #neurology,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
235,"ec trims : darin okuda, ut southwestern, shared first trial showing that treating people who have ris (ms-like mri with no symptoms) with tecfidera over 96 weeks reduced risk of having a first neurological symptom:",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
236,fantastic overview of clinical highlights and perspectives of msresearch,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.7398851116955656,False
237,results showed autologous hematopoietic stem cell transplantation to not be more beneficial for reducing disability progression than #natalizumab among patients with progressive ms. #latebreaker ec trims view:,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,1.0,False
238,progression independent of relapses #pira in ms is a key area of focus in working to decrease/halt progression in ms - dr weindel ec trims,3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
239,i missed face-to-face !great feedbacks for my poster cognitive function and imaging correlates in #mogad: a comparison with ms and #nmosd-aqp4,12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,False
240,award winner! p179 ec trims women are better able to maintain cognitive and fine motor dexterity in the face of increasing ms #neurodegeneration than men. this is the first demonstration of #sexdifferences in reserve against #neurofunctional decline in ms.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
241,"wonderful and visionary talk given by one my mentors christine stadelmann-nessler about the future of neuropathology in msresearch - the future looks very bright! congrats, christine, to be the 2022 confavreux awardee!",17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,0.859924054597987,False
242,"congratulations to professor krzysztof selmaj, member of medical and scientific board, for his honorary member award, in recognition for his outstanding contribution to the multiple sclerosis field ec trims",19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,0.9423952492061665,False
243,great to see this new and very important award recognizing and empowering #diversity and #women in msresearch - thanks,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
244,we shared a variety of new data about ocrevus at ec trims. please see full prescribing information at . intended for us healthcare professionals only. which learning did you find the most informative?,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
245,thank you for recognizing and supporting #women ms researchers and their contributions to advancing knowledge and care for women with multiple sclerosis ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
246,"we're at ec trims talking to experts about #clinicaltrials, #diseasemodifyingtreatments & developments in multiple sclerosis. register for free ms clinical resources on for #healthcareprofessionals only ms #hcp #medtwitter #nursetwitter",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
247,"p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.",25,25_outcomes_role_patient_info,Improving patient involvement in MS research through collaboration and digital health technologies.,"['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['ec trims ms', 'ms', 'trims ms', 'ec trims', 'patient', 'ec', 'outcomes', 'suggests', 'insight', 'trims', 'read', 'measures', 'needs', 'needed', 'need', 'evidence', 'info', 'improve', 'health', 'research']","['Improving patient involvement in MS research through collaboration and digital health technologies.', '', '', '', '', '', '', '', '', '']","['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:', 'wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!', 'p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.']",outcomes - role - patient - info - improve - health - trims ms - ec trims ms - need - great - opportunities - needs - used - insight - president - professor - countries - ec trims - trims - ec,1.0,True
248,it was a week full of scientific and clinical discussions at ec trims . it was great to meet face to face again and have lively relevant discussions. i was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in ms.,31,31_ec trims great_trims great_really_face,Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis,"['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['ec trims great', 'day ec trims', 'ec trims', 'day ec', 'ec', 'enjoyed', 'remyelination', 'community', 'colleagues', 'meeting', 'shared', 'thanks', 'meet', 'looking forward', 'new', 'trims', 'wonderful', 'sharing', 'great', 'scientific']","['Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['completely blown away by the city of canals and ec trims . what a great conference, we had a fantastic time. cant wait for next year! #neurology multiple sclerosis', 'it was a week full of scientific and clinical discussions at ec trims . it was great to meet face to face again and have lively relevant discussions. i was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in ms.', 'last day ec trims already. great reconnecting with global colleagues and sharing advancements for those living with ms. looking forward to continuing the conversation:']",ec trims great - trims great - really - face - great - day ec - day ec trims - day - having - gave - wonderful - enjoyed - morning - way - needed - like - colleagues - thanks - trims - ec trims,1.0,True
249,amazing ms research shared and awarded ec trims,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,1.0,False
250,lots of new insights around ms at ec trims. we enjoyed interesting discussions with neurologists and nurses around research and the issues they face in their daily practice. we keep up the good work chasing the miracles of science to help people with ms and hcps! #sanofi,10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,0.8613419749055277,False
251,final day of ec trims we very much enjoyed the exchange with the ms community about latest scientific and medical findings around the disease. let's stay connected and keep on working together to find treatments for multiple sclerosis! msresearch #immunic $imux,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
252,"ec trims : early reports from ectrims suggest vitamin d supplements do not reduce ongoing ms disease activity. however, these studies do not answer whether vitamin d can prevent ms:",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
253,"we joined over 7,000 #healthcareprofessionals at ec trims & asked for their event highlights. here's what prof. told us multiple sclerosis #meded #hcp ms register on #medthority for free. for healthcare professionals only.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
254,"so happy to read #fertility in multiple sclerosis is discussed at ec trims the evidence we had were very bad, but now we know that better communication among neurologists + repro docs and the continuation of dmts right to ivf are keys! no increased risk of relapse!",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
255,"ec trims : national ms society harry weaver scholar dr. riley bove of ucsf: natural experiment doing remote research visits during pandemic lowered costs and worked fine, opening the door to better outreach to more people living with ms :",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
256,proud of johanna oechtering presenting our team's research on how complement activation predicts disease severity in ms ec trims,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.8598070004868837,False
257,kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.7789155712970196,True
258,kalincik: msbase study compared ahsct vs natalizumab in progressive ms (ppms and spms). on a group level no difference in relapse rate or disability worsening or improvement was seen. limitation is ao low number of pts (39 ahsct pts) studied. ec trims,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.8005123403045911,False
259,"after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.859098188191851,True
260,"ec trims james sumowski of mt. sinai, nyc: newer data makes clear that cognitive issues in ms cant be blamed on just slow info processing.",8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
261,"we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims",23,23_ocrelizumab_ocrevus_real_relapse,Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.,"['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ocrelizumab', 'ocrevus', 'msnews', 'ec trims22', 'disease modifying', 'today ec trims', 'trims22', 'patients relapsing', 'efficacy', 'evidence', 'relapsing remitting', 'relapses', 'vs', 'today ec', 'patients', 'effects', 'relapse', 'reducing', 'late breaking', 'relapsing']","['Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.', '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract', 'since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>', 'we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims']",ocrelizumab - ocrevus - real - relapse - vs - showed - world - relapses - relapsing - therapy - efficacy - msnews - safety - study - patients - patients relapsing - today ec trims - ec trims22 - effects - trims22,1.0,True
262,"brenda banwell, md, of , shared the inspiration that she gets from her patients with pediatric-onset ms, which was the subject of her lecture here at ec trims.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
263,"ec trims : dr. laura piccio of washu: 12 weeks of intermittent fasting in small trial produced changes in brain structures and reduced inflammation, suggesting benefit in relapsing ms:",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
264,first evidence-based data on the possibility to prevent multiple sclerosis in at-risk individuals (radiologically isolated syndrome) ec trims,12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,False
265,early non disabling relapses are associated with increased risk of disability accumulation. this was not seen if #pwms were on high efficacy dmt! more reasons to use high efficacy #dmt early in ms ec trims,3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,0.8421228428280917,False
266,from presented in late breaking abstracssession how nfl can increase ms diagnosis specificity in cis patients not fulfilling mcdonald criteria. ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
267,"discussing innovations in technology-supported rehabilitation in ms at ec trims introduces novel high cost devices, low cost virtual solutions & mhealth apps! multiple sclerosis #neurotwitter #neurology",7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.8281943870914901,False
268,time for late breaking news at the latest breakthroughs in ms treatment and research. wrap up video coming soon ft ec trims ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
269,", currently ectrims fellow at in .. talking about relationship between slowly expanding lesions and paramagnetic rim lesions in people with multiple sclerosis ec trims",6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.9866714934413902,False
270,"our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms",14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,0.9644957635668033,True
271,another fruitful ec trims for our team. we are delighted to participate and contribute with our small portion in developing better cares for patients living with ms.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
272,do aging ms patients need a specialised approach? professor zsolt illes gave a highly inspiring talk on the management of aging ms patients at ec trims 2022,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,1.0,False
273,"i had mono in middle school & was diagnosed with ms at age 50. never had symptoms until around age 47 to 48. im 53 now. my body has fought hard against ms and to keep me looking normal. youd never know i have ms by looking at me, but i feel it every day in my legs though.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
274,"here at ec trims, i spoke with about the mechanisms underlying ms fatigue, and she shared some great insight on how it is measured.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
275,ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today,24,24_disease progression_late_onset_sclerosis news today,Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair,"['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'remyelination', 'multiple sclerosis', 'msresearch ec trims', 'sclerosis news today', 'sclerosis', 'today ec trims', 'msnews', 'msresearch', 'disease progression', 'new research', 'onset', 'today ec', 'cis', 'disease', 'multiple', 'progression']","['Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair', '', '', '', '', '', '', '', '', '']","['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms', 'ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch', 'ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today']",disease progression - late - onset - sclerosis news today - news today - multiple sclerosis news - sclerosis news - progression - news - msnews - disease - today ec trims - today ec - later - cis - life - suggests - effective - sclerosis msnews - multiple sclerosis msnews,1.0,True
276,"our own presented at ec trims today, stressing the point of also maintaining cognitive functioning of people without cognitive impairments. #mindslab multiple sclerosis",7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.8688004548543925,False
277,"ec trims is covering important news beyond ms spoke with kazuo fujihara on how & when to treat aqp4-igg+ nmosd, unmet needs and novel agents! thank you for your insights dr fujihara! #nmosd multiple sclerosis #neurotwitter",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,1.0,False
278,attendees are delighted to be here in amsterdam for the 3rd day of ec trims. todays sessions hold out the promise of more high-quality interactions between leading ms researchers & practitioners scroll right see more pictures of the day,13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,0.8098937707553481,False
279,"jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis",6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.8201237482080869,True
280,great to announce at the that the start2cure foundation will co-sponsor the macsimise-brain study: metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration.,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.5028343100270007,False
281,"brian, patrick, graham and karolina share their personal experiences of living with multiple sclerosis, and how they manage their condition every day to continue pursuing whats important to them. read more: #mymsportrait ec trims #diseaseprogression",10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,1.0,False
282,more interviews from ec trims coming soon to : dr. tomas kalincik on #hsct use in ms dr. brenda banwell on the state of care for pediatric-onset ms dr. bruce cree on the latest from inebilizumab in #nmosd,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
283,our ec trims poster presenting #covid19 vaccine hesitancy data in people with multiple sclerosis,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.9082779750631679,False
284,"dr laura cacciaguerra finishes the cognition session at ec trims: pediatric ms patients show very extensive functional connectivity changes, related to cognition. results differed in patients above and below age 16.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
285,"talented medical student sharing our team's work on risk of ms following first #opticneuritis in with this week in amsterdam, making new connections and friends to collaborate with, to extend this research for patient benefit",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
286,"dr. carolina rimkus at the cognition session at #ec trims: people with ms can be stratified based on cognitive performance combined with anxiety and depression, which is reflected by different neurodegenerative profiles.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
287,nauta: cognitive rehab therapy and mindfulness-based therapy reduced cognitive patient symptoms in clinical trial in 100 ms patients. mindfulness led to prolonged improvements in processing speed. ec trims,26,26_cognitive_reduced_therapy_based,Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients,"['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['progressive ms', 'ms multiple sclerosis', 'patients ms', 'ms multiple', 'ms', 'cognitive', 'cognition', 'interventions', 'neurotwitter', 'new research', 'therapy', 'treatment', 'rehabilitation', 'reduced', 'reduce', 'research', 'symptoms', 'patient', 'trials', 'trims']","['Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients', '', '', '', '', '', '', '', '', '']","['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #neurotwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #psychtwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #medtwitter']",cognitive - reduced - therapy - based - symptoms - shows - compared - cognition - new research - patients ms - treatment - patients - trial - ms - patient - new - interventions - evolving - center - understanding,1.0,False
288,cognition at ec trims continues with submitted abstracts. dr sumowski: are we really measuring information processing speed with the sdmt? other speed tests are not impaired in ms. time for a re-appraisal?,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
289,ec trims cognitive rehabilitation and mindfulness reduce cognitive complaints in ms (remind-ms): a randomized controlled trial presented by ilse nauta ms center amsterdam,26,26_cognitive_reduced_therapy_based,Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients,"['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['progressive ms', 'ms multiple sclerosis', 'patients ms', 'ms multiple', 'ms', 'cognitive', 'cognition', 'interventions', 'neurotwitter', 'new research', 'therapy', 'treatment', 'rehabilitation', 'reduced', 'reduce', 'research', 'symptoms', 'patient', 'trials', 'trims']","['Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients', '', '', '', '', '', '', '', '', '']","['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #neurotwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #psychtwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #medtwitter']",cognitive - reduced - therapy - based - symptoms - shows - compared - cognition - new research - patients ms - treatment - patients - trial - ms - patient - new - interventions - evolving - center - understanding,1.0,False
290,patients with ms in a real-world setting who switched their treatment to cladribine from infusion therapies experienced reduced annualized relapse rates and tolerated the oral purine antimetabolite well. ec trims22 view :,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
291,great #cognition session at ec trims in the main hall! we kicked off with prof. amato discussing cognitive profiles in elderly patients. how should we approach cognitive evaluations in these people with ms?,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.6955875371510386,False
292,fantastic talks on #cognition in patients with multiple sclerosis at ec trims . great future ahead for the research in this field!,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,1.0,False
293,sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,True
294,"ec trims | translating what people experience to scientific language is as equally important as translating scientific findings to lay language. ""silent ms progression is only silent because we don't listen to it.""",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
295,"understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims",8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,0.8920413458335479,True
296,"in 2020-2021, social distancing & masks abolished influenza season. we asked the question: did this also stop jc virus from spreading in people with ms? we looked at 20,000 patients in touch registry. the answer wasno.",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.6112498062042967,False
297,"insightful talk by prof highlighting the need for preventative interventions for cognitive problems in multiple sclerosis - ""sooner may be better than later"" ec trims",8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,0.8544278013617372,False
298,"we have a fantastic team of editorial board members at ! today we had the pleasure of catching up w/ () on important topics in multiple sclerosis discussing cognitive impairment in ms, pregnancy & oct angiography ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
299,"sumowski: ms cognition in the modern era - evolution in thinking of ms as a neurodegenerative disease, increase treatment efficacy improved diagnostic sensitivity and evolving understanding of ms cognition ec trims",26,26_cognitive_reduced_therapy_based,Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients,"['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['progressive ms', 'ms multiple sclerosis', 'patients ms', 'ms multiple', 'ms', 'cognitive', 'cognition', 'interventions', 'neurotwitter', 'new research', 'therapy', 'treatment', 'rehabilitation', 'reduced', 'reduce', 'research', 'symptoms', 'patient', 'trials', 'trims']","['Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients', '', '', '', '', '', '', '', '', '']","['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #neurotwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #psychtwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #medtwitter']",cognitive - reduced - therapy - based - symptoms - shows - compared - cognition - new research - patients ms - treatment - patients - trial - ms - patient - new - interventions - evolving - center - understanding,1.0,False
300,"hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims",8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,True
301,another busy morning for all of us at ec trims! spoke with on the 7-year ocrelizumab data from the opera oles & the importance of aggressive early treatment in ms! catch prof. cerqueira's insights soon on,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.504380491962985,False
302,what dmt should we give ms patients who have developed pml on natalizumab? injectables and teriflunomide have been used. dr joep killestein also reports there are some patients that have done well on b cell therapies following pml ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
303,"long time ago, wolswijk argued that spinal cord lesions in patients with multiple sclerosis are older than those in the brain. i feel we need more neuropathological data on the spinal cord, especially regarding early events ec trims",17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,1.0,False
304,"ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract",23,23_ocrelizumab_ocrevus_real_relapse,Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.,"['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ocrelizumab', 'ocrevus', 'msnews', 'ec trims22', 'disease modifying', 'today ec trims', 'trims22', 'patients relapsing', 'efficacy', 'evidence', 'relapsing remitting', 'relapses', 'vs', 'today ec', 'patients', 'effects', 'relapse', 'reducing', 'late breaking', 'relapsing']","['Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.', '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract', 'since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>', 'we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims']",ocrelizumab - ocrevus - real - relapse - vs - showed - world - relapses - relapsing - therapy - efficacy - msnews - safety - study - patients - patients relapsing - today ec trims - ec trims22 - effects - trims22,1.0,True
305,possibly my favorite talk of ec trims of discussing his work elucidation the mechanisms underlying lipid-mediated changes to cholesterol efflux. can't help but see implications beyond ms.,21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,1.0,False
306,at ec trims : targeting foamy macrophages provides a promising strategy to halt lesion progression and induce lesion repair in multiple sclerosis - very nice examples from his and 's lab,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.7154150832408204,False
307,aging effect on inflammatory process in ms in a way that could diminish the dmts impact and allow for stopping treatment when having a stable disease and on one of the platform injectables. stopping nat and sp1 modulators is risky due to rebound. ec trims,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,1.0,False
308,amato: peak age prevalence of ms is changing ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
309,great session summarising what we have learned so far about ms & covid-19. take home message remains - reduced ab response in pts on fingolimod & anti 20s but increase in risk is really only in those on anticd20s. the jury is still out on when to vaccinate ec trims,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.7567698994589688,False
310,"thanks for sharing, . thanks for the coverage ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
311,"live at ec trims | cristina granziera () shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice ms #neurotwitter multiple sclerosis",27,27_remyelination_imaging_sclerosis_multiple sclerosis,Advancements and challenges in remyelination research for Multiple Sclerosis.,"['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['remyelination', 'trims multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'updates', 'latest', 'question', 'latest updates', 'neurotwitter', 'topic', 'ec trims multiple', 'highlights', 'evidence', 'hear', 'ec trims', 'trims', 'insights', 'therapies', 'multiple', 'ec']","['Advancements and challenges in remyelination research for Multiple Sclerosis.', '', '', '', '', '', '', '', '', '']","['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['have you caught up on the latest in remyelination? with and multiple sclerosis ec trims', 'live at ec trims | cristina granziera () shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice ms #neurotwitter multiple sclerosis', 'catherine lubetzki at ec trims : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at']",remyelination - imaging - sclerosis - multiple sclerosis - multiple - latest - question - latest updates - therapeutic - practice - shares - novel - updates - leading - evidence - hear - topic - live - insights - therapies,1.0,True
312,i am delighted to see the results of our feasibility study of a new #cognitive #therapy for people living with multiple sclerosis being presented at ec trims. #patients have been involved at every stage of this #trial. #research,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.9190042482256052,False
313,all ms patients have silent progression / smouldering ms. relapses are just the immune systems response. lazy researchers and greedy pharma focused on relapses. trials are always about to start.,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,1.0,False
314,barriers for people with ms to access healthcare services are multifactorial and need to be addressed by all stakeholders together! this is crucial as the lack of access has detrimental negative effects that can indeed be prevented ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
315,"amato: tremendous barriers to access quality ms care: disparity in access to specialists, health literacy, transportation and costs. as a ms community, we must all work on reducing these obstacles. ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
316,our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,1.0,True
317,"find out more about work in access to multiple sclerosis healthcare online, or come and talk to us at stand b07! ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
318,the utilization goals is to implement metformin treatment in the ms clinical care pathway directly after the project.,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.5972567950055343,False
319,"this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.935324530022513,True
320,start2cure has recently awarded a new research grant co-supporting the macsimise-brain study: metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration.,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.5597039864098893,False
321,its the final day of ! come and stop by booth b02 to talk all things #trimsonline and to find out more about the initiative that aims to reach a diverse global audience of professionals in order to advance equality for everyone working in the field of ms. ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
322,improving patient and health care professional education is needed. dr. emmanuelle waubant highlights the importance to have patient-centered educational material on ms using diversified materials ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
323,ec trims | evaluation of work difficulties in ms subjects & its association with socio-demographic factors & performance measures showed that 50% of pwms are unemployed! we found the same in the workability must be a priority outcome of clinical care!,25,25_outcomes_role_patient_info,Improving patient involvement in MS research through collaboration and digital health technologies.,"['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['ec trims ms', 'ms', 'trims ms', 'ec trims', 'patient', 'ec', 'outcomes', 'suggests', 'insight', 'trims', 'read', 'measures', 'needs', 'needed', 'need', 'evidence', 'info', 'improve', 'health', 'research']","['Improving patient involvement in MS research through collaboration and digital health technologies.', '', '', '', '', '', '', '', '', '']","['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:', 'wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!', 'p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.']",outcomes - role - patient - info - improve - health - trims ms - ec trims ms - need - great - opportunities - needs - used - insight - president - professor - countries - ec trims - trims - ec,1.0,False
324,"manuela buxo, sr. vice president sanofi europe specialty care, is visiting ec trims. she explains its important to be here. next to our current ms treatments, we are committed to accelerating the development of potential treatments for ms #sanofi ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
325,octave presents data from 13 abstracts at ectrims forum 2022 following commercial launch of precision care solution for multiple sclerosis octave announced the presentation of data from 13 abstracts presented at the european committee for treatment and,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,0.35106647908247585,False
326,"viswanathan: in southeast asian countries, many ms patients do not have access to on-label #dmts via government healthcare systems based on cost. off-label azathioprine and rituximab frequently used. global ms health equity needed!! ec trims #pactrims",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.8171607860873102,False
327,"good morning from ! do you know any ms centre, hcp or patient advocate that should be nominated for an msbhaward? have they gone the extra mile to enhance outcomes for people with ms? if so, come and visit booth b02 to find out more.",10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,1.0,False
328,"drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.8598970714098747,True
329,thank you dr shanthi viswanathan from pactrims for all your efforts in the collaborative work on off-label treatment and essential medicines for multiple sclerosis - and for sharing it in this session! ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
330,excellent presentation from on effectiveness of covid-19 vaccines in people with multiple sclerosis receiving disease-modifying therapies ec trims,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,1.0,False
331,"there are more than 20 #dmts, but none are on ' list of essential medications! global efforts are still needed to improve access to treatment for people with ms. ec trims",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.7454378451563043,False
332,"final big day at ec trims almost got my sessions worked out: diagnosis, global health care access, emerging role of lipids, late breaking abstracts, treatment of progressive ms, closing session.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
333,dr milena sales pitombeira from bctrims discusses the impact of covid-19 on multiple sclerosis care - highlighting work on guidance for pwms and our collaborative data sharing initiative ec trims,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.9753578407836041,False
334,"ec trims | great idea from to organise a session about and with women with ms at ec trims2023 during in milan, italy. we hope it will become a reality.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
335,"covid-19: vaccination in ms patients - anat achiron, israel: ms patients had similar frequency of adverse events in response to #covid19 #vaccination as the rest of the population ec trims",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,1.0,False
336,"our final day at ec trims and theres no one id rather match with than my very favorite postdoc ive learned so much and cant wait to bring new discoveries, perspectives, and ideas back to my ms community in calgary #womeninstem mssoc",31,31_ec trims great_trims great_really_face,Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis,"['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['ec trims great', 'day ec trims', 'ec trims', 'day ec', 'ec', 'enjoyed', 'remyelination', 'community', 'colleagues', 'meeting', 'shared', 'thanks', 'meet', 'looking forward', 'new', 'trims', 'wonderful', 'sharing', 'great', 'scientific']","['Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['completely blown away by the city of canals and ec trims . what a great conference, we had a fantastic time. cant wait for next year! #neurology multiple sclerosis', 'it was a week full of scientific and clinical discussions at ec trims . it was great to meet face to face again and have lively relevant discussions. i was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in ms.', 'last day ec trims already. great reconnecting with global colleagues and sharing advancements for those living with ms. looking forward to continuing the conversation:']",ec trims great - trims great - really - face - great - day ec - day ec trims - day - having - gave - wonderful - enjoyed - morning - way - needed - like - colleagues - thanks - trims - ec trims,1.0,False
337,"join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims",10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,1.0,True
338,starting the last ec trims day with a super interesting hot topic session about pediatric mogad! #mogad ms #pediatrics,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
339,fresh from 22 | clinical effectiveness of ahsct is comparable to two immune reconstitution therapies alemtuzumab and cladribine,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.8699200971003868,False
340,postcard from ec trims! join us at booth #b06 for the last day of the congress! #rims ms ec trims ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
341,galleguillos: dramatic increase globally in people living with ms from 2013 and 2020. prevalence increased 50%! true increase in disease or better reporting/diagnosis/awareness? ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
342,"if you're in the ec trims22 session on #covid19 and multiple sclerosis, this is the paper on humoral immune responses to covid vaccines in patients with ms that prof anat achiron just referred to:",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,1.0,False
343,prof amato introduces the work of aiming to address healthcare disparities for people with multiple sclerosis ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
344,"*you don't realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims",7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.9800483073533338,True
345,last day at ec trims. see you at satellite symposium 11: new tools for new challenges in multiple sclerosis. marcus d'souza will introduce the work of the #promsinitiative to participants of the event. hall 12 of the amsterdam venue at 14:15 15:15pm,13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,1.0,False
346,"ec trims educational session 17: diagnosis of ms. interesting reviews and (too short) discussion about diagnosing ms with typical and atypical symptoms and early identification of disease progression, with per soerensen, tomas berger, and jiwon oh.",21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,1.0,False
347,its the final day of ec trims but the fun isnt over yet! dont miss out on these cutting-edge developments in msresearch catch up on the last 3 days of by watching our interviews at ! multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
348,ec trims: dose-dependent reductions in nfl were observed at week 144 in both those who continued on #evobrutinib from the double-blind period and those who switched from placebo. for more:,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.58961191477191,False
349,octave presents data from 13 abstracts at ectrims forum 2022 following commercial launch of precision care solution for multiple sclerosis,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,0.43440678281765394,False
350,ectrims2022 is hstc really better?,5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,0.2186068460061172,False
351,continues to interview experts at ec trims shared important insights on pregnancy planning in multiple sclerosis and #nmosd more to come on ms,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
352,i was pleased to present my 1st poster and show my data at ec trims 2022 and i am very proud to be chosen from the ec trims committee for recieving a grant. #immunology #neuroscience multiple sclerosis,19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,1.0,False
353,last day ec trims already. great reconnecting with global colleagues and sharing advancements for those living with ms. looking forward to continuing the conversation:,31,31_ec trims great_trims great_really_face,Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis,"['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['ec trims great', 'day ec trims', 'ec trims', 'day ec', 'ec', 'enjoyed', 'remyelination', 'community', 'colleagues', 'meeting', 'shared', 'thanks', 'meet', 'looking forward', 'new', 'trims', 'wonderful', 'sharing', 'great', 'scientific']","['Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['completely blown away by the city of canals and ec trims . what a great conference, we had a fantastic time. cant wait for next year! #neurology multiple sclerosis', 'it was a week full of scientific and clinical discussions at ec trims . it was great to meet face to face again and have lively relevant discussions. i was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in ms.', 'last day ec trims already. great reconnecting with global colleagues and sharing advancements for those living with ms. looking forward to continuing the conversation:']",ec trims great - trims great - really - face - great - day ec - day ec trims - day - having - gave - wonderful - enjoyed - morning - way - needed - like - colleagues - thanks - trims - ec trims,1.0,True
354,"in episode two of the ectrims podcast, from discusses day two of ec trims with , including hot topic 7 on lifestyle & wellness factors, plus the importance of supporting msresearch in this area listen now",14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,1.0,False
355,"in my case i had glandular fever in 2008, first ms symptom was 2014 (paresthesia) , diagnosed in 2022",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
356,last day of ec trims and early morning run in amsterdam. met the #chariotms team raising awareness of research focussing on hand function in ms,13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,0.6423831684066349,False
357,ccs vi venous hypertension >microbleedings >iron >inflammation >free radicals >neurodegeneration multiple sclerosis m.s. - mystery solved mysterious autoimmunity = ccsvi neurodegeneration,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.8779249311009925,False
358,"day 2 ec trims was a blast! optic neuritis lesion detection by #mri inclusion in multiple sclerosis criteria in the works from , presented our work on raw mri #machinelearning in predicting disease activity in #rrms & my 1st faculty dinner was amazing! ty!",17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,1.0,False
359,bizarre! multiple sclerosis (ms) is/has been an unproven autoimmune theory solely based on symptoms. neurologists who exclusively encompass leading treatment for the condition are the so called ms unknown origin affliction experts!!!,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,1.0,False
360,"hungover on ec trims day 3? exchange your brain this am with a refreshing (sobering?) discussion on the use of assistive mri technology in ms clinical practice - see you 9:30 at the theatre, exhibition hall 11 #assistms",17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,1.0,False
361,"fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis",19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,1.0,True
362,a ground-breaking clinical trial has found that vitamin d supplements do not prevent multiple sclerosis development in people at high risk. we look at the questions yet to be answered and what these results mean for people living with ms. ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
363,congratulations to dr julie campbell from our ms research flagship whose research on the lived experience of the covid-19 pandemic for people with multiple sclerosis based on evidence from the australian ms longitudinal study was presented in amsterdam ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
364,we were excited to join with colleagues in amsterdam for ec trims and to see the important research driving future ms treatments for patients.,13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,1.0,False
365,ocrelizumab treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. ec trims multiple sclerosis,3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
366,"fantastic days at : "" the predictive value of diffusion tensor imaging on clinical, physical and cognitive disability in multiple sclerosis"" ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
367,1/2 in this poster presented at ec trims we show that ms patients with #natalizumab develop a positive serology response to the #covid19 vaccine at the same level as hcs.,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,1.0,False
368,ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells,24,24_disease progression_late_onset_sclerosis news today,Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair,"['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'remyelination', 'multiple sclerosis', 'msresearch ec trims', 'sclerosis news today', 'sclerosis', 'today ec trims', 'msnews', 'msresearch', 'disease progression', 'new research', 'onset', 'today ec', 'cis', 'disease', 'multiple', 'progression']","['Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair', '', '', '', '', '', '', '', '', '']","['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms', 'ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch', 'ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today']",disease progression - late - onset - sclerosis news today - news today - multiple sclerosis news - sclerosis news - progression - news - msnews - disease - today ec trims - today ec - later - cis - life - suggests - effective - sclerosis msnews - multiple sclerosis msnews,1.0,False
369,#lifestyle choices: general better health or ms-specific effects? more #research needed. ec trims,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
370,"ec trims syamala buragadda (canada) walking improves with better cardiorespiratory fitness, pointing to a heart-brain connection. abstract: get help for walking problems:",15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,0.4938363819287368,False
371,dr. eva strijbis: discontinuation of dmts in older patients with stable ms on a case-to-case basis. ec trims,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.991278280891614,False
372,"harroud: first identification of two genetic variations that are associated with ms disease severity! and are cns expressed genes, meaning that this relates to ms resilience in the brain itself! early identification might help us in treatment strategy? ec trims",16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,1.0,False
373,ec trims poor myelin repair offers clues in disease multiple sclerosis news today,24,24_disease progression_late_onset_sclerosis news today,Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair,"['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'remyelination', 'multiple sclerosis', 'msresearch ec trims', 'sclerosis news today', 'sclerosis', 'today ec trims', 'msnews', 'msresearch', 'disease progression', 'new research', 'onset', 'today ec', 'cis', 'disease', 'multiple', 'progression']","['Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair', '', '', '', '', '', '', '', '', '']","['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms', 'ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch', 'ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today']",disease progression - late - onset - sclerosis news today - news today - multiple sclerosis news - sclerosis news - progression - news - msnews - disease - today ec trims - today ec - later - cis - life - suggests - effective - sclerosis msnews - multiple sclerosis msnews,0.7755628010835375,False
374,what are the barriers to accessing multiple sclerosis treatments in the middle east and north africa? maya zeineddine's poster at ec trims presents an analysis of #atlasofms data,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
375,"grateful for opportunity to discuss fatigue #mechanisms at ec trims & share work has led on to improve fatigue care in ms. thank you to the , khp challenge fund & . excited about refuel-ms - co-funded by &",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
376,may i recommend a theme for ec trims next year? can we have a session about and with women and ms? ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
377,new format at ec trims : braindates. i really like it. today morning i had my first with three wonderful ladies about women and ms and possible issues they might have. i really enjoyed it. ms,31,31_ec trims great_trims great_really_face,Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis,"['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['ec trims great', 'day ec trims', 'ec trims', 'day ec', 'ec', 'enjoyed', 'remyelination', 'community', 'colleagues', 'meeting', 'shared', 'thanks', 'meet', 'looking forward', 'new', 'trims', 'wonderful', 'sharing', 'great', 'scientific']","['Ec Trims Conference: A Platform for Discussion and Connection in Neurology and Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['ec trims great', 'trims great', 'really', 'face', 'great', 'day ec', 'day ec trims', 'day', 'having', 'gave', 'wonderful', 'enjoyed', 'morning', 'way', 'needed', 'like', 'colleagues', 'thanks', 'trims', 'ec trims']","['completely blown away by the city of canals and ec trims . what a great conference, we had a fantastic time. cant wait for next year! #neurology multiple sclerosis', 'it was a week full of scientific and clinical discussions at ec trims . it was great to meet face to face again and have lively relevant discussions. i was particularly excited to present my poster on #microglia repopulation for pro-#remyelination strategies in ms.', 'last day ec trims already. great reconnecting with global colleagues and sharing advancements for those living with ms. looking forward to continuing the conversation:']",ec trims great - trims great - really - face - great - day ec - day ec trims - day - having - gave - wonderful - enjoyed - morning - way - needed - like - colleagues - thanks - trims - ec trims,1.0,False
378,our multiple sclerosis team taking our projects to the european ec trims congress! #emxarxa #esclerosismltiple #neurologyhub #equiphub,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
379,"new data suggests that gfap may be a more reliable biomarker to track ms disease progression than neurofilament light. ec trims read more on the findings from jens kuhle, md, et al:",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
380,", one of our champion spanish nurse was present ec trims ms nurse pro organised a session on the evolving role of ms nurses in research & treatment!",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
381,it was great to catch up with of about the importance of spinal cord atrophy in ms and her work on brain mri versus spinal cord mri in measuring cervical spinal cord atrophy ec trims multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
382,"ec trims: in total, 5 relapses in 4 unique patients occurred within 3 months post-ft after observing 110 cycles of ft in 55 individuals with either ms or #cis.",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
383,"attending ec trims virtually? be sure to check out octave's eposters on ms-specific biomarkers & advanced imaging analytics on wednesday, oct. 26 & friday, oct. 28! learn more",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
384,working towards personalized medicine in multiple sclerosis eva havrdov () shares insights on optimizing treatment dmt type & dose for an individual patient. thanks for sharing prof. havrdov! learn more on ec trims ms,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.8779227236437419,False
385,excellent talk by from at ec trims presenting on the different ways ms can progress over time (using ms register data) and how important online registers are for tracking disease long term,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,1.0,False
386,"it was a great session where even the questions and answers were a lesson in themselves, and ebv factor in ms disease was the biggest question. all the answers rising the new questions in ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
387,"at ec trims, prof. gave a fantastic talk on the use of web-based tech to improve everyday functioning & quality of life in people with ms we'll be sharing her valuable insights on technology-supported rehabilitation on ! multiple sclerosis",7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,1.0,False
388,"taught us how to diagnose an episode of optic neuritis (vep are more useful in the first 3 months, and oct later on). once the diagnosis of optic neuritis related to ms is confirmed, optic nerve topography should be included in the diagnostic process ec trims",6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.39920324809070656,False
389,"important emphasis on mechanistic research by and at ec trims! there is a need for tailored interventions that target self-efficacy, agency, and fatigue to improve quality of life in people with multiple sclerosis.",8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
390,"ms news today is providing comprehensive, in-depth coverage of the 2022 ectrims conference focused on ms clinical research and care. multiple sclerosis msnews msawareness msresearch ec trims",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.6736492549741442,False
391,national swedish ms registry study. #ebv ebna1 antibodies appear 10-15 years before onset of disease. snfl levels rise 5-10 years prior to ms onset. ec trims,18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,1.0,False
392,the future is cell therapy in ms ec trims22,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.7551824035922315,False
393,#inclusive research matters. ms ec trims,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,1.0,True
394,lovely to catch up with on his latest work on ms genetics he shared data on a novel locus identified as the first genome-wide significant & replicated genetic modifier of ms severity! more to come on ! ec trims multiple sclerosis,16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,0.3052122586721312,False
395,importance of physical activity to help manage fatigue in ms highlighted at excellent quality of life session at ec trims great to hear has just funded more fatigue research in uk.,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
396,"what causes ms? ebv remains a plausible instigator, but why does ms happen years after infection and why are there no ebv proteins in the csf of ms patients? peter stys (calgary) found a unique amyloid in ms brains... maybe this is triggered by ebv ec trims",18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,1.0,False
397,lots of talk at ec trims about the need for biomarkers of progression. could gfap be one such marker? new research from kuhle et al suggest that it might be.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
398,podcast interview with dr. ascherio on ms & #ebv. ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
399,"yesterday, we shared informative ocrevus data at ec trims. if you are here in amsterdam, the netherlands, come find us at booth a22 to learn more! please see full prescribing information at . intended for us healthcare professionals only.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
400,"ascherio: molecular mimicry may be how multiple sclerosis ms occurs after epstein-barr #ebv virus. glialcam, alpha-b crystallin, anoctamin and myelin basic protein may be targets. ec trims",18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,1.0,False
401,poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.8074821452533895,True
402,"dr ulrik dalgas (): prehabilitation exercise can help build reserve capacity, rather than just trying to restore lost capacity. ec trims ms how about nordic walking?",15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,0.47771104415267795,False
403,come to visit our eposter 1022 at ec trims about mdscs as biomarker to predict the therapeutic response to fingolimod in eae and ms by celia camacho-toledano et al in colaboration with & ramon y cajal hospital,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
404,"second day at ec trims . come visit our spherix neurology team at booth #d19. our insights director of neurology, emma mcfadden will be presenting today! we can't wait to meet you! #insights #neurology multiple sclerosis",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
405,"prof alberto ascherio () shares the latest on the role of ebv in multiple sclerosis. as data suggests ebv infection is necessary for ms to develop, research moves to working out how its involved, molecular mimicry with myelin proteins seems possible ec trims",18,18_recent_developments_years_cell,Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).,"['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'sclerosis msnews msawareness', 'sclerosis news today', 'multiple sclerosis', 'ms multiple sclerosis', 'multiple sclerosis ms', 'sclerosis ms', 'sclerosis', 'msnews', 'ms', 'ms multiple', 'msresearch ec', 'msawareness msresearch ec', 'msnews msawareness msresearch', 'msresearch ec trims', 'msnews msawareness', 'ec trims']","['Epstein-Barr Virus (EBV) as a potential cause of Multiple Sclerosis (MS).', '', '', '', '', '', '', '', '', '']","['recent', 'developments', 'years', 'cell', 'msnews', 'msawareness msresearch ec', 'msresearch ec', 'msresearch ec trims', 'sclerosis', 'multiple sclerosis', 'multiple', 'msnews msawareness', 'msawareness msresearch', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'multiple sclerosis msnews', 'sclerosis msnews', 'msawareness', 'sclerosis news today', 'study']","['ec trims - signs of a prior epstein-barr virus infection precede the emergence of a biomarker of nerve damage in presymptomatic ms patients. multiple sclerosis msnews msawareness msresearch', 'ec trims - new findings show that ebv antibodies preceded an increase in nfl levels, an early biomarker of nerve cell damage, in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch', 'in our top three editorial picks from ec trims: one study found that an ebv infection consistently preceded biomarkers of nerve cell damage in people who went on to develop ms. multiple sclerosis msnews msawareness msresearch ec trims']",recent - developments - years - cell - msnews - msawareness msresearch ec - msresearch ec - msresearch ec trims - sclerosis - multiple sclerosis - multiple - msnews msawareness - msawareness msresearch - sclerosis msnews msawareness - msnews msawareness msresearch - multiple sclerosis msnews - sclerosis msnews - msawareness - sclerosis news today - study,0.6420463827873668,False
406,"this ec trims we update our data on the predictive role of blood mdscs in ms patient at relapse on the lymphoid component and relapse recovery one year later. come to visit our eposter 1029 by et al, in colaboration with chut and gregorio maraon hospital",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
407,"ec trims: dr. christoph heesen of germany points to need for more msresearch for better strategies that improve sleep, reduce stress, and stop smoking to reduce ms symptoms:",8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
408,always room for more and more diverse #research. ms ec trims,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,1.0,True
409,reynolds: a gradient of neuronal loss in the cortex in ms; more loss on outer layers. cytokines diffusing from csf into cortex seems to be a driver of neuronal loss. ec trims,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.2917755900432496,False
410,"ulrik dalgas, phd, shared an important message about incorporating lifestyle interventions early in ms, before problems related to them begin to arise. ec trims",15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,0.25599669530978764,False
411,day 2 at ec trims has already given some exciting insights on #immunetrafficking into the #cns ready now for the scientific session on #tcells and #bcells in ms!,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
412,interesting talk from sarah knowles at ec trims using data from the to discuss late-onset multiple sclerosis (loms). it was suggested that people with loms could be good participants in #clinicaltrials of therapies targeting neurodegeneration in progressive ms.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
413,mads presenting his 7t mri work on cortical lesions in multiple sclerosis at ec trims,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.9593426215692633,False
414,"the ms #community is so involved and active--patients, organizations, societies. #research is accessible and the community does follow it. if your #careteam isn't supportive of looking at all opportunities, you need to add to it. ec trims",10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,0.8364796679807348,False
415,"we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms",20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,1.0,True
416,"and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.6867484567649202,True
417,also in ec trims poster session 2: p485 impaired visual discrimination and object recognition in rrms patients despite intact visual pathway p687 attenuation of immune activation in patients with multiple sclerosis on a wheat free diet: a pilot crossover trial,12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,0.8882215940289364,False
418,cognitive impairment in ms impacts employment and correlates with sdmt. cognitive impairment negatively impacts qol more than physical impairment -dr. penner ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
419,"come to poster session 2 today (17h-19h) and check out several posters by our group, including p662 serum neurofilament light chain identifies multiple sclerosis patients with severe focal axonal damage in a 6-year longitudinal cohort being presented by ec trims",19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,1.0,False
420,"ive enjoyed and learned a lot with the talks and discussion of these outstanding neurologists, dr. hauser and dr. kappos. dr. hauser has presented a provocative slide to help decision making for relapsing ms patients ec trims",7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,1.0,False
421,"(2/2) he will highligt the excellent results of $imux's phase 2 #emphasis trial of our lead asset, #vidofludimuscalcium (#imu838). the presentation will be accessible on the events and presentations section of #immunic's website: msresearch",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.6713328906390353,False
422,msresearch has the pleasure of funding a researcher to attend this year's #conference in #amsterdam. if you are #researcher looking for funding we may be able to help. get in touch with us for more information: ec trims multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
423,"in addition to learning from other scientists and presenting our work, congresses also remind us of why we do what we do ec trims multiple sclerosis ms #science #passion",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
424,muscle strength can get reduced while aging with ms. but we need it also not to fall. therefore we need to have a proper rehabilitation plan while aging to reduce the rate of fallings. but it seems we need to do more studies to understand the different perspectives. ec trims,15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,0.9664909663975457,False
425,happy to participate and present our data at ec trims definitely among the most rewarding moments for a researcher #research #neurology #neuroscience multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
426,"have you heard of the ? if not, you're missing out. we spoke to rod middleton at about how the work they do will benefit those of you living with ms ec trims ec trims multiple sclerosis",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
427,if ec trims is the olympics of ms i met michael phelps today lovely to meet you,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
428,"seen our eposters at ec trims yet? meet our co-authors, like thibo billiet at our booth and get the nitty gritty on #brain volume analysis in #mogad #nmosd & ms.",30,30_booth_brain_like_forward,Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.,"['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['ec trims', 'ec', 'updates', 'brain', 'latest updates', 'seen', 'trims', 'neurology', 'attending', 'meet', 'thank', 'attending ec', 'nmosd', 'tomorrow', 'insights', 'looking forward', 'visit', 'ec trims congress', 'forward', 'booth']","['Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.', '', '', '', '', '', '', '', '', '']","['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['we are with the north-european team at ec trims. please visit our booth and follow us for the latest updates on our treatments and pipeline. #sanofi #neurology ms', 'seen our eposters at ec trims yet? meet our co-authors, like thibo billiet at our booth and get the nitty gritty on #brain volume analysis in #mogad #nmosd & ms.', ""the ec trims has kicked off! please come for a 'brain break' to our booth #neurology #sanofi ms""]",booth - brain - like - forward - neurology - seen - latest updates - needs - catch - amsterdam - challenges - attending ec - mogad - updates - trims congress - ec trims congress - analysis - tomorrow - thank - attending,1.0,True
429,dr adil harroud shares analysis of genetic variants and ms disease progression finding some variants have a faster time to disability ec trims,16,16_discusses_ec trims multiple_trims multiple sclerosis_trims multiple,Advancements in Multiple Sclerosis Research and Prevention,"['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","['trims multiple sclerosis', 'multiple sclerosis', 'msresearch ec', 'msawareness msresearch ec', 'ms disease', 'msresearch ec trims', 'ms', 'msnews', 'sclerosis', 'msawareness msresearch', 'msnews msawareness', 'ec trims multiple', 'findings', 'ec trims', 'research', 'dr', 'ec', 'trims', 'brain', 'discusses']","['Advancements in Multiple Sclerosis Research and Prevention', '', '', '', '', '', '', '', '', '']","['discusses', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'research', 'shares', 'help', 'dr', 'brain', 'findings', 'week', 'ms', 'novel', 'significant', 'sclerosis', 'multiple sclerosis', 'multiple', 'active', 'ms disease', 'ris']","[""there's been major progress in potentially preventing ris from developing into diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""there's been a major step forward in preventing ris from transitioning to diagnosable ms. executive vp of research, dr. bruce bebo, discusses the research and presentations that got his attention last week at ec trims multiple sclerosis"", ""scientists have identified a genetic variant that contributes to the severity of an individual's ms. my guest, executive vp of research, dr. bruce bebo, discusses the research that got his attention at ec trims multiple sclerosis""]",discusses - ec trims multiple - trims multiple sclerosis - trims multiple - research - shares - help - dr - brain - findings - week - ms - novel - significant - sclerosis - multiple sclerosis - multiple - active - ms disease - ris,1.0,False
430,people with ms affected with mcr = motorik cognitive risk syndrome have clearly more problems with #fatigue ec trims ms,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
431,interesting point! could the metaverse bring profitable effects in (cognitive) rehabilitation? #mindslab ec trims multiple sclerosis #rehabilitation #cognition,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.8822806989562689,False
432,is #remyelination the cure for ms? quizzes about this trending topic in multiple sclerosis treatment at ec trims ec trims,27,27_remyelination_imaging_sclerosis_multiple sclerosis,Advancements and challenges in remyelination research for Multiple Sclerosis.,"['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['remyelination', 'trims multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'updates', 'latest', 'question', 'latest updates', 'neurotwitter', 'topic', 'ec trims multiple', 'highlights', 'evidence', 'hear', 'ec trims', 'trims', 'insights', 'therapies', 'multiple', 'ec']","['Advancements and challenges in remyelination research for Multiple Sclerosis.', '', '', '', '', '', '', '', '', '']","['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['have you caught up on the latest in remyelination? with and multiple sclerosis ec trims', 'live at ec trims | cristina granziera () shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice ms #neurotwitter multiple sclerosis', 'catherine lubetzki at ec trims : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at']",remyelination - imaging - sclerosis - multiple sclerosis - multiple - latest - question - latest updates - therapeutic - practice - shares - novel - updates - leading - evidence - hear - topic - live - insights - therapies,1.0,False
433,some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!,19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,1.0,True
434,meet the expert: choosing therapy.. ec trims ms #amsterdam #neurology,13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,1.0,False
435,"prof challenging us all in improving research, collaboration, and outcomes in multiple sclerosis research. particular challenges in paediatric and older people with ms session. ec trims",9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,1.0,False
436,"de groot: 3d gait analysis with emg provides tailored treatment for #gait improvement. physical therapy, orthotics, botox, dalfampridine and spasticity meds can be utilized in appropriate ms patients. ec trims",15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,1.0,False
437,great to have a session at ec trims devoted entirely to improving research & #clinicaltrials in progressive multiple sclerosis. finding ways to identify & test potential treatments for people living with progressive ms is a critical challenge that we must overcome.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
438,"rehabilitation in ms : very limited with children & older pwms. we need more consistent research, to collaborate across regions for bigger groups, #digitalhealth can play a role. i would also recommend to share data across countries to learn more. ec trims #ehds",25,25_outcomes_role_patient_info,Improving patient involvement in MS research through collaboration and digital health technologies.,"['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['ec trims ms', 'ms', 'trims ms', 'ec trims', 'patient', 'ec', 'outcomes', 'suggests', 'insight', 'trims', 'read', 'measures', 'needs', 'needed', 'need', 'evidence', 'info', 'improve', 'health', 'research']","['Improving patient involvement in MS research through collaboration and digital health technologies.', '', '', '', '', '', '', '', '', '']","['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:', 'wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!', 'p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.']",outcomes - role - patient - info - improve - health - trims ms - ec trims ms - need - great - opportunities - needs - used - insight - president - professor - countries - ec trims - trims - ec,1.0,False
439,we're enjoying ec trims so far! if you are considering digital cognitive assessments for ms research we have some suggested tests on our website: contact us at enquiries.com for a more indepth discussion about which tests might best suit you.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
440,tacchino: #metaverse may be very useful for people living with ms; stimulating neuroplasticity. can improve social inclusion and well-being. ec trims,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.8289696572676246,False
441,#francescabridge presenting our work demonstrating an increased risk of cervical pre-cancer in women exposed to high efficacy ms disease modifying therapy at ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
442,"brings up an hot topic: aging and ms and i am sitting outside because room is full, this shows us that there are unmet needs, guidelines are needed and so: more research must be be done. ec trims",10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,0.9320487273528605,False
443,marrie: need to capture cognition and patient-reported outcomes for more comprehensive assessment of progressive ms trials ec trims,26,26_cognitive_reduced_therapy_based,Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients,"['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['progressive ms', 'ms multiple sclerosis', 'patients ms', 'ms multiple', 'ms', 'cognitive', 'cognition', 'interventions', 'neurotwitter', 'new research', 'therapy', 'treatment', 'rehabilitation', 'reduced', 'reduce', 'research', 'symptoms', 'patient', 'trials', 'trims']","['Cognitive Rehabilitation Therapy and Mindfulness Interventions for Multiple Sclerosis Patients', '', '', '', '', '', '', '', '', '']","['cognitive', 'reduced', 'therapy', 'based', 'symptoms', 'shows', 'compared', 'cognition', 'new research', 'patients ms', 'treatment', 'patients', 'trial', 'ms', 'patient', 'new', 'interventions', 'evolving', 'center', 'understanding']","['an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #neurotwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #psychtwitter', 'an internet-based cognitive-behavioral therapy program specifically designed for patients with ms significantly reduced depressive symptoms compared to usual treatment, new research shows. ec trims #medtwitter']",cognitive - reduced - therapy - based - symptoms - shows - compared - cognition - new research - patients ms - treatment - patients - trial - ms - patient - new - interventions - evolving - center - understanding,1.0,False
444,great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter,17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,1.0,True
445,"great presentation yesterday by matthew davis of on foralumab. the world's only fully human anti cd3 monoclonal antibody, via nasal delivery to ms patients at by showcased at 2022 $tlsa #tils ec trims",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.6249963376821682,False
446,"congratulations to amin zarghai from our multiple sclerosis research flagship who presented at his study of 237 people with a first clinical diagnosis of cns demyelination determining clinical predictors of retaining, losing or gaining employment over time ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
447,in the lifestyle session brigit de jong addressed the benefits of a healthy lifestyle and specifically diet for people with ms. more research is needed in this area to identify underlying mechanisms. ec trims ms,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
448,excellent question posed during the lifestyle intervention session at ec trims. why dont we have marketing departments to promote the benefits of #exercise and #diet in multiple sclerosis? maybe we can take on this challenge together!,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,0.89787593862561,False
449,"making an impressive case against active monitoring and treatment of people with #ris or presymptomatic ""ms"" - what would you do? vote now ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
450,interesting burning debate - should we treat ris? 50% of patients with ris will go on to develop ms 10 years after first mri scan. watch this space for results of arise trial tomorrow,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.7624582914904255,False
451,ec trims| join industry sessions at day 2 of congress and engage with leaders in ms research. todays sessions are supported by and #aegirbio full programme of industry sessions,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
452,trimsonline: good morning from ! are you interested in increasing your reach and raising your profile within the ms community? don't miss out on the opportunity to #sponsor or #exhibit at the seventh #trimsonline conference! find out more information by visiting,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
453,good morning from ! are you interested in increasing your reach and raising your profile within the ms community? don't miss out on the opportunity to #sponsor or #exhibit at the seventh #trimsonline conference! find out more information by visiting us at booth b02!,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
454,"dra. strijbis but what about in long-term stable ms on platform therapies? answer: depends. we'd look at immunosenescency, age and ms history. ec trims",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,1.0,False
455,tomorrow slowly expanding lesions and paramagnetic rim lesions in pwms at free communication 6: imaging session (10 - 11 am cest) ec trims multiple sclerosis #mri please view and participate with your questions!,17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,0.6482814787507479,False
456,de smets: should we do a better job of detecting ms earlier and treat these individuals? ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
457,"poster from a research from australia says, that telehealth was used very often from pwms during the #pandemic in the first year, its needed for health services & ms organization to prepare guidance info for patients and offering other #digithealth models too. ec trims",25,25_outcomes_role_patient_info,Improving patient involvement in MS research through collaboration and digital health technologies.,"['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['ec trims ms', 'ms', 'trims ms', 'ec trims', 'patient', 'ec', 'outcomes', 'suggests', 'insight', 'trims', 'read', 'measures', 'needs', 'needed', 'need', 'evidence', 'info', 'improve', 'health', 'research']","['Improving patient involvement in MS research through collaboration and digital health technologies.', '', '', '', '', '', '', '', '', '']","['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:', 'wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!', 'p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.']",outcomes - role - patient - info - improve - health - trims ms - ec trims ms - need - great - opportunities - needs - used - insight - president - professor - countries - ec trims - trims - ec,1.0,False
458,"what risk factors increase risk of #ris converting to ms? age <37, enhancing lesions, spinal cord lesion, infratentorial lesions & oligoclonal bands. 3 factors: 91% chance of developing ms in 2 years. ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
459,"dr ulrik dalgas () tells ec trims that starting exercise early in people living with multiple sclerosis may be the best approach to improve long-term outcomes. prehabilitation can help build reserve capacity, rather than just trying to restore lost capacity.",15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,0.38579820881720855,False
460,prof presenting in wellbeing for people with multiple sclerosis at education session at ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
461,really enjoyed a fringe meeting chaired by anat achiron about their coaching programme for pwms at diagnosis - significant impact on time to starting ms #dmt check their poster #754 for details. insights pertinent to #attackms ec trims,17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,0.6684800480539372,False
462,"diet & ms symptoms: adherence to mediterranean diet promising, superiority of one diet over another remains unclear -dr de jong ec trims",8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
463,"when someone is diagnosed with ms, 9 out of 10 ask, what can i do? can i module my disease with diet? a #healthy #lifestyle is just as beneficial for ms. - brigit de jong. ec trims",8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,1.0,False
464,dr lebrun-frenay looks at evidence on treating people with radiologically isolated syndrome ris and risk factors for ms diagnosis ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
465,congratulations and ec trims presenting their work investigating immunogenicity and disease progression in ms! great collaboration with,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.9499482782899006,False
466,"day 2 of ec trims and youve supercharged our batteries yesterday thx to all existing discussions & ideas on fighting ms through collaboration & #brainai. drop by our booth, see how we can tackle your needs & challenges! #digitalhealth #weareicometrix #icobrain #icompanion",30,30_booth_brain_like_forward,Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.,"['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['ec trims', 'ec', 'updates', 'brain', 'latest updates', 'seen', 'trims', 'neurology', 'attending', 'meet', 'thank', 'attending ec', 'nmosd', 'tomorrow', 'insights', 'looking forward', 'visit', 'ec trims congress', 'forward', 'booth']","['Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.', '', '', '', '', '', '', '', '', '']","['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['we are with the north-european team at ec trims. please visit our booth and follow us for the latest updates on our treatments and pipeline. #sanofi #neurology ms', 'seen our eposters at ec trims yet? meet our co-authors, like thibo billiet at our booth and get the nitty gritty on #brain volume analysis in #mogad #nmosd & ms.', ""the ec trims has kicked off! please come for a 'brain break' to our booth #neurology #sanofi ms""]",booth - brain - like - forward - neurology - seen - latest updates - needs - catch - amsterdam - challenges - attending ec - mogad - updates - trims congress - ec trims congress - analysis - tomorrow - thank - attending,1.0,False
467,my ec trims poster is up and hanging. come meet me this afternoon at p632 and have a chat about #mrspectroscopy and #cortical lesions in ms. or find me friday at the eposter tour.,19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,0.9938820808536795,False
468,we are here at ! come visit us at booth b03 to say hi to our team in the exhibition hall and to learn more about our projects and initiatives. ms multiple sclerosis ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
469,"our co-founder, brett drummond, is joined by dr travis stiles (ceo, ) to review day 1 of ec trims. topics covered include paediatric multiple sclerosis, remyelination, biomarkers, ahsct & treatment dosing. what were your highlights?",14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,0.7607123950836449,False
470,we are with the north-european team at ec trims. please visit our booth and follow us for the latest updates on our treatments and pipeline. #sanofi #neurology ms,30,30_booth_brain_like_forward,Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.,"['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['ec trims', 'ec', 'updates', 'brain', 'latest updates', 'seen', 'trims', 'neurology', 'attending', 'meet', 'thank', 'attending ec', 'nmosd', 'tomorrow', 'insights', 'looking forward', 'visit', 'ec trims congress', 'forward', 'booth']","['Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.', '', '', '', '', '', '', '', '', '']","['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['we are with the north-european team at ec trims. please visit our booth and follow us for the latest updates on our treatments and pipeline. #sanofi #neurology ms', 'seen our eposters at ec trims yet? meet our co-authors, like thibo billiet at our booth and get the nitty gritty on #brain volume analysis in #mogad #nmosd & ms.', ""the ec trims has kicked off! please come for a 'brain break' to our booth #neurology #sanofi ms""]",booth - brain - like - forward - neurology - seen - latest updates - needs - catch - amsterdam - challenges - attending ec - mogad - updates - trims congress - ec trims congress - analysis - tomorrow - thank - attending,1.0,True
471,"were proud to announce new data at ec trims showing important clinical and economic outcomes of early treatment in relapse-remitting multiple sclerosis, pregnancy outcomes from 2,000+ women, and 9-year safety data: $rhhby $rog",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.72511048846958,False
472,"a sculptural installation for ectrims 2022 to gain awareness around smouldering disease, a new discovery in the early stages of ms. the head fills with smoke so you cant see the lettering until the button is pressed and the smoke is released to reveal the message ec trims",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.9220499460067131,False
473,good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?,10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,1.0,True
474,"the very first ec trims podcast is now live, hosted by our co-founder, brett drummond. available on all of your favourite #podcast platforms. thank you to professor brenda banwell for her participation. multiple sclerosis ms",14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,1.0,False
475,thank you for your message. this is indeed a wonderful reminder that ectrims remains grateful for everyone's contribution dedicated to the treatment of ms.,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.9757879686095019,False
476,my patients & their families are truly incredible w/ coping with ms at a time when they should be worrying about grade 2 not about whether or not their therapy is going to work: ectrims podcast guest brenda banwell w/ . listen now,10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,0.9260410993495272,False
477,"ec trims | welcome to day 2! there are 5 scientific sessions to choose from today, as well as 10 hot topics. view the entire scientific programme here ectrims () dont forget to share your congress photos with us #jointheconversation msresearch",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
478,"what a first day back to in person yesterday ! started off with #magnims educational workshop, amazing sand art, #pediatric #nmosd ms #mogad plenary, & honoured to present our recent #machinelearning results & thoughts on multiple sclerosis #prognostics! ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
479,"the presentation of our ""charcot multiple sclerosis management master of science"" - a cooperation project of ecf and diu now is online on youtube: . we are at ec trims at ecf booth. all info on:",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.7353017496877065,False
480,congratulations to ying li from our ms research flagship who presented her poster in amsterdam. ying li's study found that high sun exposure was associated with a reduced risk of developing progressive-onset multiple sclerosis ec trims,19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,0.7562789384714163,False
481,"i am very happy to share in ec trims congress my work on longitudinal immune response to adenovirus based covid-19 vaccine astrazeneca and sputnik v in argentina, a collaborative multicenter study multiple sclerosis #vaccine",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.5538942305307012,False
482,proud to show a collaborative argentine research about rwe: multiple sclerosis activity between cycles in rrms under mavenclad treatment. ec trims congress ec trims,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.6531494478737496,False
483,"presenting our work on ahsct therapy for multiple sclerosis at ec trims. great colleagues and research from all over the world! #karolinskainstitutet, ec trims",7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.8873661762789908,False
484,there has long been interest in the possible benefits of vitamin d supplements for those living with multiple sclerosis and whether they can be used to prevent the development of ms. ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
485,ec trims fertility treatment wont raise ms relapse risk | use of dmts found to help keep relapse rate low in ms women,3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,0.9787763462505268,False
486,very honored to present our latest data on #neuroglial potassium channels as therapeutic targets in inflammatory demyelination at ec trims today. thanks for this great opportunity multiple sclerosis ms,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.5197119781850732,False
487,"great poster session 1 at ec trims early assesment of ovarian reserve , #rwe of ocrelizumab, and oct/corpus callosum atrophy",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.5820141964785006,False
488,"day 1 at : the highlights from remyelination, high efficacy therapies and an unexpected surprise about ec trims multiple sclerosis",27,27_remyelination_imaging_sclerosis_multiple sclerosis,Advancements and challenges in remyelination research for Multiple Sclerosis.,"['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['remyelination', 'trims multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'updates', 'latest', 'question', 'latest updates', 'neurotwitter', 'topic', 'ec trims multiple', 'highlights', 'evidence', 'hear', 'ec trims', 'trims', 'insights', 'therapies', 'multiple', 'ec']","['Advancements and challenges in remyelination research for Multiple Sclerosis.', '', '', '', '', '', '', '', '', '']","['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['have you caught up on the latest in remyelination? with and multiple sclerosis ec trims', 'live at ec trims | cristina granziera () shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice ms #neurotwitter multiple sclerosis', 'catherine lubetzki at ec trims : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at']",remyelination - imaging - sclerosis - multiple sclerosis - multiple - latest - question - latest updates - therapeutic - practice - shares - novel - updates - leading - evidence - hear - topic - live - insights - therapies,1.0,False
489,"people with newly diagnosed ms have increased postural sway and lower muscle strength compared to healthy individuals, even if they have no complaints (edss1.5). early rehabilitation can prevent insidious progression. #neurorehabilitation #prevention ec trims",15,15_function_phd_help_patients ms,Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.,"['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['patients ms', 'patients multiple sclerosis', 'diagnosed ms', 'patients ec trims', 'rehabilitation', 'patients ec', 'new research', 'ec trims', 'measures', 'patients multiple', 'neurotwitter', 'ec', 'trims', 'discussed', 'using', 'patients', 'study', 'function', 'risk', 'new']","['Rehabilitation strategies for improving gait quality in MS patients through functional measures and cardiorespiratory fitness.', '', '', '', '', '', '', '', '', '']","['function', 'phd', 'help', 'patients ms', 'patients', 'patients multiple', 'patients multiple sclerosis', 'measures', 'discussed', 'quality', 'need', 'just', 'using', 'shows', 'early', 'rehabilitation', 'lower', 'new research', 'risk', 'neurotwitter']","['how can using neuromuscular function measures predict fallers vs non-fallers among patients with ms? laurits taul madsen of discussed his presentation from ec trims', 'cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis, new research shows. ec trims #neurotwitter', 'laurits taul madsen, a phd candidate at aarhus university, discussed the use of lower extremity function assessments to characterize patients with ms at risk for future falls. ec trims #neurotwitter exclusive interview here:']",function - phd - help - patients ms - patients - patients multiple - patients multiple sclerosis - measures - discussed - quality - need - just - using - shows - early - rehabilitation - lower - new research - risk - neurotwitter,1.0,False
490,ec trims : banwell: ~30% of pediatric onset ms #poms have cognitive impairment. 30-50% have anxiety or depression. get help for navigating a diagnosis of pediatric ms:,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
491,"ms news today is providing comprehensive, in-depth coverage of the 2022 ectrims conference focused on ms clinical research and care. multiple sclerosis msnews msawareness msresearch",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.8599995045600755,False
492,enabling innovative approaches aimed at personalizing multiple sclerosis (ms) care is a continued pursuit of our #digitalhealth initiatives. watch to learn more about our real-world data being presented at ec trims focused on advancing this goal.,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.6771066102812175,False
493,"investigators found no increased risk of #relapse with #fertility treatments. in total, 5 relapses in 4 unique patients occurred within 3 months post-ft after observing 110 cycles of ft in 55 individuals with either ms (48) or #cis (7). ec trims",3,3_relapse_risk_relapses_sclerosis msnews msawareness,"Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis msnews msawareness', 'multiple sclerosis', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'sclerosis', 'msnews msawareness msresearch', 'msnews', 'trims ec', 'msresearch', 'msawareness msresearch', 'trims ec trims', 'ec trims ec', 'msnews msawareness', 'msawareness', 'treatment', 'disability', 'multiple']","['Managing Multiple Sclerosis: Risk Factors, Treatment Options, and Impact on Fertility', '', '', '', '', '', '', '', '', '']","['relapse', 'risk', 'relapses', 'sclerosis msnews msawareness', 'msnews msawareness msresearch', 'msawareness msresearch', 'msnews msawareness', 'sclerosis msnews', 'multiple sclerosis msnews', 'msawareness', 'lower', 'does', 'msresearch ec trims', 'msresearch ec', 'msawareness msresearch ec', 'msnews', 'increase', 'women', 'treatment', 'msresearch']","['ec trims - progression independent of relapse activity is also common in pediatric ms, study finds, and dmts can effectively lower the risk. multiple sclerosis msnews msawareness msresearch', 'ec trims - ocrevus treatment before or during pregnancy does not seem to increase the risk of major complications in women with ms or their babies. multiple sclerosis msnews msawareness msresearch', 'ec trims - fertility treatments do not significantly increase the risk of relapse in women with ms, even among those undergoing treatment linked to greater levels of hormone exposure. multiple sclerosis msnews msawareness msresearch ec trims']",relapse - risk - relapses - sclerosis msnews msawareness - msnews msawareness msresearch - msawareness msresearch - msnews msawareness - sclerosis msnews - multiple sclerosis msnews - msawareness - lower - does - msresearch ec trims - msresearch ec - msawareness msresearch ec - msnews - increase - women - treatment - msresearch,1.0,False
494,"congratulations , nice way of starting your phd journey. ec trims #postersession multiple sclerosis",19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,1.0,False
495,"next at ec trims: claire bridel, md, phd, of , who shared her perspective on the upcoming novel biomarker sun ms. clips:",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
496,dr majid pahlevan kakhki held an mcdonald fellowship and studies epigenetics of progressive multiple sclerosis ec trims,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.4027741027474281,False
497,it was a great pleasure to present our latest data on cross-regional transcriptomic reactivity in ms - the first study to integrate three cns regions on single cell resolution in human disease many thanks for this opportunity ec trims ms #singlecell,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.6514656466502119,False
498,"newest updates in multiple sclerosis at ectrims 2022: tianrong yeo, mbbs, mrcp, mmed, fams, mci, phd #medpub #medtwitter #meded #mednews",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.6578294951248705,False
499,"newest updates in multiple sclerosis at ectrims 2022: tianrong yeo, mbbs, mrcp, mmed, fams, mci, phd #medpub #neurotwitter #meded #neurology",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.6583016546915377,False
500,gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team,17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,1.0,True
501,"treating the depression or the disease? pseudo-trial with the uk ms register. our dr jeff rodgers, senior analysts poster ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
502,"the impact of healthcare symptoms on clinical diagnosis and dmt usage in relapse-onset ms: a real world perspective in five registries across europe. our clinical lead, dr richard nicholas poster ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
503,women supporting women multiple sclerosis ec trims,29,29_trims dr_ec trims dr_improve_outcomes,Improving MS Care through Nurse Training and Support,"['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['ms', 'multiple sclerosis', 'ec trims dr', 'sclerosis', 'ec trims', 'trims dr', 'women', 'ec', 'dr', 'trims', 'discussing', 'supporting', 'hear', 'need', 'efforts', 'importance', 'outcomes', 'care', 'multiple', 'use']","['Improving MS Care through Nurse Training and Support', '', '', '', '', '', '', '', '', '']","['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['joelle massouh: ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. ec trims', 'dr therese burke of and past president of ms nurses australasia at ec trims discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear!', 'do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at ec trims']",trims dr - ec trims dr - improve - outcomes - women - need - care - efforts - supporting - used - challenges - president - dr - importance - evidence - experience - discussing - presents - hear - trims,1.0,False
504,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,0.6919326772307876,False
505,new data at ectrims 2022 highlight biogens commitment to advancing individualized disease management for people living with ms,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,0.725165566500271,False
506,ocrevus has 7+ years of clinical data. see what's next at ec trims. please see full prescribing information at . intended for us healthcare professionals only.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
507,ec trims another form of progress in msresearch: 5 out of 6 presenters at myelin repair session were women:,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
508,"professor desmond graham, board member at msif and president of co-chaired this important session alongside dr maya zeineeddine, ms specialist and faculty member at the middle east north africa committee for treatment and research in ms (menactrims).",7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.7769722072369997,False
509,"one of our research analysts, james standing next to his poster ec trims the impact of changing diagnostic criteria on the incidence, prevalence and disease impact of ms using welsh routine data",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
510,we are working to realize a future where data is more readily leveraged to improve the lives of people living with multiple sclerosis (ms). read our news release to learn more about our digital health advancements. ec trims,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.6439258658731383,False
511,"meet our spherix neurology team! all ready to go and set up for success at the ectrims conference in amsterdam, nl! be sure to visit us at booth #d19, see you there!! ec trims #neurology multiple sclerosis",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
512,are you a digital health company developing tools based on #pro measures for ms? are you attending ec trims? wg3 co-leaders letizia leocani and rob hyde will explain to you how to contribute to our e-health catalogue on 27-28/10. more info at:,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
513,ec trims : growing msresearch suggests undertreatment with less effective therapies a significant problem & can lead to poorer outcomes:,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.6808025203681087,False
514,live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter,17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,0.7799816677499499,True
515,always a pleasure to speak with w/ ferhan qureshi of about their multivariate proteomic ms disease activity test interview coming soon at ec trims ms #neurology #neurotwitter,17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,1.0,False
516,dr schoonheim discusses that ms is a network disease. using fmri can measure network flexibility,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
517,the braindate team is in amsterdam we are very happy to announce that we are hosting neuro leaders in knowledge-sharing conversations at ec trims in the neuronetwork braindate lounge to accelerate research in ms ec trims #research,13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,0.9682307093353628,False
518,post 2 of the postersession at ec trims : many studies about pregnancy and young ladies. where are the studies about women in their 40s or #menopause? ms,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
519,"attending ec trims? hear more about janssens work in multiple sclerosis from allitia dibernardo, m.d., and check out our 15 abstracts at this years congress.",13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,0.6857504142462733,False
520,pleased to share the first mri evaluation of the topographical model of ms introducing a new metric lesion parenchymal fraction (lpf) as an eposter . a wonderful collab with ! ec trims,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.7260161565734095,False
521,#hcps: register and join our ec trims symposium for discussion on strategies in multiple sclerosis (ms) care across the patient lifespan. learn more here:,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
522,"jan hillert: ms is a homogeneous disease in terms of onset/serverity and treatment responses, so therefore precision medicine, tailored to a specific individual disease mechanism is likely not possiblebut does emphasize on going for personalized approach! ec trims",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,1.0,False
523,poster session at ec trims and i wonder why study / research projects dont differ in women and men when it comes to find out thing. there are differences and we should have data about it. or find. ms #datasaveslives,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
524,"prof tomas kalincik (, ) presents data at ec trims suggesting #ahsct is superior to fingolimod & natalizumab in preventing relapses in people living with multiple sclerosis. what does the future hold for stem cell transplants as a treatment option in ms?",5,5_cell_ahsct_disability_progressive ms,Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS,"['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['progressive ms', 'remitting ms', 'relapsing remitting ms', 'ms', 'rrms', 'ahsct', 'treatment', 'therapies', 'efficacy', 'patients relapsing', 'treated', 'relapsing remitting', 'better', 'disability', 'compared', 'relapses', 'reducing', 'late breaking', 'vs', 'relapse']","['Comparing the effectiveness of AHSCT versus Natalizumab in treating Progressive MS', '', '', '', '', '', '', '', '', '']","['cell', 'ahsct', 'disability', 'progressive ms', 'better', 'progressive', 'relapses', 'reducing', 'vs', 'progression', 'study', 'relapse', 'patients', 'patients relapsing', 'efficacy', 'relapsing remitting ms', 'remitting ms', 'treatment', 'ms', 'really']","['late breaking ec trims: among patients with progressive ms, advanced disability & low pretreatment relapse activity, +patients with recent disability progression, #ahsct is not superior in reducing disability progression or allowing reduction of disability than natalizumab.', 'kalincik study: propensity-matched #progressive ms patients treated with ahsct or natalizumab. no difference on relapse rates and disability progression. ec trims', 'dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events ec trims']",cell - ahsct - disability - progressive ms - better - progressive - relapses - reducing - vs - progression - study - relapse - patients - patients relapsing - efficacy - relapsing remitting ms - remitting ms - treatment - ms - really,1.0,False
525,"joelle massouh: ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. ec trims",29,29_trims dr_ec trims dr_improve_outcomes,Improving MS Care through Nurse Training and Support,"['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['ms', 'multiple sclerosis', 'ec trims dr', 'sclerosis', 'ec trims', 'trims dr', 'women', 'ec', 'dr', 'trims', 'discussing', 'supporting', 'hear', 'need', 'efforts', 'importance', 'outcomes', 'care', 'multiple', 'use']","['Improving MS Care through Nurse Training and Support', '', '', '', '', '', '', '', '', '']","['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['joelle massouh: ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. ec trims', 'dr therese burke of and past president of ms nurses australasia at ec trims discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear!', 'do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at ec trims']",trims dr - ec trims dr - improve - outcomes - women - need - care - efforts - supporting - used - challenges - president - dr - importance - evidence - experience - discussing - presents - hear - trims,1.0,True
526,keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri,19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,0.8565979638856942,True
527,were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:,13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,1.0,True
528,"joelle massouh, multiple sclerosis nurse, describes some of the methods used to increase the number of specialist nurses in the mena region - and the importance of building trust with people affected by ms ec trims",29,29_trims dr_ec trims dr_improve_outcomes,Improving MS Care through Nurse Training and Support,"['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['ms', 'multiple sclerosis', 'ec trims dr', 'sclerosis', 'ec trims', 'trims dr', 'women', 'ec', 'dr', 'trims', 'discussing', 'supporting', 'hear', 'need', 'efforts', 'importance', 'outcomes', 'care', 'multiple', 'use']","['Improving MS Care through Nurse Training and Support', '', '', '', '', '', '', '', '', '']","['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['joelle massouh: ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. ec trims', 'dr therese burke of and past president of ms nurses australasia at ec trims discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear!', 'do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at ec trims']",trims dr - ec trims dr - improve - outcomes - women - need - care - efforts - supporting - used - challenges - president - dr - importance - evidence - experience - discussing - presents - hear - trims,1.0,False
529,could ecm be a factor for successful remyelination in multiple sclerosis - great presentation by at ec trims,27,27_remyelination_imaging_sclerosis_multiple sclerosis,Advancements and challenges in remyelination research for Multiple Sclerosis.,"['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['remyelination', 'trims multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'updates', 'latest', 'question', 'latest updates', 'neurotwitter', 'topic', 'ec trims multiple', 'highlights', 'evidence', 'hear', 'ec trims', 'trims', 'insights', 'therapies', 'multiple', 'ec']","['Advancements and challenges in remyelination research for Multiple Sclerosis.', '', '', '', '', '', '', '', '', '']","['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['have you caught up on the latest in remyelination? with and multiple sclerosis ec trims', 'live at ec trims | cristina granziera () shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice ms #neurotwitter multiple sclerosis', 'catherine lubetzki at ec trims : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at']",remyelination - imaging - sclerosis - multiple sclerosis - multiple - latest - question - latest updates - therapeutic - practice - shares - novel - updates - leading - evidence - hear - topic - live - insights - therapies,1.0,False
530,"""wellness is not the absence of illness ~dr. brenda banwell ms ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
531,ms #pregnancy ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,True
532,"do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at ec trims",29,29_trims dr_ec trims dr_improve_outcomes,Improving MS Care through Nurse Training and Support,"['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['ms', 'multiple sclerosis', 'ec trims dr', 'sclerosis', 'ec trims', 'trims dr', 'women', 'ec', 'dr', 'trims', 'discussing', 'supporting', 'hear', 'need', 'efforts', 'importance', 'outcomes', 'care', 'multiple', 'use']","['Improving MS Care through Nurse Training and Support', '', '', '', '', '', '', '', '', '']","['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['joelle massouh: ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. ec trims', 'dr therese burke of and past president of ms nurses australasia at ec trims discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear!', 'do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at ec trims']",trims dr - ec trims dr - improve - outcomes - women - need - care - efforts - supporting - used - challenges - president - dr - importance - evidence - experience - discussing - presents - hear - trims,1.0,True
533,looking at your tweets this seems very poor organisation. i was diagnosed with ms just after my daughter was born - but had i been a patient with ms considering pregnancy/dmts etc this information for me (and my hcps) is so important. how will it be disseminated?,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
534,"come to see our on site posters number 48 (mdscs and disease severity in ms) and 307 (evobrutinib effect over classical dendritic cells in eae) , this wednesday, 16:30 at ec trims presented by and respectively.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
535,belinda bardsley presents research from demonstrating poorer health outcomes if you have no access to a multiple sclerosis nurse ec trims,29,29_trims dr_ec trims dr_improve_outcomes,Improving MS Care through Nurse Training and Support,"['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['ms', 'multiple sclerosis', 'ec trims dr', 'sclerosis', 'ec trims', 'trims dr', 'women', 'ec', 'dr', 'trims', 'discussing', 'supporting', 'hear', 'need', 'efforts', 'importance', 'outcomes', 'care', 'multiple', 'use']","['Improving MS Care through Nurse Training and Support', '', '', '', '', '', '', '', '', '']","['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['joelle massouh: ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. ec trims', 'dr therese burke of and past president of ms nurses australasia at ec trims discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear!', 'do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at ec trims']",trims dr - ec trims dr - improve - outcomes - women - need - care - efforts - supporting - used - challenges - president - dr - importance - evidence - experience - discussing - presents - hear - trims,1.0,False
536,dosing of monoclonal antibodies in ms should not be one size fits all - dr. van kempen ec trims,9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,0.5886228697669544,False
537,"it's a pleasure to be back in ectrims presenting our data on site! come and see our results today from 4:30 to 6:30 p.m on posters p48 and p307! we have also 2 eposters presented by camacho-toledano, c and ec trims #mdscs multiple sclerosis",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
538,dra. van kempen. eid of natalizumab is as effective as 4wk interval. we've already known but is important to remember it. personal note: it's not reduce pml risk. we'll see if extend ocrelizumab is effective. ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
539,happy to present this poster at ec trims. #ahsct ms,19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,0.9917099043440546,False
540,catherine lubetzki at ec trims : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at,27,27_remyelination_imaging_sclerosis_multiple sclerosis,Advancements and challenges in remyelination research for Multiple Sclerosis.,"['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['remyelination', 'trims multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'updates', 'latest', 'question', 'latest updates', 'neurotwitter', 'topic', 'ec trims multiple', 'highlights', 'evidence', 'hear', 'ec trims', 'trims', 'insights', 'therapies', 'multiple', 'ec']","['Advancements and challenges in remyelination research for Multiple Sclerosis.', '', '', '', '', '', '', '', '', '']","['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['have you caught up on the latest in remyelination? with and multiple sclerosis ec trims', 'live at ec trims | cristina granziera () shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice ms #neurotwitter multiple sclerosis', 'catherine lubetzki at ec trims : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at']",remyelination - imaging - sclerosis - multiple sclerosis - multiple - latest - question - latest updates - therapeutic - practice - shares - novel - updates - leading - evidence - hear - topic - live - insights - therapies,1.0,True
541,fantastic talk from on personalised medicine in multiple sclerosis,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,1.0,False
542,gave a terrific talk about optic neuritis in ms going for paired #singlecell #spatial w/ - great collaboration w/ kate fitzgerald and - very proud of for all the efforts & science!,17,17_lesions_talk_future_neurotwitter,"Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['neurology', 'ms', 'neurotwitter', 'ms clinical', 'brain', 'updates', 'disease activity', 'talk', 'lesions', 'latest updates', 'mri', 'future', 'activity', 'details', 'efforts', 'time', 'live', 'clinical', 'soon', 'wonderful']","['Advancements and discussions in Multiple Sclerosis research, including MRI imaging, neuroglial potassium channels, clinical implementation, and interviews with experts.', '', '', '', '', '', '', '', '', '']","['lesions', 'talk', 'future', 'neurotwitter', 'gave', 'mri', 'wonderful', 'neurology', 'updates', '30', 'disease activity', 'work', 'live', 'activity', 'time', 'brain', 'need', 'day', 'great', 'clinical']","['gave another beautiful talk on #neuroglial potassium channel interaction as a therapeutic target in ms - wonderful presentation putting the node of ranvier center stage - very happy to work with this amazing team', 'great interview with prof. hans lassmann about the similarities and differences between ms and mogad pathology & the latest updates on the immune mechanisms behind neurodegeneration in progressive multiple sclerosis ec trims #neurology #neurotwitter', 'live at ec trims ngela vidal-jordana () shared updates on the clinical implementation of optic nerve lesions in the mcdonald criteria & her work analyzing the association between oct measures and serum and csf biomarkers ms #neurology #neurotwitter']",lesions - talk - future - neurotwitter - gave - mri - wonderful - neurology - updates - 30 - disease activity - work - live - activity - time - brain - need - day - great - clinical,1.0,False
543,dr therese burke of and past president of ms nurses australasia at ec trims discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear!,29,29_trims dr_ec trims dr_improve_outcomes,Improving MS Care through Nurse Training and Support,"['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['ms', 'multiple sclerosis', 'ec trims dr', 'sclerosis', 'ec trims', 'trims dr', 'women', 'ec', 'dr', 'trims', 'discussing', 'supporting', 'hear', 'need', 'efforts', 'importance', 'outcomes', 'care', 'multiple', 'use']","['Improving MS Care through Nurse Training and Support', '', '', '', '', '', '', '', '', '']","['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['joelle massouh: ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. ec trims', 'dr therese burke of and past president of ms nurses australasia at ec trims discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear!', 'do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at ec trims']",trims dr - ec trims dr - improve - outcomes - women - need - care - efforts - supporting - used - challenges - president - dr - importance - evidence - experience - discussing - presents - hear - trims,1.0,True
544,how would you describe the role of the multiple sclerosis nurse? ec trims,29,29_trims dr_ec trims dr_improve_outcomes,Improving MS Care through Nurse Training and Support,"['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['ms', 'multiple sclerosis', 'ec trims dr', 'sclerosis', 'ec trims', 'trims dr', 'women', 'ec', 'dr', 'trims', 'discussing', 'supporting', 'hear', 'need', 'efforts', 'importance', 'outcomes', 'care', 'multiple', 'use']","['Improving MS Care through Nurse Training and Support', '', '', '', '', '', '', '', '', '']","['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['joelle massouh: ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. ec trims', 'dr therese burke of and past president of ms nurses australasia at ec trims discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear!', 'do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at ec trims']",trims dr - ec trims dr - improve - outcomes - women - need - care - efforts - supporting - used - challenges - president - dr - importance - evidence - experience - discussing - presents - hear - trims,1.0,False
545,dr therese burke starts the session on why we urgently need more multiple sclerosis nurses across the globe ec trims,29,29_trims dr_ec trims dr_improve_outcomes,Improving MS Care through Nurse Training and Support,"['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['ms', 'multiple sclerosis', 'ec trims dr', 'sclerosis', 'ec trims', 'trims dr', 'women', 'ec', 'dr', 'trims', 'discussing', 'supporting', 'hear', 'need', 'efforts', 'importance', 'outcomes', 'care', 'multiple', 'use']","['Improving MS Care through Nurse Training and Support', '', '', '', '', '', '', '', '', '']","['trims dr', 'ec trims dr', 'improve', 'outcomes', 'women', 'need', 'care', 'efforts', 'supporting', 'used', 'challenges', 'president', 'dr', 'importance', 'evidence', 'experience', 'discussing', 'presents', 'hear', 'trims']","['joelle massouh: ms prevalence on the rise in #middleeast/#northafrica. 2011 brought in ms #nursing, but many challenges. now: lots of efforts to improve training, certification, access to care. ec trims', 'dr therese burke of and past president of ms nurses australasia at ec trims discussing what ms nurses do and how they use patient experience to enhance nursing care. powerful presentation all politicians should hear!', 'do ms nurses improve outcomes for patients? massively! and the evidence is well now documented. so, why is our australian ms nurse workforce shrinking, not growing to meet unmet need? belinda bardsley presenting at ec trims']",trims dr - ec trims dr - improve - outcomes - women - need - care - efforts - supporting - used - challenges - president - dr - importance - evidence - experience - discussing - presents - hear - trims,1.0,False
546,we are pleased to present new data from across our portfolio of multiple sclerosis (ms) therapies at ec trims. read more:,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.72511048846958,False
547,congratulations and $tanuja chitnis on your presentation today: nasal anti-cd3 monoclonal antibody (foralumab) reduces pet microglial activation and blood inflammatory biomarkers in two patients with non-active spms multiple sclerosis ec trims,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.511827187714907,False
548,"great to talk about improving ms care via blood #biomarkers, advanced imaging metrics and innovative biosensor digital monitoring with , dr. chitnis & dr. graves. ec trims",10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,0.9115980176006852,False
549,"more than 8,200 participants from 109 countries ec trims to accelerate research in ms",9,9_ms ec_research_ms ec trims_ec,Advancements in MS treatment through targeted therapy and inclusive research.,"['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['ms research', 'ms ec trims', 'trims multiple sclerosis', 'ms ec', 'ec trims ec', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims22', 'ms', 'ec trims multiple', 'ec trims prof', 'ec', 'trims22', 'research', 'highlights', 'trims', 'cell', 'outcomes', 'trims multiple']","['Advancements in MS treatment through targeted therapy and inclusive research.', '', '', '', '', '', '', '', '', '']","['ms ec', 'research', 'ms ec trims', 'ec', 'trims', 'ec trims', 'trims ec trims', 'trims ec', 'ec trims ec', 'ms', 'immune', 'future', 'highlights', 'presenting', 'cell', 'outcomes', 'ms research', 'trims multiple', 'ec trims multiple', 'therapy']","['#inclusive research matters. ms ec trims', 'always room for more and more diverse #research. ms ec trims', 'bruce cree, md, phd, spoke about a successful drug that does not block out the immune function, transforming into a more tolerant immune system for patients with ms. ec trims ec trims multiple sclerosis ms']",ms ec - research - ms ec trims - ec - trims - ec trims - trims ec trims - trims ec - ec trims ec - ms - immune - future - highlights - presenting - cell - outcomes - ms research - trims multiple - ec trims multiple - therapy,1.0,False
550,"can ms be prevented by treating it in the subclinical/prodromal (before characteristic symptoms) phase? trials mentioned during evolving the paradigm of patient care in ms and forging a path ahead (cello, teris and arise) aim to explore just that. ec trims",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.8295424952620476,False
551,today we presented new mri biomarker data and updated open-label extension (ole) clinical data from our phase 1 study of investigational ata188 for progressive forms of ms at . catch the details below: ec trims,28,28_label_progressive multiple sclerosis_progressive multiple_presents,New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022.,"['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['progressive multiple sclerosis', 'multiple sclerosis', 'mri', 'ectrims 2022', 'progressive multiple', 'sclerosis', 'imaging', 'data', '2022', 'news', 'presented', 'ectrims', 'clinical', 'new', 'multiple', 'face', 'details', 'late breaking', 'progressive', 'study']","[""New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022."", '', '', '', '', '', '', '', '', '']","['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', '$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', 'atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 businesswire']",label - progressive multiple sclerosis - progressive multiple - presents - phase - progressive - study - mri - data - new - ectrims 2022 - ectrims - 2022 - forms - presented - details - central - catch - multiple sclerosis - sclerosis,1.0,False
552,the positive impact of #research and dmt for multiple sclerosis patients ec trims,8,8_cognitive_specific_quality_just,Improving Quality of Life in MS Patients through Tailored Cognitive Interventions,"['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['ec trims ms', 'multiple sclerosis', 'trims ms', 'ms', 'sclerosis', 'people ms', 'ec trims', 'session ec trims', 'session ec', 'cognitive', 'dr', 'ec', 'interventions', 'trims', 'research', 'important', 'patient', 'improve', 'reduce', 'symptoms']","['Improving Quality of Life in MS Patients through Tailored Cognitive Interventions', '', '', '', '', '', '', '', '', '']","['cognitive', 'specific', 'quality', 'just', 'life', 'improve', 'trims', 'ec trims', 'better', 'ec', 'ms', 'important', 'interventions', 'need', 'needed', 'research', 'reduce', 'session', 'session ec trims', 'session ec']","['hulst: cognitive rehab should be implemented in ms patients prior to cognitive impairment or with only mild impairment, rather than waiting only for moderate to severe cognitive impairment. ec trims', 'sumowski: processing speed is not specific in ms. important to truly understand the reason for cognitive impairment such as memory or word-finding issues in each ms patient. ec trims', 'understanding specific cognitive complaints in ms patient is important to improve research, prevention and treatment. by james sumowski ec trims']",cognitive - specific - quality - just - life - improve - trims - ec trims - better - ec - ms - important - interventions - need - needed - research - reduce - session - session ec trims - session ec,0.9247366506891399,False
553,progress in ms dr. giovannoni. we still must do better ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
554,ec trims kickoff: $tgtx will be presenting data from the ph3 ultimate i & ii trials of ublituximab in ms ectrims this wed & thurs. check out our 5 presentations - visit our booth-d30. schedule/details: #fearlessforpatients,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.3812994697463757,False
555,$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022,28,28_label_progressive multiple sclerosis_progressive multiple_presents,New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022.,"['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['progressive multiple sclerosis', 'multiple sclerosis', 'mri', 'ectrims 2022', 'progressive multiple', 'sclerosis', 'imaging', 'data', '2022', 'news', 'presented', 'ectrims', 'clinical', 'new', 'multiple', 'face', 'details', 'late breaking', 'progressive', 'study']","[""New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022."", '', '', '', '', '', '', '', '', '']","['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', '$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', 'atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 businesswire']",label - progressive multiple sclerosis - progressive multiple - presents - phase - progressive - study - mri - data - new - ectrims 2022 - ectrims - 2022 - forms - presented - details - central - catch - multiple sclerosis - sclerosis,1.0,True
556,ectrims2022: all anti-cd20 monoclonal antibodies have similar efficacy and safety risks: yes #ofatumumab #rituximab #ocrelizumab ublituximab $tgtx $rhhby ec trims22 ec trims,23,23_ocrelizumab_ocrevus_real_relapse,Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.,"['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ocrelizumab', 'ocrevus', 'msnews', 'ec trims22', 'disease modifying', 'today ec trims', 'trims22', 'patients relapsing', 'efficacy', 'evidence', 'relapsing remitting', 'relapses', 'vs', 'today ec', 'patients', 'effects', 'relapse', 'reducing', 'late breaking', 'relapsing']","['Efficacy and safety comparison of Ocrelizumab versus Rituximab in treating Relapsing Multiple Sclerosis in real-world settings.', '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'ocrevus', 'real', 'relapse', 'vs', 'showed', 'world', 'relapses', 'relapsing', 'therapy', 'efficacy', 'msnews', 'safety', 'study', 'patients', 'patients relapsing', 'today ec trims', 'ec trims22', 'effects', 'trims22']","['ec trims in real-world settings, relapsing ms patients on #ocrelizumab achieved 28% greater neda-3 rates compared to ones treated with other disease-modifying agents #visualabstract', 'since the ec trims later-breaker showing that ocrelizumab is superior to rituximab in treating ms, this ms_seflife case study on ""ocrelizumab vs ofatumumab, which would you choose?"" has been getting a lot of attention. does it make sense to you? =>', 'we previously showed that ocrelizumab has wider immunomodulatory effects than rituximab, and thus more likely stronger clinical efficacy (). this is now real-world evidence! ec trims']",ocrelizumab - ocrevus - real - relapse - vs - showed - world - relapses - relapsing - therapy - efficacy - msnews - safety - study - patients - patients relapsing - today ec trims - ec trims22 - effects - trims22,1.0,False
557,come and have a chat with me & team on trends in fertility and pregnancy in multiple sclerosis (poster 082),-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
558,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms - globenewswire,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,1.0,False
559,fascinating opening lecture on paediatric onset ms by dr brenda banwell. treat early. fingolimod established as effective. trials of ocrelizumab & dimethyl fumarate are recruiting #neuropharmacy ec trims,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.4483132728467563,False
560,"the european committee for treatment & research in multiple sclerosis conference is taking place i'm not there, but great to see nutrition being highlighting by , one of the leaders in the field highlighted by fellow dietitian & mser ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
561,treatment is not all we havewellness is a therapy [in ms] too. - prof brenda banwell ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
562,"in these pictures are professor mario battaglia, president of the aism - associazione italiana sclerosi multipla sharing an overview of the proms initiative and helga weiland, co-chair of the proms engagement and coordination team introducing the session. ec trims",25,25_outcomes_role_patient_info,Improving patient involvement in MS research through collaboration and digital health technologies.,"['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['ec trims ms', 'ms', 'trims ms', 'ec trims', 'patient', 'ec', 'outcomes', 'suggests', 'insight', 'trims', 'read', 'measures', 'needs', 'needed', 'need', 'evidence', 'info', 'improve', 'health', 'research']","['Improving patient involvement in MS research through collaboration and digital health technologies.', '', '', '', '', '', '', '', '', '']","['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:', 'wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!', 'p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.']",outcomes - role - patient - info - improve - health - trims ms - ec trims ms - need - great - opportunities - needs - used - insight - president - professor - countries - ec trims - trims - ec,0.8222052502485087,False
563,today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:,25,25_outcomes_role_patient_info,Improving patient involvement in MS research through collaboration and digital health technologies.,"['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['ec trims ms', 'ms', 'trims ms', 'ec trims', 'patient', 'ec', 'outcomes', 'suggests', 'insight', 'trims', 'read', 'measures', 'needs', 'needed', 'need', 'evidence', 'info', 'improve', 'health', 'research']","['Improving patient involvement in MS research through collaboration and digital health technologies.', '', '', '', '', '', '', '', '', '']","['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:', 'wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!', 'p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.']",outcomes - role - patient - info - improve - health - trims ms - ec trims ms - need - great - opportunities - needs - used - insight - president - professor - countries - ec trims - trims - ec,0.9921165486919622,True
564,a captivating sand performance at ec trims instilling hope through multiple sclerosis research and clinical care grounded in patient engagement.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
565,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022,28,28_label_progressive multiple sclerosis_progressive multiple_presents,New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022.,"['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['progressive multiple sclerosis', 'multiple sclerosis', 'mri', 'ectrims 2022', 'progressive multiple', 'sclerosis', 'imaging', 'data', '2022', 'news', 'presented', 'ectrims', 'clinical', 'new', 'multiple', 'face', 'details', 'late breaking', 'progressive', 'study']","[""New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022."", '', '', '', '', '', '', '', '', '']","['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', '$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', 'atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 businesswire']",label - progressive multiple sclerosis - progressive multiple - presents - phase - progressive - study - mri - data - new - ectrims 2022 - ectrims - 2022 - forms - presented - details - central - catch - multiple sclerosis - sclerosis,1.0,True
566,beautiful opening to ec trims looking forward to learning the latest on multiple sclerosis and related conditions over the coming days,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
567,"dr brenda banwell of delivering her ec trims lecture on #paediatric ms now vit d independent risk driver of ms in kids, healthy levels protective",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
568,honoured to hear dr brenda banwells lecture on paediatric multiple sclerosis incredibly insightful regarding the challenges associated with diagnosing early-onset ms. ec trims ec trims #paediatricms,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
569,trimsonline: it's day 1 of the congress in #amsterdam! are you interested in sharing your ms research with international peers at the upcoming seventh #trimsonline conference? come and see the team at booth b02 for information on how to submit,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
570,it's day 1 of the congress in #amsterdam! are you interested in sharing your ms research with international peers at the upcoming seventh #trimsonline conference? come and see the team at booth b02 for information on how to submit and display your work.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
571,new data at ectrims 2022 highlight biogen $biib s commitment to advancing individualized disease management for people living with ms,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,0.9098849968774404,False
572,biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,1.0,True
573,biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,1.0,True
574,$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,1.0,False
575,$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,1.0,True
576,new data at ectrims 2022 highlight biogens commitment to advancing individualized disease management for people l,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,0.8528987455905954,False
577,new data at ectrims 2022 highlight biogen's commitment to advancing individualized disease management for people living with ms,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,1.0,False
578,new data at ectrims 2022 highlight biogens commitment to advancing individualized disease management for people living with ms - safety and efficacy results from the phase 3 evolve-ms-1 trial demonstrate decreases in disease activity and favorable tole...,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,0.9322581818256596,False
579,$biib new data at ectrims 2022 highlight biogen's commitment to advancing individualized disease management for people living with ms 45 seconds delayed.,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,0.900431404086622,False
580,$biib new data at ectrims 2022 highlight biogens commitment to advancing individualized disease management for people living with ms,11,11_people living ms_living ms_people living_ectrims 2022,Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022,"['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['ectrims 2022', 'ectrims', 'living ms', 'ms', 'abstracts', 'new data', 'disease activity', 'people living ms', '2022', 'data', 'results', 'people', 'presentation', 'new', 'european', 'european committee treatment', 'disease', 'digital', 'health', 'treatment']","['Innovations in Digital Health for Multiple Sclerosis Treatment and Personalized Care at ECTRIMS 2022', '', '', '', '', '', '', '', '', '']","['people living ms', 'living ms', 'people living', 'ectrims 2022', 'living', '2022', 'ectrims', 'data', 'digital', 'management', 'care', 'people', 'new data', 'health', 'treatment', 'disease', 'abstracts', 'new', 'presents', 'ms']","['biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms $biib', '$biib biogen data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms 45 seconds delayed.', 'biogen $biib data at ectrims 2022 highlight innovation in digital health focused on advancing treatment and personalized care of people living with ms']",people living ms - living ms - people living - ectrims 2022 - living - 2022 - ectrims - data - digital - management - care - people - new data - health - treatment - disease - abstracts - new - presents - ms,0.9313961908435132,False
581,"multiple sclerosis is a network disease, and is a network organisation, says ec trims chair bernard uitdehaag, emphasising the importance of the hybrid nature the event to ensure people can attend from all over the world and many different stakeholder groups",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
582,ms is a network disease and were once again gathered amsterdam to reflect on the advances & challenges in multiple sclerosis care. we need to stay connected prof. uitdehaag.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
583,we are at ec trims come and say hello and discover the many ways you could work with us. lets make sense of ms msresearch ms,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
584,"#news: ec trims is underway, and we are presenting key data on the role btk inhibitors can play in fighting ms. find out more here: ms #neurology msinsideout",0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.31976966344299596,False
585,prof maria pia amato welcomes the 7000+ in person & 2000+ online participants to the 38th annual ec trims conference. its time to embrace the evolution with 365 - a year long commitment to communication & improving outcomes for people living with multiple sclerosis.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
586,we are here at ! come and find us at booth b02 in the exhibition hall at the 38th congress of the european committee for treatment and research in multiple sclerosis to find out more about msbh and the opportunities we have to offer! ms ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
587,"26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims",20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,1.0,True
588,ectrims is there for you! sign up to hear about the most interesting scientific developments presented at ec trims ! ms #mindslab,14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,0.6483887212514141,False
589,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 businesswire,28,28_label_progressive multiple sclerosis_progressive multiple_presents,New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022.,"['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['progressive multiple sclerosis', 'multiple sclerosis', 'mri', 'ectrims 2022', 'progressive multiple', 'sclerosis', 'imaging', 'data', '2022', 'news', 'presented', 'ectrims', 'clinical', 'new', 'multiple', 'face', 'details', 'late breaking', 'progressive', 'study']","[""New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022."", '', '', '', '', '', '', '', '', '']","['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', '$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', 'atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 businesswire']",label - progressive multiple sclerosis - progressive multiple - presents - phase - progressive - study - mri - data - new - ectrims 2022 - ectrims - 2022 - forms - presented - details - central - catch - multiple sclerosis - sclerosis,1.0,True
590,found your poster 2022 . (apologies for my poor photography skills!). ec trims multiple sclerosis,19,19_poster_come_ec trims multiple_trims multiple sclerosis,Multiple Sclerosis Research Presentations at EC Trims Conference,"['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['trims multiple sclerosis', 'multiple sclerosis patients', 'sclerosis patients', 'ms research', 'multiple sclerosis', 'sclerosis', 'poster', 'ec trims multiple', 'ec', 'ec trims22', 'ec trims', 'presented', 'pathway', 'trims22', 'multiple', 'onset', 'trims', 'present', 'progressive', 'risk']","['Multiple Sclerosis Research Presentations at EC Trims Conference', '', '', '', '', '', '', '', '', '']","['poster', 'come', 'ec trims multiple', 'trims multiple sclerosis', 'trims multiple', 'presented', 'sclerosis', 'multiple sclerosis', 'multiple', 'check', 'committee', 'ec', 'amsterdam', 'onset', 'ms research', 'trims', 'ec trims', 'present', 'progressive', 'multiple sclerosis patients']","['fabulous to see our colleague ying li, from our ms research flagship, presenting her poster ""sun exposure and the risk of progressive-onset multiple sclerosis"" in amsterdam. congratulations! ec trims multiple sclerosis', 'keeping working on #mtr in the #optic pathway. come and have a look to our poster on the use of mtr in demonstrating the neuroprotective effect of phenytoin in patients with acute optic neuritis at ec trims (poster p320). ec trims multiple sclerosis #mri', ""some lovely pictures of 's poster presentation at ec trims on memory rehabilitation for people with multiple sclerosis. come check her poster (no. 777) in the poster area!""]",poster - come - ec trims multiple - trims multiple sclerosis - trims multiple - presented - sclerosis - multiple sclerosis - multiple - check - committee - ec - amsterdam - onset - ms research - trims - ec trims - present - progressive - multiple sclerosis patients,1.0,False
591,"is there much biomarker variability over time in an individual with multiple sclerosis? if so, what are we missing when we measure these factors via a single snapshot in time? thoughts , and other ec trims attendees?",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
592,"ec trims 2022. for multiple sclerosis, we need to emulate the concept of time is brain as is relevant in stroke care. the longer we delay use of high efficacy therapy the higher probability of rapid progression to disability the case for saving brain and spine in ms",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
593,dominic shadbolt making the case for early discussion of long term prognosis in people with ms ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
594,"the has a governance model that is participatory, multistakeholder and ensures we are involving all the necessary expertise, especially people affected by multiple sclerosis ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
595,"has organised an event for people living with ms which will take place on saturday, 29th of october. more details can be found here",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.8215800720919236,False
596,"has also arranged an event for people living with ms on saturday, find out more here",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.856085773617537,False
597,during ec trims learn about smoldering #neuroinflammation in multiple sclerosis. join 3 sessions moderated by in the theatre in the exhibition hall. these sessions are generously supported by ectrims sponsor,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.8776011195997725,False
598,ec trims | engage with leading ms researchers and practitioners in industry sessions. todays sessions are supported by and view the full programme of industry sessions,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
599,prof. discussing the role of non-conventional mri in predicting the prognosis of ms patients in the earliest phases of the disease but also in those with definite ms ec trims #mri ms,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,1.0,False
600,"helga weiland, co-chair of the engagement coordination team, introduces the session and explains the importance of involving people affected by multiple sclerosis in the study and development of #pros ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
601,"while we arent yet at a point where we can measure the effectiveness of multiple sclerosis treatments via a simple blood test, () tells ec trims that technology is improving and progress is being made.",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.6494204241865982,False
602,"ec trims hot topic 1: hugh efficacy therapies in ms. , dalia rotstein and review which baseline poor prognosis factors are also relevant for treatment response, the importance of timely switch and giving patients the choice of starting het.",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.728595913267233,False
603,proms is a great initiative. what surprises me is the insight that the voice of pwms is so relevant. really? in 2022y what do we talk about since years? sorry i turn off the ironic mode now. ec trims ms #patientengagement #patientincluded,25,25_outcomes_role_patient_info,Improving patient involvement in MS research through collaboration and digital health technologies.,"['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['ec trims ms', 'ms', 'trims ms', 'ec trims', 'patient', 'ec', 'outcomes', 'suggests', 'insight', 'trims', 'read', 'measures', 'needs', 'needed', 'need', 'evidence', 'info', 'improve', 'health', 'research']","['Improving patient involvement in MS research through collaboration and digital health technologies.', '', '', '', '', '', '', '', '', '']","['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:', 'wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!', 'p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.']",outcomes - role - patient - info - improve - health - trims ms - ec trims ms - need - great - opportunities - needs - used - insight - president - professor - countries - ec trims - trims - ec,1.0,False
604,the proms project was announced in 2019 bringing pwms with doctors together to discuss the involvement of pwms by and . goal: info must come directly from pwms without being interpreted. ec trims ms,25,25_outcomes_role_patient_info,Improving patient involvement in MS research through collaboration and digital health technologies.,"['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['ec trims ms', 'ms', 'trims ms', 'ec trims', 'patient', 'ec', 'outcomes', 'suggests', 'insight', 'trims', 'read', 'measures', 'needs', 'needed', 'need', 'evidence', 'info', 'improve', 'health', 'research']","['Improving patient involvement in MS research through collaboration and digital health technologies.', '', '', '', '', '', '', '', '', '']","['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:', 'wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!', 'p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.']",outcomes - role - patient - info - improve - health - trims ms - ec trims ms - need - great - opportunities - needs - used - insight - president - professor - countries - ec trims - trims - ec,1.0,False
605,"bielekova: pira prediction biomarkers. inflammatory and fibrosis pathways prevail the most. (spinal cord more fibrosis, brain lesions more inflammatory) no inflammatory independent pira found & ms types are non predictive. ec trims",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
606,prof bielekova starts a fascinating hot topics session at ec trims by showing data indicating how important the identification of csf #biomarkers are for predicting disease progression in people living with multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
607,prof. nicola de stefano summarizing the relevance of conventional mri to provide reliable and accurate marker of ms progression mri can give several information about the prognosis of our patients ec trims #mri ms,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,1.0,False
608,"wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!",25,25_outcomes_role_patient_info,Improving patient involvement in MS research through collaboration and digital health technologies.,"['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['ec trims ms', 'ms', 'trims ms', 'ec trims', 'patient', 'ec', 'outcomes', 'suggests', 'insight', 'trims', 'read', 'measures', 'needs', 'needed', 'need', 'evidence', 'info', 'improve', 'health', 'research']","['Improving patient involvement in MS research through collaboration and digital health technologies.', '', '', '', '', '', '', '', '', '']","['outcomes', 'role', 'patient', 'info', 'improve', 'health', 'trims ms', 'ec trims ms', 'need', 'great', 'opportunities', 'needs', 'used', 'insight', 'president', 'professor', 'countries', 'ec trims', 'trims', 'ec']","['today representatives at ec trims have been talking about the role of patient reported outcomes in ms research. shone a spotlight on the . read more about the global proms initiative here:', 'wow, helga weiland , woman living with ms is live at ec trims speaking about the needs an the proms initiative. the role to involve pwms into patient reported outcomes. agree. great initiative! we need much more of this!', 'p110 ec trims evidence suggests: #black patients with ms experience more aggressive disease & worse outcomes; schisms in patient-provider perceptions may impact. data highlights opportunities to improve: align p&p goals, improve shared-decision making, ensure health equity.']",outcomes - role - patient - info - improve - health - trims ms - ec trims ms - need - great - opportunities - needs - used - insight - president - professor - countries - ec trims - trims - ec,1.0,True
609,these days there are two things keep me going: #menopause and ms. there is not enough info out and also we need more research for women living with ms and going into the next life changing phase. i wrote about it on my blog: ec trims,10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,1.0,False
610,prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,1.0,True
611,"ec trims, hot topic 1: hugh efficacy therapies for ms:",12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,False
612,want to hear more about #promsinitiative topics and connected activities? dont miss the ec trims symposium by dedicated to the role of #pros happening now in the hall 12 (10-11am)! for more info #patientengagement multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
613,"#news: ec trims is underway, and we are presenting key data on the role btk inhibitors can play in fighting ms. ms #neurology msinsideout",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
614,is my first session at ec trims theme: european charcot foundation symposium: the patient at the centre - role of patient reported outcomes. room is still empty but i think people are on their way ms,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
615,"great rims session on updates in ms rehabilitation focusing on cognitive and physical functioning and fatigue management in multiple sclerosis by roshan das nair, anders guldhammer skjerbk and daphne kos ec trims",7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.8096019454287257,False
616,"we're underway at ec trims where we are sharing the latest data, research and breakthrough innovations that have the potential to improve outcomes for people living with ms.",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.6927883645285131,False
617,"day 1 of ec trims has started here in amsterdam! fantastic to be able to attend in person again. stay tuned as we live tweet sessions highlighting the latest in multiple sclerosis research over the next 3 days. if you are here, say hi - wed love to chat!",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
618,"educational session 6, ec trims: mri and the diagnosis of ms. shows examples of mri green and red flags in the diagnosis of ms.",6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.8826694286214748,False
619,today at ec trims learn about managing patients with relapsing remitting ms 26 oct 17:30 cest satellite symposium 4: putting your everyday patient first: the here & now in rrms this ectrims symposium is proudly sponsored by,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,1.0,False
620,prof. discussing mri mimics in the diagnostic work-up of ms green (typical) and red (atypical) flags lets reduce the risk of multiple sclerosis misdiagnosis ec trims #mri,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,1.0,False
621,"educational session 6, ec trims: mri and the diagnosis of ms. reviews future mri measures. re: anterior visual pathway, work by and suggests the added value of paraclinical tools is greatest in on symptomatic cases.",6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,1.0,False
622,prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis,6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,1.0,True
623,"educational session 6, ec trims: mri and the diagnosis of ms. walks us through a critical reapprisal of the criteria, reminding us they should not be applied robotically.",6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,1.0,False
624,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 - neuro central via brainsights for ios,28,28_label_progressive multiple sclerosis_progressive multiple_presents,New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022.,"['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['progressive multiple sclerosis', 'multiple sclerosis', 'mri', 'ectrims 2022', 'progressive multiple', 'sclerosis', 'imaging', 'data', '2022', 'news', 'presented', 'ectrims', 'clinical', 'new', 'multiple', 'face', 'details', 'late breaking', 'progressive', 'study']","[""New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022."", '', '', '', '', '', '', '', '', '']","['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', '$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', 'atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 businesswire']",label - progressive multiple sclerosis - progressive multiple - presents - phase - progressive - study - mri - data - new - ectrims 2022 - ectrims - 2022 - forms - presented - details - central - catch - multiple sclerosis - sclerosis,1.0,False
625,the ec trims has kicked off! please come for a 'brain break' to our booth #neurology #sanofi ms,30,30_booth_brain_like_forward,Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.,"['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['ec trims', 'ec', 'updates', 'brain', 'latest updates', 'seen', 'trims', 'neurology', 'attending', 'meet', 'thank', 'attending ec', 'nmosd', 'tomorrow', 'insights', 'looking forward', 'visit', 'ec trims congress', 'forward', 'booth']","['Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.', '', '', '', '', '', '', '', '', '']","['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['we are with the north-european team at ec trims. please visit our booth and follow us for the latest updates on our treatments and pipeline. #sanofi #neurology ms', 'seen our eposters at ec trims yet? meet our co-authors, like thibo billiet at our booth and get the nitty gritty on #brain volume analysis in #mogad #nmosd & ms.', ""the ec trims has kicked off! please come for a 'brain break' to our booth #neurology #sanofi ms""]",booth - brain - like - forward - neurology - seen - latest updates - needs - catch - amsterdam - challenges - attending ec - mogad - updates - trims congress - ec trims congress - analysis - tomorrow - thank - attending,1.0,True
626,$mrk.gy merck kgaa merck showcases depth of ms portfolio at ectrims supporting commitment to advancing ms care >merck will present 39 abstracts at the 38th congress of the european committee for treatment and research in multiple sclerosis (ectrims),2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.7886241392646196,False
627,ec trims first session. first talk. lets go! ms #ris,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
628,#media: new data on covid-19 outcomes and cognition in patients with relapsing forms of multiple sclerosis ec trims,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.9803455656129506,False
629,"we're underway at ec trims where we are sharing the latest data, research and breakthrough innovations that have the potential to improve outcomes for people living with ms. read more:",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.6574544930004295,False
630,atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 20.. $atra,28,28_label_progressive multiple sclerosis_progressive multiple_presents,New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022.,"['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['progressive multiple sclerosis', 'multiple sclerosis', 'mri', 'ectrims 2022', 'progressive multiple', 'sclerosis', 'imaging', 'data', '2022', 'news', 'presented', 'ectrims', 'clinical', 'new', 'multiple', 'face', 'details', 'late breaking', 'progressive', 'study']","[""New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022."", '', '', '', '', '', '', '', '', '']","['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', '$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', 'atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 businesswire']",label - progressive multiple sclerosis - progressive multiple - presents - phase - progressive - study - mri - data - new - ectrims 2022 - ectrims - 2022 - forms - presented - details - central - catch - multiple sclerosis - sclerosis,1.0,False
631,its the first day of the 38th congress of the european committee for treatment and research in multiple sclerosis 2022! we cant wait to be joined by over 9000 participants from over 100 countries here at ec trims ms #neurology #neurotwitter,20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,1.0,False
632,$atra news atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022,28,28_label_progressive multiple sclerosis_progressive multiple_presents,New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022.,"['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['progressive multiple sclerosis', 'multiple sclerosis', 'mri', 'ectrims 2022', 'progressive multiple', 'sclerosis', 'imaging', 'data', '2022', 'news', 'presented', 'ectrims', 'clinical', 'new', 'multiple', 'face', 'details', 'late breaking', 'progressive', 'study']","[""New MRI and open-label extension data from Atara Biotherapeutics' Phase 1 study of ATA188 in progressive multiple sclerosis presented at ECTRIMS 2022."", '', '', '', '', '', '', '', '', '']","['label', 'progressive multiple sclerosis', 'progressive multiple', 'presents', 'phase', 'progressive', 'study', 'mri', 'data', 'new', 'ectrims 2022', 'ectrims', '2022', 'forms', 'presented', 'details', 'central', 'catch', 'multiple sclerosis', 'sclerosis']","['atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', '$atra atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022', 'atara biotherapeutics presents new mri and updated open-label extension data from phase 1 study of ata188 in progressive multiple sclerosis at ectrims 2022 businesswire']",label - progressive multiple sclerosis - progressive multiple - presents - phase - progressive - study - mri - data - new - ectrims 2022 - ectrims - 2022 - forms - presented - details - central - catch - multiple sclerosis - sclerosis,1.0,False
633,"interested in connecting with fellow colleagues at ec trims to discuss innovative technologies in msresearch? join us this evening for cocktails, hors d'oeuvres & networking w/ some of the brightest minds in #neurology! request your invitation:",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
634,welcome to ec trims! let's share our knowledge on ms and together make a world free of ms.,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
635,browsing e-posters at ec trims? be sure to check out our late-breaking abstract - ep1269: surrogates for sars-cov-2 vaccination response in multiple sclerosis identified in a real world scenario. exciting new work by and others!,0,0_ocrelizumab_patients_data_treated,Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination,"['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['ocrelizumab', 'patients ms', 'ms patients', 'ms', 'treated', 'trims ec', 'trims ec trims', 'ec trims', 'presented', 'ec trims ec', 'new data', 'ec', 'trials', 'data ec trims', 'patients', 'new', 'spms', 'vs', 'showed', 'poster']","[""Impact of Ocrelizumab on MS Patients' Immunological Response to COVID-19 Vaccination"", '', '', '', '', '', '', '', '', '']","['ocrelizumab', 'patients', 'data', 'treated', 'presentation', 'ms patients', 'ec', 'trims', 'ec trims', 'poster', 'check', 'trims ec', 'ec trims ec', 'presenting', 'work', 'new data', 'patients ms', 'ms', 'session', 'spms']","['and finally, stop by poster session 2 to check out p748-impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis. we cant wait to share our work with you! ec trims', 'after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from ec trims suggest a third booster dose can revive such response safely.', 'new data suggest that among patients with ms treated with ocrelizumab or fingolimod, a humoral response can be revived with the administration of a third booster of the #covid-19 vaccine. ec trims view:']",ocrelizumab - patients - data - treated - presentation - ms patients - ec - trims - ec trims - poster - check - trims ec - ec trims ec - presenting - work - new data - patients ms - ms - session - spms,0.824770715572697,False
636,amazing to see a session on the latest research findings in ms specifically for ms patients! we absolutely need more patient involvement in research! ec trims,10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,0.9213758802310161,False
637,"everything is ready!!! ec trims starts tomorrow! more than 8,200 participants !!! a lot of news about multiple sclerosis !!!",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
638,the whole #icofamily is eager to welcome all visiting ec trims as of tomorrow. well make sure to pop your brain with insights & meaningful discussions on #brainai #digitalhealth ms #icobrain #icompanion & #popcorn,30,30_booth_brain_like_forward,Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.,"['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['ec trims', 'ec', 'updates', 'brain', 'latest updates', 'seen', 'trims', 'neurology', 'attending', 'meet', 'thank', 'attending ec', 'nmosd', 'tomorrow', 'insights', 'looking forward', 'visit', 'ec trims congress', 'forward', 'booth']","['Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.', '', '', '', '', '', '', '', '', '']","['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['we are with the north-european team at ec trims. please visit our booth and follow us for the latest updates on our treatments and pipeline. #sanofi #neurology ms', 'seen our eposters at ec trims yet? meet our co-authors, like thibo billiet at our booth and get the nitty gritty on #brain volume analysis in #mogad #nmosd & ms.', ""the ec trims has kicked off! please come for a 'brain break' to our booth #neurology #sanofi ms""]",booth - brain - like - forward - neurology - seen - latest updates - needs - catch - amsterdam - challenges - attending ec - mogad - updates - trims congress - ec trims congress - analysis - tomorrow - thank - attending,1.0,False
639,"an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,1.0,True
640,we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms,13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,0.9718948692067044,True
641,we have arrived in amsterdam ready for were looking forward to hearing about the latest breakthroughs in ms treatment and bringing the info straight to you stay tuned ec trims ec trims,13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,1.0,False
642,"ec trims starts tomorrow! more than 8,200 participants from 109 countries are already registered, and the numbers are climbing. dont miss this opportunity to join the conversation w/ leading ms researchers & practitioners. join today",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
643,"it is a really good sign that when asked about the most exciting multiple sclerosis research topics to be presented at ec trims, the panel at the official press conference lists more than 10 different themes! a lot to look forward to over the coming days.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
644,"professor on :""flipping the pyramid"" (early use of high-efficacy disease modifying therapy in multiple sclerosis) (for ec trims)",4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.8161397138965166,False
645,"we are excited to attend 2022 and eager to meet participants involved in multiple sclerosis #research from all over the world. our e-poster: ""heterogeneous virtual multiple sclerosis patients for analysis of personalized treatment responses""",20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,1.0,False
646,"tomorrow at ec trims, learn more about our late-breaking data on an approved medicine for people with relapsing multiple sclerosis.",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.6574544930004295,False
647,on a train (brussels to amsterdam) for first international conference. cant wait to learn on new advances in multiple sclerosis. ec trims,20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,0.952568216257632,False
648,dont miss the opportunity to connect with novartis medical at ectrims and learn whats happening in ms and neuroscience. ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
649,"if you're at ec trims this week make sure you come and visit our poster which discusses remote web-based assessment of mood, fatigue and cognition in people with multiple sclerosis.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
650,"motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.",20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,0.9127580214661885,True
651,"insysbio team is going to present its eposter ""neurodegeneration quantitative systems pharmacology modelling for analysis of multiple sclerosis therapy"" at ectrims 2022, october 26. ec trims22 #neurodegeneration multiple sclerosis #biopharma #biotechnology",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
652,"amazing to be back in person for this meeting after so long! cant wait to see you all there and to share our collective insights with the multiple sclerosis community. please get in touch if youd like to meet up over the coming days, wed love to hear from you.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
653,"ectrims2022 draws near. what will it tell us? yep dont be an umpalumpa. if it is worth saying this once, its worth saying again.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
654,ready to learn/share the latest ms research at ec trims in amsterdam. will be live tweeting starting tomorrow. looking forward to seeing colleagues!,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
655,"how can we target the pathologic cns immune cell response for people living with multiple sclerosis? to find out more, join us in hall 12 for our gma symposium connecting the dots: immune cells and cns inflammation on october 26, 13:15-14:15 cest. ec trims #hcpsonly",21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,0.5815993931290171,False
656,"the wait is over! ec trims begins tomorrow, and we cant wait to hear from you and the experts you can stay up-to-date on all the latest news by visiting ms msresearch #neurology",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
657,see you beyond the (treatment) barriers #godomgo ms #attackms ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
658,travelled from switzerland to the netherlands to join the ectrims congress as an ms patient myself...and guess what? covid+ since yesterday... bad luck,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.6756203264170317,False
659,the karolinska institutets academic specialist center (asc) to present results of geneuros protect-ms phase 2 study of temelimab at ectrims 2022 - ms #fightneurodegeneration #herv $gnro,22,22_present_ocrevus_ocrelizumab_ectrims 2022,Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.,"['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['ocrelizumab', 'ectrims 2022', 'multiple sclerosis', 'ocrevus', 'remitting ms', 'relapsing remitting ms', 'sclerosis', 'ectrims', 'ms', '2022', 'disease activity', 'oct', 'research', 'new', 'results', 'data', 'disease', 'relapsing remitting', 'multiple', 'patients']","['Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.', '', '', '', '', '', '', '', '', '']","['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -', '$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022', '$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022']",present - ocrevus - ocrelizumab - ectrims 2022 - 2022 - new - data - ectrims - research - sclerosis - multiple sclerosis - multiple - center - remitting ms - relapsing remitting ms - significant - relapsing remitting - remitting - disease activity - meeting,1.0,False
660,officially in amsterdam for ectrims 2022! looking forward to a great week of exciting new data in the multiple sclerosis space. would love to meet up with any colleagues and connections that have also traveled across the pond to attend! ec trims multiple sclerosis,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.5899697228684813,False
661,"the team is off to ec trims! you can find us at b07 in the exhibition if you want to chat about #atlasofms, #fellowships or our work to improve global access to multiple sclerosis treatments",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
662,landing in amsterdam. lets join ec trims! exciting times ahead ms #nmosd #ris,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
663,"thrilled our multiple sclerosis precision care solution featured in 13 ec trims presentations in amsterdam, oct 26-28. growing body of evidence on value for ms patients and their physicians.",13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,1.0,False
664,looking forward to attending later this week. come and visit us at booth b02 in the exhibition hall to find out about our ongoing health policy initiative ec trims ms #healthpolicy,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
665,are you attending this year? come and visit us at booth b02 in the exhibition hall to chat with our team about the latest msbh news and insights. ms ec trims,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
666,"join us at ec trims to experience ms slowly expanding lesions in 3d and via augmented reality! through our ms-link initiative, well print 3d sels created from the combination of two mri timepoints that you can see, feel, and take home. multiple sclerosis #neurology",6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.41937404587978644,False
667,"more than 8,200 ms professionals from over 108 countries around the world have signed up for ec trims, and the numbers are climbing! two days until ectrims 2022, can you feel the excitement? join us in amsterdam, or online, on 26-28 october:",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
668,we look forward to sharing our latest multiple sclerosis (ms) research at the ec trims congress. hcps: join us virtually or in amsterdam at booth #a30 in hall 10 to learn more about our new data and upcoming presentations. view the program:,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
669,ec trims the #immunic team is already looking forward to meeting the ms community this week. let's get connected and learn from one another! $imux multiple sclerosis #scientificresearch msresearch,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
670,super excited and on our way to amsterdam for the largest multiple sclerosis meeting!! world experts in ms meet & once again face to face,20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,1.0,False
671,"looks like a promising ec trims weather forecast. safe travels, everyone - looking forward to many great sessions, talks as well as 1:1 catch ups in amsterdam. #dtx #rct ms",30,30_booth_brain_like_forward,Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.,"['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['ec trims', 'ec', 'updates', 'brain', 'latest updates', 'seen', 'trims', 'neurology', 'attending', 'meet', 'thank', 'attending ec', 'nmosd', 'tomorrow', 'insights', 'looking forward', 'visit', 'ec trims congress', 'forward', 'booth']","['Neurology professionals discussing treatments and pipeline at EC Trims Congress in Amsterdam.', '', '', '', '', '', '', '', '', '']","['booth', 'brain', 'like', 'forward', 'neurology', 'seen', 'latest updates', 'needs', 'catch', 'amsterdam', 'challenges', 'attending ec', 'mogad', 'updates', 'trims congress', 'ec trims congress', 'analysis', 'tomorrow', 'thank', 'attending']","['we are with the north-european team at ec trims. please visit our booth and follow us for the latest updates on our treatments and pipeline. #sanofi #neurology ms', 'seen our eposters at ec trims yet? meet our co-authors, like thibo billiet at our booth and get the nitty gritty on #brain volume analysis in #mogad #nmosd & ms.', ""the ec trims has kicked off! please come for a 'brain break' to our booth #neurology #sanofi ms""]",booth - brain - like - forward - neurology - seen - latest updates - needs - catch - amsterdam - challenges - attending ec - mogad - updates - trims congress - ec trims congress - analysis - tomorrow - thank - attending,1.0,False
672,ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme,21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,1.0,True
673,"heading to ec trims & looking for something to listen to on your flight? check out ms diagnosis journey podcast, where real people with ms tell their dx experience. over 30 curated episodes available where you get your podcasts or",14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,1.0,False
674,the question on many of our minds leading up to : ? we want to find out what the evidence is saying and get your questions answered #remyelination multiple sclerosis,27,27_remyelination_imaging_sclerosis_multiple sclerosis,Advancements and challenges in remyelination research for Multiple Sclerosis.,"['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['remyelination', 'trims multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'updates', 'latest', 'question', 'latest updates', 'neurotwitter', 'topic', 'ec trims multiple', 'highlights', 'evidence', 'hear', 'ec trims', 'trims', 'insights', 'therapies', 'multiple', 'ec']","['Advancements and challenges in remyelination research for Multiple Sclerosis.', '', '', '', '', '', '', '', '', '']","['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['have you caught up on the latest in remyelination? with and multiple sclerosis ec trims', 'live at ec trims | cristina granziera () shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice ms #neurotwitter multiple sclerosis', 'catherine lubetzki at ec trims : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at']",remyelination - imaging - sclerosis - multiple sclerosis - multiple - latest - question - latest updates - therapeutic - practice - shares - novel - updates - leading - evidence - hear - topic - live - insights - therapies,1.0,False
675,$tgtx upcoming event october 26: 2022 european committee for treatment and research in multiple sclerosis (ectrims) annual meeting. options expiring on november 18 that cover the event have an implied move of 30.1%,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
676,$hznp upcoming event october 26: 38th congress of the european committee for treatment and research in multiple sclerosis (ectrims) 2022. options expiring on november 18 that cover the event have an implied move of 11.8%,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
677,excited for collaboration and research updates in ms #nmosd #mogad ready for ec trims #amsterdam,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
678,"ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme",21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,1.0,True
679,"we're packing up and hitting the road to ec trims! visit us at booth d26, hall 11. don't miss our panel discussion on 10/26 with leading msresearch experts, presentations, poster sessions & a cocktail reception!",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
680,how do peripheral and central drivers of inflammation affect people living with ms? we are making the connection. learn more at our symposia: multiple sclerosis ec trims #hcpsonly,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
681,"visit our booth, stand a20 in hall 10 to learn about the unmet need of addressing silent progression in ms. ms multiple sclerosis ec trims #hcpsonly",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
682,there is still time to register for the joint pre-ectrims 2022 workshop! attend in-person or online. register now using the link below! multiple sclerosis ec trims #preectrims #cme,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.8184177280472528,False
683,"only 5 days until ec trims starts! if you havent already, please fill out this survey that will help us deliver the hangout the best way possible:",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
684,"don't miss octave's ec trims precision medicine: from research to clinical practice panel discussion on oct. 26! join , , & others for a chat on precision medicine in ms & available tools. more info",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
685,less than to go until make sure you're subscribed to be the first to hear the latest updates about the in ms #chatms multiple sclerosis #remyelination,27,27_remyelination_imaging_sclerosis_multiple sclerosis,Advancements and challenges in remyelination research for Multiple Sclerosis.,"['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['remyelination', 'trims multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'updates', 'latest', 'question', 'latest updates', 'neurotwitter', 'topic', 'ec trims multiple', 'highlights', 'evidence', 'hear', 'ec trims', 'trims', 'insights', 'therapies', 'multiple', 'ec']","['Advancements and challenges in remyelination research for Multiple Sclerosis.', '', '', '', '', '', '', '', '', '']","['remyelination', 'imaging', 'sclerosis', 'multiple sclerosis', 'multiple', 'latest', 'question', 'latest updates', 'therapeutic', 'practice', 'shares', 'novel', 'updates', 'leading', 'evidence', 'hear', 'topic', 'live', 'insights', 'therapies']","['have you caught up on the latest in remyelination? with and multiple sclerosis ec trims', 'live at ec trims | cristina granziera () shares insights on all things remyelination! monitoring remyelination, therapeutic strategies, novel imaging markers of myelin repair & implementing imaging markers in daily practice ms #neurotwitter multiple sclerosis', 'catherine lubetzki at ec trims : remyelination is currently the major challenge in multiple sclerosis. luckily we have quite some expertise about this at']",remyelination - imaging - sclerosis - multiple sclerosis - multiple - latest - question - latest updates - therapeutic - practice - shares - novel - updates - leading - evidence - hear - topic - live - insights - therapies,1.0,False
686,"the countdown is on in less than a week well be at ec trims where you can expect featured presidential lectures, teaching courses, and much more! has so much to offer everyone interested in multiple sclerosis, so dont miss out! msresearch ms #neurology",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
687,do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.9722179173396351,True
688,"attending ec trims? check our abstracts on #ai-based characterization of ms clinical symptomatology using lesion parenchymal fraction; and on x-sectional & long. comparative analyses of brain volumes in mogad, nmosd & ms. see you at our booth d11!",6,6_mri_diagnosis_lesions_discussing,Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis,"['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['sclerosis ec trims', 'multiple sclerosis ec', 'multiple sclerosis', 'sclerosis ec', 'mri', 'ms', 'sclerosis', 'ms ec', 'ms ec trims', 'ec trims dr', 'dr', 'ec trims', 'brain', 'trims dr', 'diagnosis', 'ec', 'session ec', 'lesions', 'session ec trims', 'prof']","['Advancements in MRI Techniques for Accurate Diagnosis and Prognosis of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['mri', 'diagnosis', 'lesions', 'discussing', 'prof', 'ms', 'work', 'ec trims', 'trims', 'ec', 'session ec trims', 'session ec', 'sclerosis ec trims', 'sclerosis ec', 'multiple sclerosis ec', 'measures', 'ms ec trims', 'using', 'ms ec', 'trims dr']","['prof. claudio gasperini discussing the relevance of mri in establishing prognosis in multiple sclerosis ec trims ms #mri', 'prof. discussing novel promising #mri measures for ms diagnosis ec trims moving towards an early and more accurate diagnosis of ms using mri multiple sclerosis', ""jaume sastre-garriga's research focuses on mri techniques & neurorehabilitation at ec trims, we discussed the 2017 mcdonald criteria, the future of mri in ms diagnosis, & spinal cord volumetric mri to determine resilience multiple sclerosis""]",mri - diagnosis - lesions - discussing - prof - ms - work - ec trims - trims - ec - session ec trims - session ec - sclerosis ec trims - sclerosis ec - multiple sclerosis ec - measures - ms ec trims - using - ms ec - trims dr,0.4133677571568753,False
689,#brainstorm #cell #therapeutics #presents #nurown #phase 2 #progressive ms #biomarker #data at the 38th ec trims #congress $bcli,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
690,"how can digital innovations improve the treatment of ms? join us in amsterdam next week to find out. our long-term research partner dr. stefan gold will be at this year's ec trims to share new results from an international, multicenter trial investigating gaias new #dtx",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
691,we discuss our evolving understanding of multiple sclerosis and tools to detect progression early in the disease course. we also explore the role of btk pathway in ms. join us in hall 12 during our symposium on october 28 14:15-15:15 cest. ec trims #hcpsonly,21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,1.0,False
692,mark your ec trims calendar! visit us on thurs. oct. 27 during poster session 2 to learn more on octave's innovations around multivariate blood serum biomarkers for ms. poster session 2: thurs. oct. 27 | 5:007:00 p.m. cest | poster hall 9,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
693,genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into #neuromyelitisopticaspectrumdisorder at ec trims,22,22_present_ocrevus_ocrelizumab_ectrims 2022,Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.,"['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['ocrelizumab', 'ectrims 2022', 'multiple sclerosis', 'ocrevus', 'remitting ms', 'relapsing remitting ms', 'sclerosis', 'ectrims', 'ms', '2022', 'disease activity', 'oct', 'research', 'new', 'results', 'data', 'disease', 'relapsing remitting', 'multiple', 'patients']","['Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.', '', '', '', '', '', '', '', '', '']","['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -', '$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022', '$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022']",present - ocrevus - ocrelizumab - ectrims 2022 - 2022 - new - data - ectrims - research - sclerosis - multiple sclerosis - multiple - center - remitting ms - relapsing remitting ms - significant - relapsing remitting - remitting - disease activity - meeting,1.0,False
694,roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 - oct 19 2022,22,22_present_ocrevus_ocrelizumab_ectrims 2022,Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.,"['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['ocrelizumab', 'ectrims 2022', 'multiple sclerosis', 'ocrevus', 'remitting ms', 'relapsing remitting ms', 'sclerosis', 'ectrims', 'ms', '2022', 'disease activity', 'oct', 'research', 'new', 'results', 'data', 'disease', 'relapsing remitting', 'multiple', 'patients']","['Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.', '', '', '', '', '', '', '', '', '']","['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -', '$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022', '$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022']",present - ocrevus - ocrelizumab - ectrims 2022 - 2022 - new - data - ectrims - research - sclerosis - multiple sclerosis - multiple - center - remitting ms - relapsing remitting ms - significant - relapsing remitting - remitting - disease activity - meeting,1.0,False
695,"we are in the home stretch! one week remains before ec trims on 2628 oct in amsterdam. will we be seeing you there? register today to join the conversation on the latest research & developments in ms research, treatment and care sign up today",13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,0.7538004293505244,False
696,"we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,1.0,True
697,genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022,22,22_present_ocrevus_ocrelizumab_ectrims 2022,Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.,"['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['ocrelizumab', 'ectrims 2022', 'multiple sclerosis', 'ocrevus', 'remitting ms', 'relapsing remitting ms', 'sclerosis', 'ectrims', 'ms', '2022', 'disease activity', 'oct', 'research', 'new', 'results', 'data', 'disease', 'relapsing remitting', 'multiple', 'patients']","['Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.', '', '', '', '', '', '', '', '', '']","['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -', '$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022', '$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022']",present - ocrevus - ocrelizumab - ectrims 2022 - 2022 - new - data - ectrims - research - sclerosis - multiple sclerosis - multiple - center - remitting ms - relapsing remitting ms - significant - relapsing remitting - remitting - disease activity - meeting,0.5514413477636765,False
698,roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 - data will show significant benefit on slowing disease activity and progression in patients with tr...,22,22_present_ocrevus_ocrelizumab_ectrims 2022,Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.,"['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['ocrelizumab', 'ectrims 2022', 'multiple sclerosis', 'ocrevus', 'remitting ms', 'relapsing remitting ms', 'sclerosis', 'ectrims', 'ms', '2022', 'disease activity', 'oct', 'research', 'new', 'results', 'data', 'disease', 'relapsing remitting', 'multiple', 'patients']","['Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.', '', '', '', '', '', '', '', '', '']","['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -', '$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022', '$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022']",present - ocrevus - ocrelizumab - ectrims 2022 - 2022 - new - data - ectrims - research - sclerosis - multiple sclerosis - multiple - center - remitting ms - relapsing remitting ms - significant - relapsing remitting - remitting - disease activity - meeting,0.879035247414809,False
699,$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022,22,22_present_ocrevus_ocrelizumab_ectrims 2022,Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.,"['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['ocrelizumab', 'ectrims 2022', 'multiple sclerosis', 'ocrevus', 'remitting ms', 'relapsing remitting ms', 'sclerosis', 'ectrims', 'ms', '2022', 'disease activity', 'oct', 'research', 'new', 'results', 'data', 'disease', 'relapsing remitting', 'multiple', 'patients']","['Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.', '', '', '', '', '', '', '', '', '']","['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -', '$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022', '$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022']",present - ocrevus - ocrelizumab - ectrims 2022 - 2022 - new - data - ectrims - research - sclerosis - multiple sclerosis - multiple - center - remitting ms - relapsing remitting ms - significant - relapsing remitting - remitting - disease activity - meeting,1.0,True
700,genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -,22,22_present_ocrevus_ocrelizumab_ectrims 2022,Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.,"['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['ocrelizumab', 'ectrims 2022', 'multiple sclerosis', 'ocrevus', 'remitting ms', 'relapsing remitting ms', 'sclerosis', 'ectrims', 'ms', '2022', 'disease activity', 'oct', 'research', 'new', 'results', 'data', 'disease', 'relapsing remitting', 'multiple', 'patients']","['Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.', '', '', '', '', '', '', '', '', '']","['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -', '$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022', '$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022']",present - ocrevus - ocrelizumab - ectrims 2022 - 2022 - new - data - ectrims - research - sclerosis - multiple sclerosis - multiple - center - remitting ms - relapsing remitting ms - significant - relapsing remitting - remitting - disease activity - meeting,1.0,True
701,#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,1.0,True
702,$rhhby genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022,22,22_present_ocrevus_ocrelizumab_ectrims 2022,Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.,"['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['ocrelizumab', 'ectrims 2022', 'multiple sclerosis', 'ocrevus', 'remitting ms', 'relapsing remitting ms', 'sclerosis', 'ectrims', 'ms', '2022', 'disease activity', 'oct', 'research', 'new', 'results', 'data', 'disease', 'relapsing remitting', 'multiple', 'patients']","['Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.', '', '', '', '', '', '', '', '', '']","['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -', '$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022', '$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022']",present - ocrevus - ocrelizumab - ectrims 2022 - 2022 - new - data - ectrims - research - sclerosis - multiple sclerosis - multiple - center - remitting ms - relapsing remitting ms - significant - relapsing remitting - remitting - disease activity - meeting,1.0,False
703,$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022,22,22_present_ocrevus_ocrelizumab_ectrims 2022,Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.,"['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['ocrelizumab', 'ectrims 2022', 'multiple sclerosis', 'ocrevus', 'remitting ms', 'relapsing remitting ms', 'sclerosis', 'ectrims', 'ms', '2022', 'disease activity', 'oct', 'research', 'new', 'results', 'data', 'disease', 'relapsing remitting', 'multiple', 'patients']","['Genentech presents new Ocrevus data for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at ECTRIMS 2022.', '', '', '', '', '', '', '', '', '']","['present', 'ocrevus', 'ocrelizumab', 'ectrims 2022', '2022', 'new', 'data', 'ectrims', 'research', 'sclerosis', 'multiple sclerosis', 'multiple', 'center', 'remitting ms', 'relapsing remitting ms', 'significant', 'relapsing remitting', 'remitting', 'disease activity', 'meeting']","['genentech to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022 -', '$ro.sw | $rog.sw | $rhhby roche roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022', '$rhhby roche to present new ocrevus (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ectrims 2022']",present - ocrevus - ocrelizumab - ectrims 2022 - 2022 - new - data - ectrims - research - sclerosis - multiple sclerosis - multiple - center - remitting ms - relapsing remitting ms - significant - relapsing remitting - remitting - disease activity - meeting,1.0,True
704,1 week until ec trims! visit three of octave's posters on wed. oct. 26 to learn how we're transforming ms care through innovations in biomarkers & advanced imaging analytics. poster session 1: wed. oct. 26 | 4:306:30 p.m. cest | poster hall 9,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
705,"there will be an ms patient-focused event at ec trims on saturday 29th october, both in-person and online (live streamed) sign up here:",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.7950326672219078,False
706,new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch,14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,1.0,True
707,"have you heard? the new ectrims podcast is live & ready for ec trims! subscribe today on all your favourite podcast channels (spotify, apple etc) & listen to the latest insights unfolding at the world`s largest msresearch congress",14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,0.8446752892939017,False
708,ec trims | meet the speakers: agustin pappolla about his session: prediction of response in relapsing-remitting ms patients initiating oral dmts thu 27 oct 15:0016:00 cest (free communications 5: treatment) see the programme,21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,1.0,False
709,what would you like to hear about from ectrims 2022?,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
710,when viewed strictly incorrect criteria that multiple sclerosis theory is causative mysterious elusive autoimmune response of unknown origin.mri results show plaques development which can be treated indefinitely w/ neurology often harsh corrosive sometimes deadly drugs. ccs vi,4,4_dmt_dmts_disease_treated,Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.,"['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['ms patients', 'dmts', 'ms', 'ec trims ms', 'trims ms', 'dmt', 'therapies', 'treatment', 'patient', 'efficacy', 'treated', 'ec trims', 'mri', 'disease activity', 'patients', 'trials', 'results', 'symptoms', 'ec', 'trims']","['Personalized treatment strategies for Multiple Sclerosis focusing on DMT types and dosage.', '', '', '', '', '', '', '', '', '']","['dmt', 'dmts', 'disease', 'treated', 'efficacy', 'symptoms', 'inflammatory', 'ms', 'patients', 'therapies', 'treatment', 'high', 'trials', 'patient', 'trims ms', 'ec trims ms', 'ms patients', 'weeks', 'needed', 'just']","['drs. alan thompson and bianca weinstock-guttman: there is no ""right age to stop dmt in ms. must consider comorbidities, mri, disease stability and patient preference. ec trims', 'dmt discontinuation in multiple sclerosis - ectrims 2022 data: chappuis et al : 49 patients >45 y treated with high/moderate-efficacy dmt: relapse risk in the year after discontinuation 6% if on moderate-efficacy dmts, 9% if on fingolimod and 43% if on natalizumab (ep1163) 1/1', 'this is a very important trial as for ms patients with silent progression (inflammatory inactive disease, either treated with dmt or not, but who show clinical disability progression), currently no therapies are available.']",dmt - dmts - disease - treated - efficacy - symptoms - inflammatory - ms - patients - therapies - treatment - high - trials - patient - trims ms - ec trims ms - ms patients - weeks - needed - just,0.9111372963184593,False
711,my initial thoughts on ectrims 2022 and the return of the round up!,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
712,"join us at ec trims on october 26-28 in amsterdam, the netherlands, to hear mitzi williams, gavin giovannoni, and alexandra goodyear present key ocrevus data. please see full prescribing information at . intended for us healthcare professionals only.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
713,"heading to ? we look forward to connecting with you, oct 26-28! visit us at booth d26 in hall 11. learn more about octave's ectrims activities & mark your calendars: ec trims msresearch #neurodegenerativediseases",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
714,"we're thrilled to share that ocrevus data will be presented at the ec trims conference in amsterdam, the netherlands, from october 26-28. please see full prescribing info at . intended for us healthcare professionals only. how will you attend this year?",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
715,"next week, we will be in #amsterdam attending the 2022 congress. we can't wait to bring you all of the latest updates on multiple sclerosis research. stay tuned to all of our channels for a number of special features we will be releasing from the meeting. ec trims",20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,1.0,False
716,the ec trims 38th annual congress will be hosted in amsterdam for the first time in 11 years! 26th-28th october will join live to learn all about the exciting new discoveries in msresearch from leading professionals ms #neurology #neurotwitter,20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,0.952568216257632,False
717,dont be an umpalumpa when it comes to s1ps ectrims 2022.,14,14_listen_day ec_day ec trims_day,Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors,"['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","['day ec trims', 'ectrims', 'ec trims', 'day ec', 'ec', 'discuss', 'trims', 'highlights', 'msresearch', 'dr', 'remyelination', 'new', 'listen', 'live', 'key', 'interesting', 'supporting', 'opportunities', 'day', 'interventions']","['Ec Trims Podcast Discussion on Multiple Sclerosis Research and Lifestyle Factors', '', '', '', '', '', '', '', '', '']","['listen', 'day ec', 'day ec trims', 'day', 'available', 'key', 'live', 'highlights', 'largest', 'ectrims', 'interesting', 'including', 'msresearch', 'discuss', 'remyelination', 'ec', 'world', 'dr', 'trims', 'ec trims']","[""new! tune in next week for the debut of the official ec trimspodcast. enjoy three back-to-back episodes of each day of ec trims & stay up to date on all the key happenings unfolding at the world's largest international congress for msresearch"", 'listen to , chief advocacy, services & science officer at the national ms society, discuss highlights from day two of ec trims, including lifestyle, well-being and progressive ms. listen here to the ec trimspodcast: .', 'our reflections on day 2 of ec trims are now available. our co-founder, brett drummond, & ceo, dr travis stiles, discuss lifestyle interventions, remyelination, progressive multiple sclerosis & more. tweet us your highlights. ms']",listen - day ec - day ec trims - day - available - key - live - highlights - largest - ectrims - interesting - including - msresearch - discuss - remyelination - ec - world - dr - trims - ec trims,0.594741913663398,False
718,how can we target the pathologic cns immune cell response for people living with multiple sclerosis? to find out more visit hall 12 for our gma symposium connecting the dots: immune cells and cns inflammation on october 26 13:15-14:15 cest. ec trims #hcpsonly,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
719,"less than 10 days to go - looking forward to joining ec trims in person in amsterdam, hearing and discussing latest news and scientific results in ms. feel free to dm me for 1:1 on #digitaltherapeutics in ms, research ideas - or simply a coffee chat. #rct #dtx #diga",13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,0.596080008054379,False
720,we are attending conference 2022 we'll be bringing about the research that will to your life with ms. make sure you're subscribed so you don't miss anything multiple sclerosis,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
721,ec trims is showcasing the work of talented ms researchers in a series of three young scientific investigators sessions. make sure to add these to your ectrims 2022 personal programme:,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
722,vote now: i'm looking forward to following coverage of the upcoming ec trims congress (october 26-28) and hearing all of the latest developments in multiple sclerosis research.,20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,0.8907578243066238,False
723,ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme,21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,1.0,True
724,"we are supporting an ms researcher to visit the conference in amsterdam this month! if you need financial help to attend ms-specific conferences, our #bursary can help. get in touch today: multiple sclerosis msresearch",20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,1.0,False
725,"neuromyelitis optica spectrum disorder is often compared with multiple sclerosis. whilst there are similarities, there are important differences. watch the animations here: ec trims #nmosd multiple sclerosis",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,1.0,False
726,"octave is excited to sponsor #precisionmedicine: from research to clinical practice panel discussion at ec trims! you won't want to miss this event with , , & on the future of msresearch & care. more info",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
727,"good news! the wait for the ec trims abstract book is finally over. from oral presentations to posters, enjoy a peak into all the publications this year's congress has to offer msresearch msjournal ms",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
728,new article: ectrims 2022 committees ms multiple sclerosis #neurology,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.9557579011726928,False
729,"#ultomiris for #nmosd - #astrazeneca announced that the results were exceptional; after a median treatment duration of 73 weeks, there were zero relapses #pharma #pharmaceutical #globalhealth ec trims22 ec trims multiple sclerosis #news #media",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.8975231905305374,False
730,ec trims: b-cell depletion and return in participant subgroups of the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis $tgtx,12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,False
731,"ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx",12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,0.9487467281525154,True
732,"multiple sclerosis is an irreversible, neurological condition that may deteriorate the nerves in both the grey and white matter of the brain. join us at ec trims to see how were exploring potential solutions for people living with ms.",24,24_disease progression_late_onset_sclerosis news today,Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair,"['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['multiple sclerosis news', 'multiple sclerosis msnews', 'sclerosis msnews', 'sclerosis news', 'remyelination', 'multiple sclerosis', 'msresearch ec trims', 'sclerosis news today', 'sclerosis', 'today ec trims', 'msnews', 'msresearch', 'disease progression', 'new research', 'onset', 'today ec', 'cis', 'disease', 'multiple', 'progression']","['Late-Onset Multiple Sclerosis Disease Progression and Myelin Repair', '', '', '', '', '', '', '', '', '']","['disease progression', 'late', 'onset', 'sclerosis news today', 'news today', 'multiple sclerosis news', 'sclerosis news', 'progression', 'news', 'msnews', 'disease', 'today ec trims', 'today ec', 'later', 'cis', 'life', 'suggests', 'effective', 'sclerosis msnews', 'multiple sclerosis msnews']","['audio news price wooldridge discusses a study that shows how new myelin production may be less efficient in late-onset ms patients, which could underlie more severe disease progression. he also reads a column from ed tobias. msnews ec trims ms', 'ec trims - new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression. multiple sclerosis msnews msawareness msresearch', 'ec trims poor myelin repair offers clues in disease progression | patients with late-onset ms have fewer myelin-making cells | multiple sclerosis news today']",disease progression - late - onset - sclerosis news today - news today - multiple sclerosis news - sclerosis news - progression - news - msnews - disease - today ec trims - today ec - later - cis - life - suggests - effective - sclerosis msnews - multiple sclerosis msnews,0.9881025581510711,False
733,"damage caused by multiple sclerosis can disrupt communication between the brain and the rest of the body. at ec trims, well discuss our work to address the needs of people living with ms.",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
734,"like matt, people living with multiple sclerosis can face daily challenges. we aim to empower individuals with ms to take back control of their lives. ec trims",10,10_people ms_ms_patient_need,Patient Involvement in MS Research and Care,"['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","['ms patients', 'living ms', 'living multiple sclerosis', 'people ms', 'ms', 'patient', 'patients', 'community', 'living multiple', 'people', 'ec trims', 'ec trims great', 'ec', 'care', 'looking forward', 'needed', 'need', 'trims', 'research', 'center']","['Patient Involvement in MS Research and Care', '', '', '', '', '', '', '', '', '']","['people ms', 'ms', 'patient', 'need', 'research', 'people', 'community', 'great', 'looking', 'center', 'living', 'morning', 'ms patients', 'ec trims great', 'needed', 'trims great', 'face', 'looking forward', 'care', 'living multiple']","[""join emsp's interim ceo, jana hlavacova, tomorrow as she joins efforts to highlight the patient experience! people with ms should be at the center of services, support, care, and research ec trims"", ""'s interim ceo proudly wrapping up sessions by highlighting the indispensable & central role people with ms have in research! more patient engagement and involvement is needed | people with ms need to be the center in every step ec trims"", 'good morning ms community! looking forward to day 2 ec trims. great sessions. whats been impactful for you to improve the future care of people living with ms?']",people ms - ms - patient - need - research - people - community - great - looking - center - living - morning - ms patients - ec trims great - needed - trims great - face - looking forward - care - living multiple,0.985915673962675,False
735,"during ec trims, learn how were committed to delivering meaningful, scientific innovations to address unmet needs for patients living with multiple sclerosis.",1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,0.6927883645285131,False
736,"ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx",12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,True
737,"ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx",12,12_phase_relapsing_participants_significant,Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis,"['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['progressive ms', 'ms multiple sclerosis', 'multiple sclerosis', 'ms multiple', 'sclerosis', 'ectrims 2022', 'ectrims', 'participants', 'ms ec', 'ms ec trims', 'pathway', 'disability', 'multiple', 'clinical', 'face', 'treatment', 'relapses', '2022', 'significant', 'disease']","['Efficacy of Ublituximab in Treating Relapsing Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['phase', 'relapsing', 'participants', 'significant', 'disability', 'ms multiple sclerosis', 'ms multiple', 'multiple', 'ectrims', 'multiple sclerosis', 'sclerosis', 'face', '2022', 'progressive ms', 'ectrims 2022', 'patients', 'relapses', 'therapy', 'trial', 'disease']","['ec trims: functional systems scores and expanded disability status scale score evaluations in the ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""... significant improvements in edss score and multiple fss"" $tgtx', 'ectrims: disease outcomes with ublituximab in treatment-naive participants: subpopulation analyses of the phase 3 ultimate i and ii studies in participants with relapsing multiple sclerosis conclusions: ""... with significant treatment benefit..."" $tgtx', 'ectrims: disability changes in the absence of relapse in the phase 3 ultimate i and ii studies of ublituximab versus teriflunomide in participants with relapsing multiple sclerosis ""...with significant improvement versus teriflunomide"" $tgtx']",phase - relapsing - participants - significant - disability - ms multiple sclerosis - ms multiple - multiple - ectrims - multiple sclerosis - sclerosis - face - 2022 - progressive ms - ectrims 2022 - patients - relapses - therapy - trial - disease,1.0,True
738,we are thrilled to announce that ec trims has been accredited by the european accreditation council for continuing medical education (eaccme) with 18 european #cmecredits. join us this october 26-28 for the world's largest msresearch congress:,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
739,"ec trims: abstracts are live! $tgtx will have five poster presentations, highlighting data from the phase 3 ultimate i & ii clinical trials. read more: visit our booth-d30 multiple sclerosis #fearlessforpatients",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
740,"the countdown is on! two weeks to go before ec trims on 2628 oct in amsterdam. will we be seeing you there? register today to join the conversation on the latest research & developments in msresearch, treatment & care msconnections ms",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
741,"with nearly one million people in the u.s. living with multiple sclerosis, were proud to be attending ec trims on 26-28 october in amsterdam, where we will have the opportunity to discuss the latest innovations in ms diagnosis and treatment options:",13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,1.0,False
742,news: new data for our neuromyelitis optica spectrum disorder (#nmosd) medicine will be presented at the 38th congress of the european committee for treatment and research in multiple sclerosis (): learn more: . ec trims,1,1_nmosd_data_multiple sclerosis_sclerosis,Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims,"['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['multiple sclerosis ms', 'sclerosis ms', 'multiple sclerosis', 'ec trims', 'new data', 'sclerosis', 'trims', 'nmosd', 'ec', 'latest', 'news', 'research', 'data', 'new', 'read', 'sharing', 'outcomes', 'brain', 'learn', 'breaking']","['Comparing Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: New Data and Research Presented at EC Trims', '', '', '', '', '', '', '', '', '']","['nmosd', 'data', 'multiple sclerosis', 'sclerosis', 'multiple', 'watch', 'multiple sclerosis ms', 'sclerosis ms', 'learn', 'outcomes', 'new data', 'news', 'ec', 'improve', 'trims', 'ec trims', 'understanding', 'proud', 'clinical', 'latest']","['we are proud to announce new data to be presented at ec trims on disease activity and progression in patients with early-stage relapsing remitting multiple sclerosis, and new research on misdiagnosis and delayed treatment in #nmosd: $rhhby $rog', 'do you know the differences between neuromyelitis optica spectrum disorder and multiple sclerosis? follow nadas journey as she discovers the differences between the two disorders ec trims #nmosd multiple sclerosis', '#breaking: were presenting new data at ec trims that further advance the scientific understanding of multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (#nmosd). learn more:']",nmosd - data - multiple sclerosis - sclerosis - multiple - watch - multiple sclerosis ms - sclerosis ms - learn - outcomes - new data - news - ec - improve - trims - ec trims - understanding - proud - clinical - latest,1.0,False
743,its only 3 weeks until ec trims did you know it is the worlds largest conference devoted to basic and clinical research & care in ms?! cant wait to catch up with the presenters & share all of their latest work on,-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
744,how is our evolving understanding of centrally driven multiple sclerosis pathology shaping patient management? we explore this question with our sponsored activities at the 38th annual ectrims hosted in amsterdam from 26-28 october 2022. ec trims #hcpsonly,2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.8607350322661317,False
745,"breaking news: ec trims has been accredited with 18 european #cmecredits by the european accreditation council for continuing medical education! register now for three exciting days in the latest updates in ms research, treatment and care:",-1,-1_ec_ec trims_trims_ms,Advancements and risks in Multiple Sclerosis research and treatments.,"['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['ec trims', 'msnews', 'ms', 'ec', 'multiple sclerosis', 'msresearch', 'sclerosis', 'trims', 'news', 'dr', 'people', 'conference', 'multiple', 'treatment', 'care', 'session', 'research', 'visit', 'disease', 'team']","['Advancements and risks in Multiple Sclerosis research and treatments.', '', '', '', '', '', '', '', '', '']","['ec', 'ec trims', 'trims', 'ms', 'sclerosis', 'multiple sclerosis', 'multiple', 'people', 'msresearch', 'session', 'research', 'come', 'risk', 'dr', 'team', 'visit', 'day', 'booth', 'disease', 'conference']","['long-term use of the investigational btk inhibitor evobrutinib among people with relapsing forms of ms maintained disease stability for up to three and half years. multiple sclerosis msnews msawareness msresearch ec trims', 'exposure to high-efficacy dmts has been linked to a higher risk of cervical abnormalities in women with ms, although additional studies are needed to further substantiate this relationship. multiple sclerosis msnews msawareness msresearch ec trims', 'ms #pregnancy ec trims']",ec - ec trims - trims - ms - sclerosis - multiple sclerosis - multiple - people - msresearch - session - research - come - risk - dr - team - visit - day - booth - disease - conference,0.0,False
746,forest bathing for multiple sclerosis patients. best practice from denmark ec trims #sclerosehospital multiple sclerosis,7,7_rehabilitation_cognitive_sclerosis ec trims_multiple sclerosis ec,"Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['multiple sclerosis ec', 'sclerosis ec trims', 'people multiple sclerosis', 'multiple sclerosis', 'sclerosis ec', 'sclerosis', 'presented ec', 'dr', 'discussing', 'presented ec trims', 'rehabilitation', 'presented', 'people', 'ec trims great', 'ec trims', 'talk', 'research', 'session', 'cognition', 'ec']","['Rehabilitation strategies for improving cognitive function and employment opportunities in individuals with Multiple Sclerosis, as discussed by EC Trims.', '', '', '', '', '', '', '', '', '']","['rehabilitation', 'cognitive', 'sclerosis ec trims', 'multiple sclerosis ec', 'sclerosis ec', 'talk', 'people multiple sclerosis', 'people multiple', 'people', 'multiple sclerosis', 'sclerosis', 'multiple', 'cognition', 'dr', 'great', 'ec trims', 'trims', 'effects', 'ec', 'presented']","['our from nottingham ms research group giving a talk about optimising employment and preventing job loss in people with multiple sclerosis ec trims', 'poster 777 #memory #rehabilitation for people with multiple sclerosis ec trims', '*you don\'t realise that you still have value until somebody tells you"". such an insightful and informative presentation on vocational rehabilitation for people with multiple sclerosis by ec trims']",rehabilitation - cognitive - sclerosis ec trims - multiple sclerosis ec - sclerosis ec - talk - people multiple sclerosis - people multiple - people - multiple sclerosis - sclerosis - multiple - cognition - dr - great - ec trims - trims - effects - ec - presented,0.8117560124237875,False
747,"and don't miss out on wednesday, 12 october 2022 from 5 to 6 p.m. the virtual 60 minutes presentation of our international and english-speaking master's programme ""charcot multiple sclerosis management master of science"" ec trims",2,2_ectrims_2022_ectrims 2022_management,ECTRIMS 2022: Latest MS Research and Patient Experience Updates,"['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['ectrims 2022', 'living ms', 'multiple sclerosis', 'ectrims', 'ms', 'ms clinical', 'sclerosis', 'people living ms', '2022', 'conference', 'latest', 'presentation', 'multiple', 'people', 'watch', 'community', 'today', 'october', 'patient', 'science']","['ECTRIMS 2022: Latest MS Research and Patient Experience Updates', '', '', '', '', '', '', '', '', '']","['ectrims', '2022', 'ectrims 2022', 'management', 'ms', 'patient', 'people living ms', 'living ms', 'october', 'people living', 'phd', 'join', 'living', 'watch', 'presentation', 'community', 'today', 'congress', 'sessions', 'latest']","['this year ectrims is ensuring the latest ms research unveiled at our congress reaches the entire ms community. the ectrims 2022: for people with ms event is now available for viewing in english, dutch, french, german, italian & spanish. watch it now', 'an invitation for all people living with ms join us today for ""ectrims 2022: for people living with ms"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event', 'an invitation for all people living with ms join us this sat 29 oct for ""ectrims 2022: the patient experience"" in amsterdam at the rai & online, where ms experts will breakdown the latest insight from ec trims register now for this free event']",ectrims - 2022 - ectrims 2022 - management - ms - patient - people living ms - living ms - october - people living - phd - join - living - watch - presentation - community - today - congress - sessions - latest,0.9821497606423976,False
748,ec trims | meet the speakers: from talks about electronic health interventions in ms fri 28 oct 10:0011:30 cest (scientific session 14: e-health) view the full scientific programme,21,21_15_hot topic_topic_programme,Advancing Understanding and Treatment of Multiple Sclerosis,"['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ms', 'topic', 'ec trims', 'ec', 'dmts', 'pathway', 'scientific', 'oct', 'hot topic', 'trims', 'session', 'disease', 'immune', 'programme', 'meet', 'clinical', '10', 'therapeutic', 'health', 'progression']","['Advancing Understanding and Treatment of Multiple Sclerosis', '', '', '', '', '', '', '', '', '']","['15', 'hot topic', 'topic', 'programme', 'hot', '10', '12', 'oct', 'session', 'scientific', '28', 'meet', 'progression', 'role', 'immune', 'disease', 'hall', 'dmts', 'october', 'ms']","['ec trims | hot topic 5 is about the escalation and de-escalation of ms treatments in specific situations thur 27 oct 10:0011:00 (hot topic 5: escalating & de-escalating dmts) review the full scientific programme', 'ec trims | hot topic 10 will explore new avenues to exploit lipid mediators as novel diagnostic & therapeutic opportunities for ms fri 28 oct 12:0013:00 (hot topic 10: emerging role of lipids in ms) full programme', 'ec trims | meet the speakers: talks about his session on the progression of ms lesions. fri, 28 oct, 12:0013:00 cest (hot topic 10: emerging role of lipids in ms) full scientific programme']",15 - hot topic - topic - programme - hot - 10 - 12 - oct - session - scientific - 28 - meet - progression - role - immune - disease - hall - dmts - october - ms,0.8525629866369191,False
749,it is only three weeks until our team travel to amsterdam to attend the 38th congress . book a time with us to learn how symri is useful in the management of ms patients. #mri #symri #quantitativemri #patientexperience ms multiple sclerosis,20,20_congress_amsterdam_research multiple sclerosis_treatment research multiple,"38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['research multiple sclerosis', 'multiple sclerosis', 'sclerosis', 'conference', 'european committee treatment', 'european committee', 'european', '2022', 'meeting', 'participants', 'meet', 'neurotwitter', 'treatment research multiple', 'amsterdam', 'committee treatment research', 'treatment research', 'research multiple', 'congress', '26', 'october']","['38th European Committee Congress on Multiple Sclerosis Research & Treatment in Amsterdam, October 2022', '', '', '', '', '', '', '', '', '']","['congress', 'amsterdam', 'research multiple sclerosis', 'treatment research multiple', 'research multiple', 'european committee treatment', 'committee treatment research', 'european committee', 'committee treatment', 'committee', 'treatment research', 'european', 'october', '28', '26 28', '2022', 'research', '26', 'multiple sclerosis', 'sclerosis']","['we are at the 38th congress of the european committee for treatment and research in multiple sclerosis taking place right now in amsterdam! swing by our booth (b24) and say hello we will be here until tomorrow, oct 28. see you soon! ec trims ms', 'motomed at ectrims 2022 the 38th congress of the european committee for treatment and research in multiple sclerosis will take place from october 26 to 28 in amsterdam. three days with a diverse scientific program, motomed will accompany the congress with an exhibition booth.', '26 28 october 2022 amsterdam, the netherlands 38th congress of the european committee for treatment and research in multiple sclerosis #amsterdam ec trims']",congress - amsterdam - research multiple sclerosis - treatment research multiple - research multiple - european committee treatment - committee treatment research - european committee - committee treatment - committee - treatment research - european - october - 28 - 26 28 - 2022 - research - 26 - multiple sclerosis - sclerosis,1.0,False
750,ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more,13,13_amsterdam_latest_research_15,Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam,"['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['ms research', 'ms', 'day ec trims', 'ec trims', 'ec', 'day ec', 'latest', 'discuss', 'neurology', 'trims', 'looking forward', 'oct', 'attending ec', 'week', 'meet', 'amsterdam', 'attending', 'hear', 'forward', 'treatment']","['Advancements in Multiple Sclerosis Research: A Discussion at EC Trims in Amsterdam', '', '', '', '', '', '', '', '', '']","['amsterdam', 'latest', 'research', '15', '26 28', 'looking forward', 'day', 'day ec trims', 'day ec', 'looking', '28', 'forward', '26', 'oct', 'join', 'attending ec', 'ec trims', 'trims', 'ec', 'attending']","['were pleased to be in amsterdam this week at ec trims! were ready to tackle the latest in multiple sclerosis research and innovation. drop by our booth #d07:', 'we are at ec trims in amsterdam to be updated about the latest research in ms! looking forward to meet you at our booth and at the congress. ec trims #neurology ms', 'ms is a disease that often occurs in women of childbearing age. join us at ec trims on 26-28 oct in amsterdam to hear about and discuss the latest research on treatment options. see the fully searchable programme for more']",amsterdam - latest - research - 15 - 26 28 - looking forward - day - day ec trims - day ec - looking - 28 - forward - 26 - oct - join - attending ec - ec trims - trims - ec - attending,0.9804710225949741,True
